id	sid	tid	token	lemma	pos
bptjm-21	1	1	abstract	abstract	ADJ
bptjm-21	1	2	activation	activation	NOUN
bptjm-21	1	3	induced	induce	VERB
bptjm-21	1	4	cytidine	cytidine	NOUN
bptjm-21	1	5	deaminase	deaminase	NOUN
bptjm-21	1	6	(	(	PUNCT
bptjm-21	1	7	aid	aid	NOUN
bptjm-21	1	8	)	)	PUNCT
bptjm-21	1	9	is	be	AUX
bptjm-21	1	10	an	an	DET
bptjm-21	1	11	important	important	ADJ
bptjm-21	1	12	enzyme	enzyme	NOUN
bptjm-21	1	13	that	that	PRON
bptjm-21	1	14	creates	create	VERB
bptjm-21	1	15	mutations	mutation	NOUN
bptjm-21	1	16	in	in	ADP
bptjm-21	1	17	dna	dna	PROPN
bptjm-21	1	18	via	via	ADP
bptjm-21	1	19	deamination	deamination	NOUN
bptjm-21	1	20	of	of	ADP
bptjm-21	1	21	a	a	DET
bptjm-21	1	22	cytosine	cytosine	NOUN
bptjm-21	1	23	base	base	NOUN
bptjm-21	1	24	into	into	ADP
bptjm-21	1	25	a	a	DET
bptjm-21	1	26	uracil	uracil	NOUN
bptjm-21	1	27	.	.	PUNCT
bptjm-21	1	28	aid	aid	PROPN
bptjm-21	1	29	,	,	PUNCT
bptjm-21	1	30	also	also	ADV
bptjm-21	1	31	referred	refer	VERB
bptjm-21	1	32	to	to	ADP
bptjm-21	1	33	as	as	ADP
bptjm-21	1	34	activation	activation	NOUN
bptjm-21	1	35	induced	induce	VERB
bptjm-21	1	36	deaminase	deaminase	NOUN
bptjm-21	1	37	(	(	PUNCT
bptjm-21	1	38	aicda	aicda	PROPN
bptjm-21	1	39	)	)	PUNCT
bptjm-21	1	40	,	,	PUNCT
bptjm-21	1	41	plays	play	VERB
bptjm-21	1	42	a	a	DET
bptjm-21	1	43	crucial	crucial	ADJ
bptjm-21	1	44	part	part	NOUN
bptjm-21	1	45	in	in	ADP
bptjm-21	1	46	the	the	DET
bptjm-21	1	47	human	human	ADJ
bptjm-21	1	48	immune	immune	ADJ
bptjm-21	1	49	response	response	NOUN
bptjm-21	1	50	as	as	SCONJ
bptjm-21	1	51	it	it	PRON
bptjm-21	1	52	is	be	AUX
bptjm-21	1	53	essential	essential	ADJ
bptjm-21	1	54	for	for	ADP
bptjm-21	1	55	isotype	isotype	NOUN
bptjm-21	1	56	switching	switching	NOUN
bptjm-21	1	57	and	and	CCONJ
bptjm-21	1	58	cellular	cellular	ADJ
bptjm-21	1	59	differentiation	differentiation	NOUN
bptjm-21	1	60	.	.	PUNCT
bptjm-21	2	1	however	however	ADV
bptjm-21	2	2	,	,	PUNCT
bptjm-21	2	3	aberrant	aberrant	ADJ
bptjm-21	2	4	expressions	expression	NOUN
bptjm-21	2	5	in	in	ADP
bptjm-21	2	6	some	some	DET
bptjm-21	2	7	pathways	pathway	NOUN
bptjm-21	2	8	has	have	AUX
bptjm-21	2	9	been	be	AUX
bptjm-21	2	10	implicated	implicate	VERB
bptjm-21	2	11	in	in	ADP
bptjm-21	2	12	a	a	DET
bptjm-21	2	13	plethora	plethora	NOUN
bptjm-21	2	14	of	of	ADP
bptjm-21	2	15	diseases	disease	NOUN
bptjm-21	2	16	.	.	PUNCT
bptjm-21	3	1	there	there	PRON
bptjm-21	3	2	is	be	VERB
bptjm-21	3	3	a	a	DET
bptjm-21	3	4	pressing	press	VERB
bptjm-21	3	5	need	need	NOUN
bptjm-21	3	6	for	for	ADP
bptjm-21	3	7	research	research	NOUN
bptjm-21	3	8	and	and	CCONJ
bptjm-21	3	9	comparison	comparison	NOUN
bptjm-21	3	10	of	of	ADP
bptjm-21	3	11	current	current	ADJ
bptjm-21	3	12	literature	literature	NOUN
bptjm-21	3	13	that	that	PRON
bptjm-21	3	14	informs	inform	VERB
bptjm-21	3	15	related	related	ADJ
bptjm-21	3	16	therapies	therapy	NOUN
bptjm-21	3	17	.	.	PUNCT
bptjm-21	4	1	previous	previous	ADJ
bptjm-21	4	2	studies	study	NOUN
bptjm-21	4	3	have	have	AUX
bptjm-21	4	4	explored	explore	VERB
bptjm-21	4	5	potential	potential	ADJ
bptjm-21	4	6	mechanisms	mechanism	NOUN
bptjm-21	4	7	by	by	ADP
bptjm-21	4	8	which	which	PRON
bptjm-21	4	9	aid	aid	NOUN
bptjm-21	4	10	works	work	VERB
bptjm-21	4	11	and	and	CCONJ
bptjm-21	4	12	subsequently	subsequently	ADJ
bptjm-21	4	13	ways	way	NOUN
bptjm-21	4	14	to	to	PART
bptjm-21	4	15	target	target	VERB
bptjm-21	4	16	gene	gene	NOUN
bptjm-21	4	17	therapies	therapy	NOUN
bptjm-21	4	18	based	base	VERB
bptjm-21	4	19	on	on	ADP
bptjm-21	4	20	this	this	DET
bptjm-21	4	21	information	information	NOUN
bptjm-21	4	22	.	.	PUNCT
bptjm-21	5	1	due	due	ADP
bptjm-21	5	2	to	to	ADP
bptjm-21	5	3	aid	aid	VERB
bptjm-21	5	4	’s	’s	PART
bptjm-21	5	5	complexity	complexity	NOUN
bptjm-21	5	6	,	,	PUNCT
bptjm-21	5	7	there	there	PRON
bptjm-21	5	8	have	have	AUX
bptjm-21	5	9	been	be	AUX
bptjm-21	5	10	many	many	ADJ
bptjm-21	5	11	challenges	challenge	NOUN
bptjm-21	5	12	along	along	ADP
bptjm-21	5	13	the	the	DET
bptjm-21	5	14	path	path	NOUN
bptjm-21	5	15	that	that	PRON
bptjm-21	5	16	led	lead	VERB
bptjm-21	5	17	to	to	ADP
bptjm-21	5	18	our	our	PRON
bptjm-21	5	19	current	current	ADJ
bptjm-21	5	20	understanding	understanding	NOUN
bptjm-21	5	21	of	of	ADP
bptjm-21	5	22	the	the	DET
bptjm-21	5	23	beneficial	beneficial	ADJ
bptjm-21	5	24	and	and	CCONJ
bptjm-21	5	25	harmful	harmful	ADJ
bptjm-21	5	26	nature	nature	NOUN
bptjm-21	5	27	of	of	ADP
bptjm-21	5	28	aid	aid	NOUN
bptjm-21	5	29	.	.	PUNCT
bptjm-21	6	1	furthermore	furthermore	ADV
bptjm-21	6	2	,	,	PUNCT
bptjm-21	6	3	a	a	DET
bptjm-21	6	4	better	well	ADJ
bptjm-21	6	5	understanding	understanding	NOUN
bptjm-21	6	6	of	of	ADP
bptjm-21	6	7	the	the	DET
bptjm-21	6	8	way	way	NOUN
bptjm-21	6	9	aid	aid	NOUN
bptjm-21	6	10	works	work	NOUN
bptjm-21	6	11	can	can	AUX
bptjm-21	6	12	aid	aid	VERB
bptjm-21	6	13	with	with	ADP
bptjm-21	6	14	the	the	DET
bptjm-21	6	15	development	development	NOUN
bptjm-21	6	16	of	of	ADP
bptjm-21	6	17	more	more	ADV
bptjm-21	6	18	efficacious	efficacious	ADJ
bptjm-21	6	19	therapies	therapy	NOUN
bptjm-21	6	20	.	.	PUNCT
bptjm-21	7	1	although	although	SCONJ
bptjm-21	7	2	further	further	ADJ
bptjm-21	7	3	research	research	NOUN
bptjm-21	7	4	on	on	ADP
bptjm-21	7	5	the	the	DET
bptjm-21	7	6	topic	topic	NOUN
bptjm-21	7	7	and	and	CCONJ
bptjm-21	7	8	additional	additional	ADJ
bptjm-21	7	9	testing	testing	NOUN
bptjm-21	7	10	in	in	ADP
bptjm-21	7	11	humans	human	NOUN
bptjm-21	7	12	and	and	CCONJ
bptjm-21	7	13	animal	animal	NOUN
bptjm-21	7	14	models	model	NOUN
bptjm-21	7	15	are	be	AUX
bptjm-21	7	16	needed	need	VERB
bptjm-21	7	17	,	,	PUNCT
bptjm-21	7	18	it	it	PRON
bptjm-21	7	19	is	be	AUX
bptjm-21	7	20	clear	clear	ADJ
bptjm-21	7	21	that	that	SCONJ
bptjm-21	7	22	aid	aid	NOUN
bptjm-21	7	23	may	may	AUX
bptjm-21	7	24	play	play	VERB
bptjm-21	7	25	an	an	DET
bptjm-21	7	26	important	important	ADJ
bptjm-21	7	27	role	role	NOUN
bptjm-21	7	28	in	in	ADP
bptjm-21	7	29	the	the	DET
bptjm-21	7	30	development	development	NOUN
bptjm-21	7	31	of	of	ADP
bptjm-21	7	32	therapeutic	therapeutic	ADJ
bptjm-21	7	33	treatments	treatment	NOUN
bptjm-21	7	34	in	in	ADP
bptjm-21	7	35	diseases	disease	NOUN
bptjm-21	7	36	like	like	ADP
bptjm-21	7	37	cancer	cancer	NOUN
bptjm-21	7	38	,	,	PUNCT
bptjm-21	7	39	lupus	lupus	NOUN
bptjm-21	7	40	,	,	PUNCT
bptjm-21	7	41	and	and	CCONJ
bptjm-21	7	42	type	type	NOUN
bptjm-21	7	43	1	1	NUM
bptjm-21	7	44	diabetes	diabetes	NOUN
bptjm-21	7	45	.	.	PUNCT
bptjm-21	8	1	"	"	PUNCT
bptjm-21	8	2	dujwbujpo	dujwbujpo	PROPN
bptjm-21	8	3	�	�	PROPN
bptjm-21	8	4	*oevdfe	*oevdfe	PROPN
bptjm-21	8	5	�	�	PROPN
bptjm-21	8	6	%fbnjobtf	%fbnjobtf	PROPN
bptjm-21	8	7	�	�	PROPN
bptjm-21	8	8	boe	boe	PROPN
bptjm-21	8	9	�	�	PROPN
bptjm-21	8	10	1pufoujbm	1pufoujbm	NUM
bptjm-21	8	11	�	�	PROPN
bptjm-21	8	12	5ifsbqfvujd	5ifsbqfvujd	NUM
bptjm-21	8	13	�	�	NOUN
bptjm-21	8	14	"wfovft	"wfovft	NOUN
bptjm-21	8	15	�	�	PROPN
bptjm-21	8	16	ïw	ïw	PROPN
bptjm-21	8	17	�	�	PROPN
bptjm-21	8	18	¦	¦	PROPN
bptjm-21	8	19	×ýú×	×ýú×	PROPN
bptjm-21	8	20	�	�	PROPN
bptjm-21	8	21	°	°	ADJ
bptjm-21	8	22	åàê×è×	åàê×è×	NOUN
bptjm-21	8	23	berkeley	berkeley	PROPN
bptjm-21	8	24	pharma	pharma	PROPN
bptjm-21	8	25	tech	tech	NOUN
bptjm-21	8	26	journal	journal	NOUN
bptjm-21	8	27	of	of	ADP
bptjm-21	8	28	medicine	medicine	NOUN
bptjm-21	8	29	correspondence	correspondence	NOUN
bptjm-21	8	30	:	:	PUNCT
bptjm-21	8	31	�	�	PROPN
bptjm-21	8	32	�	�	PROPN
bptjm-21	8	33	xpkubsbn@vnjdi	xpkubsbn@vnjdi	NOUN
bptjm-21	8	34	�	�	PROPN
bptjm-21	8	35	fev	fev	PROPN
bptjm-21	8	36	keywords	keyword	VERB
bptjm-21	8	37	:	:	PUNCT
bptjm-21	8	38	"	"	PUNCT
bptjm-21	8	39	*	*	PUNCT
bptjm-21	8	40	$	$	SYM
bptjm-21	8	41	%	%	NOUN
bptjm-21	8	42	"	"	PUNCT
bptjm-21	8	43	-vqvt	-vqvt	NOUN
bptjm-21	8	44	(	(	PUNCT
bptjm-21	8	45	fof	fof	X
bptjm-21	8	46	�	�	PROPN
bptjm-21	8	47	5ifsbqz	5ifsbqz	NUM
bptjm-21	8	48	"	"	PUNCT
bptjm-21	8	49	vupjnnvof	vupjnnvof	NOUN
bptjm-21	8	50	$	$	SYM
bptjm-21	8	51	bodfs	bodfs	NOUN
bptjm-21	8	52	5ifsbqfvujd	5ifsbqfvujd	NUM
bptjm-21	8	53	�	�	NOUN
bptjm-21	8	54	"ewbodft	"ewbodft	NOUN
bptjm-21	8	55	submitted	submit	VERB
bptjm-21	8	56	�	�	PROPN
bptjm-21	8	57	"qsjm	"qsjm	PROPN
bptjm-21	8	58	2	2	NUM
bptjm-21	8	59	�	�	PROPN
bptjm-21	8	60	,	,	PUNCT
bptjm-21	8	61	202	202	NUM
bptjm-21	8	62	�	�	PROPN
bptjm-21	8	63	�	�	PROPN
bptjm-21	8	64	accepted	accept	VERB
bptjm-21	8	65	�	�	PROPN
bptjm-21	8	66	juof	juof	PROPN
bptjm-21	8	67	�	�	PROPN
bptjm-21	8	68	�	�	PROPN
bptjm-21	8	69	�	�	PROPN
bptjm-21	8	70	,	,	PUNCT
bptjm-21	8	71	20	20	NUM
bptjm-21	8	72	�	�	PROPN
bptjm-21	8	73	�	�	PROPN
bptjm-21	8	74	�	�	PROPN
bptjm-21	8	75	1vcmjtife	1vcmjtife	NUM
bptjm-21	8	76	�	�	PROPN
bptjm-21	8	77	+vmz	+vmz	PROPN
bptjm-21	8	78	�	�	PROPN
bptjm-21	8	79	�	�	PROPN
bptjm-21	8	80	�	�	PROPN
bptjm-21	8	81	�	�	PROPN
bptjm-21	8	82	�	�	PROPN
bptjm-21	8	83	�	�	PROPN
bptjm-21	8	84	�	�	PROPN
bptjm-21	8	85	�	�	PROPN
bptjm-21	8	86	full	full	ADJ
bptjm-21	8	87	open	open	ADJ
bptjm-21	8	88	access	access	NOUN
bptjm-21	8	89	creative	creative	ADJ
bptjm-21	8	90	commons	common	NOUN
bptjm-21	8	91	attribution	attribution	PROPN
bptjm-21	8	92	�	�	PROPN
bptjm-21	8	93	�	�	PROPN
bptjm-21	8	94	license	license	VERB
bptjm-21	8	95	4.0	4.0	NUM
bptjm-21	8	96	activation	activation	NOUN
bptjm-21	8	97	induced	induce	VERB
bptjm-21	8	98	cytidine	cytidine	NOUN
bptjm-21	8	99	deaminase	deaminase	NOUN
bptjm-21	8	100	image	image	NOUN
bptjm-21	8	101	by	by	ADP
bptjm-21	8	102	emw	emw	PRON
bptjm-21	8	103	own	own	ADJ
bptjm-21	8	104	work	work	NOUN
bptjm-21	8	105	,	,	PUNCT
bptjm-21	8	106	cc	cc	VERB
bptjm-21	8	107	by	by	ADP
bptjm-21	8	108	-	-	PUNCT
bptjm-21	8	109	sa	sa	PROPN
bptjm-21	8	110	3.0	3.0	NUM
bptjm-21	8	111	,	,	PUNCT
bptjm-21	8	112	https://commons.wikimedia.org/w/index.php?curid=8764396	https://commons.wikimedia.org/w/index.php?curid=8764396	NOUN
bptjm-21	8	113	introduction	introduction	NOUN
bptjm-21	8	114	previous	previous	ADJ
bptjm-21	8	115	studies	study	NOUN
bptjm-21	8	116	and	and	CCONJ
bptjm-21	8	117	research	research	NOUN
bptjm-21	8	118	have	have	AUX
bptjm-21	8	119	established	establish	VERB
bptjm-21	8	120	that	that	DET
bptjm-21	8	121	aid	aid	NOUN
bptjm-21	8	122	regulates	regulate	VERB
bptjm-21	8	123	secondary	secondary	ADJ
bptjm-21	8	124	antibody	antibody	NOUN
bptjm-21	8	125	diversi	diversi	NOUN
bptjm-21	8	126	�	�	PROPN
bptjm-21	8	127	cation	cation	NOUN
bptjm-21	8	128	.	.	PUNCT
bptjm-21	9	1	there	there	PRON
bptjm-21	9	2	are	be	VERB
bptjm-21	9	3	many	many	ADJ
bptjm-21	9	4	di	di	NOUN
bptjm-21	9	5	�	�	PROPN
bptjm-21	9	6	erent	erent	NOUN
bptjm-21	9	7	immunoglobulin	immunoglobulin	NOUN
bptjm-21	9	8	(	(	PUNCT
bptjm-21	9	9	ig	ig	PROPN
bptjm-21	9	10	)	)	PUNCT
bptjm-21	9	11	diversi	diversi	PROPN
bptjm-21	9	12	�	�	PROPN
bptjm-21	9	13	cation	cation	NOUN
bptjm-21	9	14	processes	process	NOUN
bptjm-21	9	15	,	,	PUNCT
bptjm-21	9	16	such	such	ADJ
bptjm-21	9	17	as	as	ADP
bptjm-21	9	18	somatic	somatic	ADJ
bptjm-21	9	19	hypermutation	hypermutation	NOUN
bptjm-21	9	20	(	(	PUNCT
bptjm-21	9	21	shm	shm	NOUN
bptjm-21	9	22	)	)	PUNCT
bptjm-21	9	23	,	,	PUNCT
bptjm-21	9	24	class	class	NOUN
bptjm-21	9	25	switch	switch	NOUN
bptjm-21	9	26	recombination	recombination	NOUN
bptjm-21	9	27	(	(	PUNCT
bptjm-21	9	28	csr	csr	NOUN
bptjm-21	9	29	)	)	PUNCT
bptjm-21	9	30	,	,	PUNCT
bptjm-21	9	31	and	and	CCONJ
bptjm-21	9	32	gene	gene	NOUN
bptjm-21	9	33	conversion	conversion	NOUN
bptjm-21	9	34	(	(	PUNCT
bptjm-21	9	35	gc)4	gc)4	PROPN
bptjm-21	9	36	.	.	PUNCT
bptjm-21	9	37	shm	shm	PROPN
bptjm-21	9	38	allows	allow	VERB
bptjm-21	9	39	for	for	SCONJ
bptjm-21	9	40	b	b	PROPN
bptjm-21	9	41	cells	cell	NOUN
bptjm-21	9	42	to	to	PART
bptjm-21	9	43	diversify	diversify	VERB
bptjm-21	9	44	in	in	ADP
bptjm-21	9	45	order	order	NOUN
bptjm-21	9	46	to	to	PART
bptjm-21	9	47	respond	respond	VERB
bptjm-21	9	48	to	to	ADP
bptjm-21	9	49	threats	threat	NOUN
bptjm-21	9	50	to	to	ADP
bptjm-21	9	51	the	the	DET
bptjm-21	9	52	immune	immune	ADJ
bptjm-21	9	53	system,5	system,5	NOUN
bptjm-21	9	54	while	while	SCONJ
bptjm-21	9	55	csr	csr	NOUN
bptjm-21	9	56	allows	allow	VERB
bptjm-21	9	57	for	for	ADP
bptjm-21	9	58	the	the	DET
bptjm-21	9	59	generation	generation	NOUN
bptjm-21	9	60	of	of	ADP
bptjm-21	9	61	di	di	PROPN
bptjm-21	9	62	�	�	PROPN
bptjm-21	9	63	erent	erent	NOUN
bptjm-21	9	64	classes	class	NOUN
bptjm-21	9	65	of	of	ADP
bptjm-21	9	66	antibodies5	antibodies5	PROPN
bptjm-21	9	67	.	.	PUNCT
bptjm-21	10	1	gc	gc	PROPN
bptjm-21	10	2	is	be	AUX
bptjm-21	10	3	a	a	DET
bptjm-21	10	4	process	process	NOUN
bptjm-21	10	5	in	in	ADP
bptjm-21	10	6	which	which	PRON
bptjm-21	10	7	mutations	mutation	NOUN
bptjm-21	10	8	can	can	AUX
bptjm-21	10	9	occur	occur	VERB
bptjm-21	10	10	in	in	ADP
bptjm-21	10	11	the	the	DET
bptjm-21	10	12	antibody	antibody	NOUN
bptjm-21	10	13	genes5	genes5	PROPN
bptjm-21	10	14	.	.	PUNCT
bptjm-21	11	1	aid	aid	NOUN
bptjm-21	11	2	is	be	AUX
bptjm-21	11	3	central	central	ADJ
bptjm-21	11	4	to	to	ADP
bptjm-21	11	5	csr	csr	NOUN
bptjm-21	11	6	/	/	SYM
bptjm-21	11	7	shm	shm	NOUN
bptjm-21	11	8	and	and	CCONJ
bptjm-21	11	9	plasma	plasma	NOUN
bptjm-21	11	10	cell	cell	NOUN
bptjm-21	11	11	di	di	NOUN
bptjm-21	11	12	�	�	PROPN
bptjm-21	11	13	erentiation	erentiation	NOUN
bptjm-21	11	14	and	and	CCONJ
bptjm-21	11	15	is	be	AUX
bptjm-21	11	16	encoded	encode	VERB
bptjm-21	11	17	by	by	ADP
bptjm-21	11	18	aicda	aicda	NOUN
bptjm-21	11	19	and	and	CCONJ
bptjm-21	11	20	b	b	NOUN
bptjm-21	11	21	lymphocyte	lymphocyte	ADJ
bptjm-21	11	22	maturation	maturation	NOUN
bptjm-21	11	23	protein	protein	NOUN
bptjm-21	11	24	1	1	NUM
bptjm-21	11	25	(	(	PUNCT
bptjm-21	11	26	blimp-1	blimp-1	X
bptjm-21	11	27	)	)	PUNCT
bptjm-21	11	28	which	which	PRON
bptjm-21	11	29	is	be	AUX
bptjm-21	11	30	a	a	DET
bptjm-21	11	31	transcription	transcription	NOUN
bptjm-21	11	32	factor	factor	NOUN
bptjm-21	11	33	encoded	encode	VERB
bptjm-21	11	34	by	by	ADP
bptjm-21	11	35	prdm16	prdm16	NOUN
bptjm-21	11	36	.	.	PUNCT
bptjm-21	12	1	aid	aid	NOUN
bptjm-21	12	2	and	and	CCONJ
bptjm-21	12	3	its	its	PRON
bptjm-21	12	4	transcription	transcription	NOUN
bptjm-21	12	5	factors	factor	NOUN
bptjm-21	12	6	underpin	underpin	VERB
bptjm-21	12	7	ab	ab	PROPN
bptjm-21	12	8	and	and	CCONJ
bptjm-21	12	9	autoantibody	autoantibody	ADJ
bptjm-21	12	10	responses7	responses7	PROPN
bptjm-21	12	11	.	.	PUNCT
bptjm-21	13	1	the	the	DET
bptjm-21	13	2	deamination	deamination	NOUN
bptjm-21	13	3	results	result	VERB
bptjm-21	13	4	in	in	ADP
bptjm-21	13	5	a	a	DET
bptjm-21	13	6	change	change	NOUN
bptjm-21	13	7	from	from	ADP
bptjm-21	13	8	a	a	DET
bptjm-21	13	9	cytosine	cytosine	NOUN
bptjm-21	13	10	base	base	NOUN
bptjm-21	13	11	to	to	ADP
bptjm-21	13	12	a	a	DET
bptjm-21	13	13	uracil	uracil	ADJ
bptjm-21	13	14	base	base	NOUN
bptjm-21	13	15	in	in	ADP
bptjm-21	13	16	ig	ig	PROPN
bptjm-21	13	17	genes	gene	NOUN
bptjm-21	13	18	,	,	PUNCT
bptjm-21	13	19	and	and	CCONJ
bptjm-21	13	20	this	this	PRON
bptjm-21	13	21	can	can	AUX
bptjm-21	13	22	result	result	VERB
bptjm-21	13	23	in	in	ADP
bptjm-21	13	24	either	either	DET
bptjm-21	13	25	csr	csr	NOUN
bptjm-21	13	26	or	or	CCONJ
bptjm-21	13	27	shm	shm	NOUN
bptjm-21	13	28	,	,	PUNCT
bptjm-21	13	29	depending	depend	VERB
bptjm-21	13	30	on	on	ADP
bptjm-21	13	31	the	the	DET
bptjm-21	13	32	deoxyribonucleic	deoxyribonucleic	ADJ
bptjm-21	13	33	acid	acid	NOUN
bptjm-21	13	34	(	(	PUNCT
bptjm-21	13	35	dna	dna	NOUN
bptjm-21	13	36	)	)	PUNCT
bptjm-21	13	37	repair	repair	NOUN
bptjm-21	13	38	pathway	pathway	NOUN
bptjm-21	13	39	.	.	PUNCT
bptjm-21	14	1	aid	aid	NOUN
bptjm-21	14	2	expression	expression	NOUN
bptjm-21	14	3	is	be	AUX
bptjm-21	14	4	upregulated	upregulate	VERB
bptjm-21	14	5	by	by	ADP
bptjm-21	14	6	in	in	ADP
bptjm-21	14	7	�	�	PROPN
bptjm-21	14	8	ammatory	ammatory	NOUN
bptjm-21	14	9	cytokines	cytokine	NOUN
bptjm-21	14	10	like	like	ADP
bptjm-21	14	11	interferon	interferon	ADJ
bptjm-21	14	12	-	-	PUNCT
bptjm-21	14	13	γ	γ	NOUN
bptjm-21	14	14	and	and	CCONJ
bptjm-21	14	15	tumor	tumor	NOUN
bptjm-21	14	16	necrosis	necrosis	NOUN
bptjm-21	14	17	factor	factor	NOUN
bptjm-21	14	18	(	(	PUNCT
bptjm-21	14	19	tnf)-α	tnf)-α	NOUN
bptjm-21	14	20	which	which	PRON
bptjm-21	14	21	induces	induce	VERB
bptjm-21	14	22	p53	p53	NOUN
bptjm-21	14	23	mutations	mutation	NOUN
bptjm-21	14	24	in	in	ADP
bptjm-21	14	25	in	in	ADP
bptjm-21	14	26	�	�	NOUN
bptjm-21	14	27	ammatory	ammatory	NOUN
bptjm-21	14	28	or	or	CCONJ
bptjm-21	14	29	cancer	cancer	NOUN
bptjm-21	14	30	cells	cell	NOUN
bptjm-21	14	31	.	.	PUNCT
bptjm-21	15	1	although	although	SCONJ
bptjm-21	15	2	aid	aid	NOUN
bptjm-21	15	3	is	be	AUX
bptjm-21	15	4	typically	typically	ADV
bptjm-21	15	5	associated	associate	VERB
bptjm-21	15	6	with	with	ADP
bptjm-21	15	7	and	and	CCONJ
bptjm-21	15	8	expressed	express	VERB
bptjm-21	15	9	in	in	ADP
bptjm-21	15	10	b	b	NOUN
bptjm-21	15	11	-	-	PUNCT
bptjm-21	15	12	cells	cell	NOUN
bptjm-21	15	13	,	,	PUNCT
bptjm-21	15	14	it	it	PRON
bptjm-21	15	15	can	can	AUX
bptjm-21	15	16	also	also	ADV
bptjm-21	15	17	be	be	AUX
bptjm-21	15	18	expressed	express	VERB
bptjm-21	15	19	,	,	PUNCT
bptjm-21	15	20	for	for	ADP
bptjm-21	15	21	example	example	NOUN
bptjm-21	15	22	,	,	PUNCT
bptjm-21	15	23	in	in	ADP
bptjm-21	15	24	embryonic	embryonic	ADJ
bptjm-21	15	25	germ	germ	NOUN
bptjm-21	15	26	cells	cell	NOUN
bptjm-21	15	27	or	or	CCONJ
bptjm-21	15	28	pluripotent	pluripotent	ADJ
bptjm-21	15	29	cells	cell	NOUN
bptjm-21	15	30	like	like	ADP
bptjm-21	15	31	oocytes	oocyte	NOUN
bptjm-21	15	32	.	.	PUNCT
bptjm-21	16	1	aid	aid	NOUN
bptjm-21	16	2	proteins	protein	NOUN
bptjm-21	16	3	have	have	AUX
bptjm-21	16	4	been	be	AUX
bptjm-21	16	5	shown	show	VERB
bptjm-21	16	6	to	to	PART
bptjm-21	16	7	be	be	AUX
bptjm-21	16	8	expressed	express	VERB
bptjm-21	16	9	during	during	ADP
bptjm-21	16	10	early	early	ADJ
bptjm-21	16	11	b	b	NOUN
bptjm-21	16	12	-	-	PUNCT
bptjm-21	16	13	cell	cell	NOUN
bptjm-21	16	14	development	development	NOUN
bptjm-21	16	15	in	in	ADP
bptjm-21	16	16	both	both	DET
bptjm-21	16	17	human	human	ADJ
bptjm-21	16	18	fetal	fetal	ADJ
bptjm-21	16	19	liver	liver	NOUN
bptjm-21	16	20	and	and	CCONJ
bptjm-21	16	21	adult	adult	NOUN
bptjm-21	16	22	bone	bone	NOUN
bptjm-21	16	23	marrow	marrow	NOUN
bptjm-21	16	24	9	9	NUM
bptjm-21	16	25	.	.	PUNCT
bptjm-21	17	1	it	it	PRON
bptjm-21	17	2	is	be	AUX
bptjm-21	17	3	important	important	ADJ
bptjm-21	17	4	to	to	PART
bptjm-21	17	5	note	note	VERB
bptjm-21	17	6	that	that	DET
bptjm-21	17	7	aid	aid	NOUN
bptjm-21	17	8	is	be	AUX
bptjm-21	17	9	a	a	DET
bptjm-21	17	10	potent	potent	ADJ
bptjm-21	17	11	enzyme	enzyme	NOUN
bptjm-21	17	12	which	which	PRON
bptjm-21	17	13	instigates	instigate	VERB
bptjm-21	17	14	genomic	genomic	ADJ
bptjm-21	17	15	diversity	diversity	NOUN
bptjm-21	17	16	for	for	ADP
bptjm-21	17	17	both	both	DET
bptjm-21	17	18	bene	bene	PROPN
bptjm-21	17	19	�	�	PROPN
bptjm-21	17	20	cial10	cial10	NOUN
bptjm-21	17	21	and	and	CCONJ
bptjm-21	17	22	harmful	harmful	ADJ
bptjm-21	17	23	outcomes	outcome	NOUN
bptjm-21	17	24	in	in	ADP
bptjm-21	17	25	humans	human	NOUN
bptjm-21	17	26	.	.	PUNCT
bptjm-21	18	1	this	this	PRON
bptjm-21	18	2	can	can	AUX
bptjm-21	18	3	best	well	ADV
bptjm-21	18	4	be	be	AUX
bptjm-21	18	5	depicted	depict	VERB
bptjm-21	18	6	in	in	ADP
bptjm-21	18	7	figure	figure	NOUN
bptjm-21	18	8	1	1	NUM
bptjm-21	18	9	,	,	PUNCT
bptjm-21	18	10	which	which	PRON
bptjm-21	18	11	summarizes	summarize	VERB
bptjm-21	18	12	much	much	ADJ
bptjm-21	18	13	of	of	ADP
bptjm-21	18	14	the	the	DET
bptjm-21	18	15	following	follow	VERB
bptjm-21	18	16	section	section	NOUN
bptjm-21	18	17	.	.	PUNCT
bptjm-21	19	1	aid	aid	PROPN
bptjm-21	19	2	di	di	PROPN
bptjm-21	19	3	�	�	PROPN
bptjm-21	19	4	ers	er	NOUN
bptjm-21	19	5	from	from	ADP
bptjm-21	19	6	other	other	ADJ
bptjm-21	19	7	apolipoprotein	apolipoprotein	PROPN
bptjm-21	20	1	b	b	PROPN
bptjm-21	20	2	mrrna	mrrna	NOUN
bptjm-21	20	3	editing	edit	VERB
bptjm-21	20	4	catalytic	catalytic	ADJ
bptjm-21	20	5	polypeptides	polypeptide	NOUN
bptjm-21	20	6	(	(	PUNCT
bptjm-21	20	7	apobecs	apobec	NOUN
bptjm-21	20	8	)	)	PUNCT
bptjm-21	20	9	speci	speci	PROPN
bptjm-21	20	10	�	�	PROPN
bptjm-21	20	11	cally	cally	ADV
bptjm-21	20	12	due	due	ADP
bptjm-21	20	13	to	to	ADP
bptjm-21	20	14	the	the	DET
bptjm-21	20	15	size	size	NOUN
bptjm-21	20	16	and	and	CCONJ
bptjm-21	20	17	orientation	orientation	NOUN
bptjm-21	20	18	of	of	ADP
bptjm-21	20	19	its	its	PRON
bptjm-21	20	20	substrate	substrate	NOUN
bptjm-21	20	21	speci	speci	ADJ
bptjm-21	20	22	�	�	PROPN
bptjm-21	20	23	city	city	PROPN
bptjm-21	20	24	loop12	loop12	PROPN
bptjm-21	21	1	.	.	PUNCT
bptjm-21	22	1	it	it	PRON
bptjm-21	22	2	has	have	VERB
bptjm-21	22	3	a	a	DET
bptjm-21	22	4	larger	large	ADJ
bptjm-21	22	5	loop	loop	NOUN
bptjm-21	22	6	that	that	PRON
bptjm-21	22	7	extends	extend	VERB
bptjm-21	22	8	away	away	ADV
bptjm-21	22	9	from	from	ADP
bptjm-21	22	10	the	the	DET
bptjm-21	22	11	active	active	ADJ
bptjm-21	22	12	site	site	NOUN
bptjm-21	22	13	and	and	CCONJ
bptjm-21	22	14	thus	thus	ADV
bptjm-21	22	15	can	can	AUX
bptjm-21	22	16	accommodate	accommodate	VERB
bptjm-21	22	17	two	two	NUM
bptjm-21	22	18	purines	purine	NOUN
bptjm-21	22	19	next	next	ADV
bptjm-21	22	20	to	to	ADP
bptjm-21	22	21	a	a	DET
bptjm-21	22	22	target	target	NOUN
bptjm-21	22	23	c12	c12	NOUN
bptjm-21	22	24	.	.	PUNCT
bptjm-21	23	1	despite	despite	SCONJ
bptjm-21	23	2	some	some	DET
bptjm-21	23	3	sequence	sequence	NOUN
bptjm-21	23	4	similarity	similarity	NOUN
bptjm-21	23	5	to	to	ADP
bptjm-21	23	6	apobec	apobec	NOUN
bptjm-21	23	7	cytidine	cytidine	NOUN
bptjm-21	23	8	deaminases	deaminase	NOUN
bptjm-21	23	9	,	,	PUNCT
bptjm-21	23	10	aid	aid	NOUN
bptjm-21	23	11	’s	’s	PART
bptjm-21	23	12	critical	critical	ADJ
bptjm-21	23	13	function	function	NOUN
bptjm-21	23	14	in	in	ADP
bptjm-21	23	15	ab	ab	PROPN
bptjm-21	23	16	diversi	diversi	PROPN
bptjm-21	23	17	�	�	PROPN
bptjm-21	23	18	cation	cation	NOUN
bptjm-21	23	19	in	in	ADP
bptjm-21	23	20	csr	csr	NOUN
bptjm-21	23	21	can	can	AUX
bptjm-21	23	22	not	not	PART
bptjm-21	23	23	be	be	AUX
bptjm-21	23	24	substituted	substitute	VERB
bptjm-21	23	25	by	by	ADP
bptjm-21	23	26	other	other	ADJ
bptjm-21	23	27	apobec	apobec	NOUN
bptjm-21	23	28	proteins10	proteins10	NOUN
bptjm-21	23	29	.	.	PUNCT
bptjm-21	24	1	while	while	SCONJ
bptjm-21	24	2	aberrant	aberrant	ADJ
bptjm-21	24	3	deaminase	deaminase	NOUN
bptjm-21	24	4	activity	activity	NOUN
bptjm-21	24	5	can	can	AUX
bptjm-21	24	6	certainly	certainly	ADV
bptjm-21	24	7	threaten	threaten	VERB
bptjm-21	24	8	the	the	DET
bptjm-21	24	9	genome	genome	NOUN
bptjm-21	24	10	,	,	PUNCT
bptjm-21	24	11	recent	recent	ADJ
bptjm-21	24	12	biotechnological	biotechnological	ADJ
bptjm-21	24	13	e	e	NOUN
bptjm-21	24	14	�	�	NOUN
bptjm-21	24	15	orts	ort	NOUN
bptjm-21	24	16	have	have	AUX
bptjm-21	24	17	focused	focus	VERB
bptjm-21	24	18	on	on	ADP
bptjm-21	24	19	harnessing	harness	VERB
bptjm-21	24	20	and	and	CCONJ
bptjm-21	24	21	targeting	target	VERB
bptjm-21	24	22	deaminase	deaminase	NOUN
bptjm-21	24	23	activity	activity	NOUN
bptjm-21	24	24	in	in	ADP
bptjm-21	24	25	base	base	NOUN
bptjm-21	24	26	editors	editor	NOUN
bptjm-21	24	27	that	that	PRON
bptjm-21	24	28	are	be	AUX
bptjm-21	24	29	related	relate	VERB
bptjm-21	24	30	to	to	ADP
bptjm-21	24	31	aid11	aid11	PROPN
bptjm-21	24	32	.	.	PUNCT
bptjm-21	25	1	berkeley	berkeley	PROPN
bptjm-21	25	2	pharma	pharma	PROPN
bptjm-21	25	3	tech	tech	PROPN
bptjm-21	25	4	journal	journal	NOUN
bptjm-21	25	5	of	of	ADP
bptjm-21	25	6	medicine	medicine	NOUN
bptjm-21	25	7	|	|	ADV
bptjm-21	25	8	108	108	NUM
bptjm-21	25	9	figure	figure	NOUN
bptjm-21	25	10	1	1	NUM
bptjm-21	25	11	:	:	PUNCT
bptjm-21	25	12	a	a	DET
bptjm-21	25	13	diagram	diagram	NOUN
bptjm-21	25	14	summarizing	summarize	VERB
bptjm-21	25	15	some	some	PRON
bptjm-21	25	16	of	of	ADP
bptjm-21	25	17	the	the	DET
bptjm-21	25	18	beneficial	beneficial	ADJ
bptjm-21	25	19	and	and	CCONJ
bptjm-21	25	20	harmful	harmful	ADJ
bptjm-21	25	21	outcomes	outcome	NOUN
bptjm-21	25	22	of	of	ADP
bptjm-21	25	23	aid	aid	NOUN
bptjm-21	25	24	aid	aid	NOUN
bptjm-21	25	25	,	,	PUNCT
bptjm-21	25	26	a	a	DET
bptjm-21	25	27	potent	potent	ADJ
bptjm-21	25	28	dna	dna	NOUN
bptjm-21	25	29	mutator	mutator	NOUN
bptjm-21	25	30	,	,	PUNCT
bptjm-21	25	31	must	must	AUX
bptjm-21	25	32	be	be	AUX
bptjm-21	25	33	tightly	tightly	ADV
bptjm-21	25	34	regulated	regulate	VERB
bptjm-21	25	35	to	to	PART
bptjm-21	25	36	prevent	prevent	VERB
bptjm-21	25	37	any	any	DET
bptjm-21	25	38	o	o	NOUN
bptjm-21	25	39	�	�	NOUN
bptjm-21	25	40	-target	-target	NOUN
bptjm-21	25	41	e	e	NOUN
bptjm-21	25	42	�	�	NOUN
bptjm-21	25	43	ects	ect	NOUN
bptjm-21	25	44	which	which	PRON
bptjm-21	25	45	can	can	AUX
bptjm-21	25	46	result	result	VERB
bptjm-21	25	47	in	in	ADP
bptjm-21	25	48	a	a	DET
bptjm-21	25	49	plethora	plethora	NOUN
bptjm-21	25	50	of	of	ADP
bptjm-21	25	51	problems	problem	NOUN
bptjm-21	25	52	including	include	VERB
bptjm-21	25	53	mutations	mutation	NOUN
bptjm-21	25	54	in	in	ADP
bptjm-21	25	55	non	non	ADJ
bptjm-21	25	56	-	-	ADJ
bptjm-21	25	57	ig	ig	ADJ
bptjm-21	25	58	genes	gene	NOUN
bptjm-21	25	59	,	,	PUNCT
bptjm-21	25	60	genomic	genomic	NOUN
bptjm-21	25	61	instability	instability	NOUN
bptjm-21	25	62	,	,	PUNCT
bptjm-21	25	63	interchromosomal	interchromosomal	ADJ
bptjm-21	25	64	translocations	translocation	NOUN
bptjm-21	25	65	,	,	PUNCT
bptjm-21	25	66	and	and	CCONJ
bptjm-21	25	67	cellular	cellular	ADJ
bptjm-21	25	68	neoplastic	neoplastic	ADJ
bptjm-21	25	69	transformation13	transformation13	NOUN
bptjm-21	25	70	.	.	PUNCT
bptjm-21	26	1	aid	aid	NOUN
bptjm-21	26	2	has	have	AUX
bptjm-21	26	3	previously	previously	ADV
bptjm-21	26	4	been	be	AUX
bptjm-21	26	5	implicated	implicate	VERB
bptjm-21	26	6	in	in	ADP
bptjm-21	26	7	the	the	DET
bptjm-21	26	8	tumorigenic	tumorigenic	ADJ
bptjm-21	26	9	process	process	NOUN
bptjm-21	26	10	in	in	ADP
bptjm-21	26	11	b	b	NOUN
bptjm-21	26	12	cell	cell	NOUN
bptjm-21	26	13	tumors	tumor	NOUN
bptjm-21	26	14	potentially	potentially	ADV
bptjm-21	26	15	through	through	ADP
bptjm-21	26	16	the	the	DET
bptjm-21	26	17	induction	induction	NOUN
bptjm-21	26	18	of	of	ADP
bptjm-21	26	19	chromosomal	chromosomal	ADJ
bptjm-21	26	20	translocations	translocation	NOUN
bptjm-21	26	21	and	and	CCONJ
bptjm-21	26	22	mutations	mutation	NOUN
bptjm-21	26	23	in	in	ADP
bptjm-21	26	24	tumor	tumor	NOUN
bptjm-21	26	25	suppressor	suppressor	NOUN
bptjm-21	26	26	genes	gene	NOUN
bptjm-21	26	27	and	and	CCONJ
bptjm-21	26	28	oncogenes14	oncogenes14	NOUN
bptjm-21	26	29	.	.	PUNCT
bptjm-21	27	1	aid	aid	NOUN
bptjm-21	27	2	expression	expression	NOUN
bptjm-21	27	3	has	have	AUX
bptjm-21	27	4	also	also	ADV
bptjm-21	27	5	been	be	AUX
bptjm-21	27	6	implicated	implicate	VERB
bptjm-21	27	7	in	in	ADP
bptjm-21	27	8	the	the	DET
bptjm-21	27	9	pathogenesis	pathogenesis	NOUN
bptjm-21	27	10	of	of	ADP
bptjm-21	27	11	human	human	PROPN
bptjm-21	27	12	b	b	PROPN
bptjm-21	27	13	cell	cell	NOUN
bptjm-21	27	14	malignancies15	malignancies15	NOUN
bptjm-21	27	15	.	.	PUNCT
bptjm-21	28	1	indeed	indeed	ADV
bptjm-21	28	2	,	,	PUNCT
bptjm-21	28	3	accumulating	accumulate	VERB
bptjm-21	28	4	evidence	evidence	NOUN
bptjm-21	28	5	suggests	suggest	VERB
bptjm-21	28	6	aid	aid	NOUN
bptjm-21	28	7	is	be	AUX
bptjm-21	28	8	pro	pro	ADJ
bptjm-21	28	9	-	-	ADJ
bptjm-21	28	10	oncogenic	oncogenic	ADJ
bptjm-21	28	11	and	and	CCONJ
bptjm-21	28	12	induces	induce	VERB
bptjm-21	28	13	cancerpromoting	cancerpromote	VERB
bptjm-21	28	14	mutations	mutation	NOUN
bptjm-21	28	15	or	or	CCONJ
bptjm-21	28	16	chromosomalrearrangements16	chromosomalrearrangements16	NOUN
bptjm-21	28	17	.	.	PUNCT
bptjm-21	29	1	another	another	DET
bptjm-21	29	2	detrimental	detrimental	ADJ
bptjm-21	29	3	impact	impact	NOUN
bptjm-21	29	4	of	of	ADP
bptjm-21	29	5	aid	aid	NOUN
bptjm-21	29	6	is	be	AUX
bptjm-21	29	7	the	the	DET
bptjm-21	29	8	generation	generation	NOUN
bptjm-21	29	9	of	of	ADP
bptjm-21	29	10	autoimmunity	autoimmunity	NOUN
bptjm-21	29	11	,	,	PUNCT
bptjm-21	29	12	which	which	PRON
bptjm-21	29	13	can	can	AUX
bptjm-21	29	14	occur	occur	VERB
bptjm-21	29	15	after	after	ADP
bptjm-21	29	16	on	on	ADP
bptjm-21	29	17	-	-	PUNCT
bptjm-21	29	18	target	target	NOUN
bptjm-21	29	19	point	point	NOUN
bptjm-21	29	20	mutations	mutation	NOUN
bptjm-21	29	21	in	in	ADP
bptjm-21	29	22	variable	variable	ADJ
bptjm-21	29	23	genes	gene	NOUN
bptjm-21	29	24	produce	produce	VERB
bptjm-21	29	25	antibodies	antibody	NOUN
bptjm-21	29	26	with	with	ADP
bptjm-21	29	27	high	high	ADJ
bptjm-21	29	28	a	a	DET
bptjm-21	29	29	�	�	NOUN
bptjm-21	29	30	nity	nity	NOUN
bptjm-21	29	31	for	for	ADP
bptjm-21	29	32	self	self	NOUN
bptjm-21	29	33	-	-	PUNCT
bptjm-21	29	34	proteins11	proteins11	NOUN
bptjm-21	29	35	.	.	PUNCT
bptjm-21	30	1	these	these	DET
bptjm-21	30	2	detrimental	detrimental	ADJ
bptjm-21	30	3	e	e	NOUN
bptjm-21	30	4	�	�	NOUN
bptjm-21	30	5	ects	ect	NOUN
bptjm-21	30	6	are	be	AUX
bptjm-21	30	7	important	important	ADJ
bptjm-21	30	8	to	to	PART
bptjm-21	30	9	consider	consider	VERB
bptjm-21	30	10	when	when	SCONJ
bptjm-21	30	11	choosing	choose	VERB
bptjm-21	30	12	to	to	PART
bptjm-21	30	13	target	target	VERB
bptjm-21	30	14	aid	aid	NOUN
bptjm-21	30	15	in	in	ADP
bptjm-21	30	16	potential	potential	ADJ
bptjm-21	30	17	research	research	NOUN
bptjm-21	30	18	projects	project	NOUN
bptjm-21	30	19	.	.	PUNCT
bptjm-21	31	1	other	other	ADJ
bptjm-21	31	2	studies	study	NOUN
bptjm-21	31	3	have	have	AUX
bptjm-21	31	4	proposed	propose	VERB
bptjm-21	31	5	more	more	ADJ
bptjm-21	31	6	novel	novel	ADJ
bptjm-21	31	7	functions	function	NOUN
bptjm-21	31	8	for	for	ADP
bptjm-21	31	9	aid	aid	NOUN
bptjm-21	31	10	.	.	PUNCT
bptjm-21	32	1	for	for	ADP
bptjm-21	32	2	instance	instance	NOUN
bptjm-21	32	3	,	,	PUNCT
bptjm-21	32	4	one	one	PRON
bptjm-21	32	5	has	have	AUX
bptjm-21	32	6	suggested	suggest	VERB
bptjm-21	32	7	that	that	SCONJ
bptjm-21	32	8	aid	aid	NOUN
bptjm-21	32	9	functions	function	NOUN
bptjm-21	32	10	as	as	ADP
bptjm-21	32	11	an	an	DET
bptjm-21	32	12	adaptor	adaptor	NOUN
bptjm-21	32	13	protein	protein	NOUN
bptjm-21	32	14	that	that	PRON
bptjm-21	32	15	represses	repress	VERB
bptjm-21	32	16	viral	viral	ADJ
bptjm-21	32	17	transcription	transcription	NOUN
bptjm-21	32	18	,	,	PUNCT
bptjm-21	32	19	which	which	PRON
bptjm-21	32	20	would	would	AUX
bptjm-21	32	21	have	have	VERB
bptjm-21	32	22	implications	implication	NOUN
bptjm-21	32	23	for	for	ADP
bptjm-21	32	24	the	the	DET
bptjm-21	32	25	development	development	NOUN
bptjm-21	32	26	of	of	ADP
bptjm-21	32	27	anti	anti	ADJ
bptjm-21	32	28	-	-	ADJ
bptjm-21	32	29	hiv	hiv	ADJ
bptjm-21	32	30	therapeutics	therapeutic	NOUN
bptjm-21	32	31	and	and	CCONJ
bptjm-21	32	32	other	other	ADJ
bptjm-21	32	33	therapies	therapy	NOUN
bptjm-21	32	34	17	17	NUM
bptjm-21	32	35	.	.	PUNCT
bptjm-21	33	1	moreover	moreover	ADV
bptjm-21	33	2	,	,	PUNCT
bptjm-21	33	3	aid	aid	NOUN
bptjm-21	33	4	can	can	AUX
bptjm-21	33	5	exert	exert	VERB
bptjm-21	33	6	non	non	ADJ
bptjm-21	33	7	canonical	canonical	ADJ
bptjm-21	33	8	functions	function	NOUN
bptjm-21	33	9	when	when	SCONJ
bptjm-21	33	10	aberrantly	aberrantly	ADV
bptjm-21	33	11	expressed	express	VERB
bptjm-21	33	12	in	in	ADP
bptjm-21	33	13	epithelial	epithelial	ADJ
bptjm-21	33	14	cells	cell	NOUN
bptjm-21	33	15	and	and	CCONJ
bptjm-21	33	16	was	be	AUX
bptjm-21	33	17	berkeley	berkeley	PROPN
bptjm-21	33	18	pharma	pharma	PROPN
bptjm-21	33	19	tech	tech	NOUN
bptjm-21	33	20	journal	journal	NOUN
bptjm-21	33	21	of	of	ADP
bptjm-21	33	22	medicine	medicine	NOUN
bptjm-21	34	1	|	|	ADV
bptjm-21	34	2	109	109	NUM
bptjm-21	34	3	long	long	ADV
bptjm-21	34	4	known	know	VERB
bptjm-21	34	5	to	to	PART
bptjm-21	34	6	lack	lack	VERB
bptjm-21	34	7	speci	speci	PROPN
bptjm-21	34	8	�	�	PROPN
bptjm-21	34	9	c	c	NOUN
bptjm-21	34	10	inhibitors	inhibitor	NOUN
bptjm-21	34	11	which	which	PRON
bptjm-21	34	12	prevented	prevent	VERB
bptjm-21	34	13	therapeutic	therapeutic	ADJ
bptjm-21	34	14	applications	application	NOUN
bptjm-21	34	15	to	to	PART
bptjm-21	34	16	modulate	modulate	VERB
bptjm-21	34	17	aid	aid	NOUN
bptjm-21	34	18	functions18	functions18	NOUN
bptjm-21	34	19	.	.	PUNCT
bptjm-21	35	1	mechanism	mechanism	NOUN
bptjm-21	35	2	historically	historically	ADV
bptjm-21	35	3	,	,	PUNCT
bptjm-21	35	4	the	the	DET
bptjm-21	35	5	discovery	discovery	NOUN
bptjm-21	35	6	of	of	ADP
bptjm-21	35	7	aid	aid	NOUN
bptjm-21	35	8	and	and	CCONJ
bptjm-21	35	9	its	its	PRON
bptjm-21	35	10	essential	essential	ADJ
bptjm-21	35	11	role	role	NOUN
bptjm-21	35	12	in	in	ADP
bptjm-21	35	13	antibody	antibody	NOUN
bptjm-21	35	14	diversi	diversi	NOUN
bptjm-21	35	15	�	�	PROPN
bptjm-21	35	16	cation	cation	NOUN
bptjm-21	35	17	kindled	kindle	VERB
bptjm-21	35	18	a	a	DET
bptjm-21	35	19	debate	debate	NOUN
bptjm-21	35	20	over	over	ADP
bptjm-21	35	21	aid	aid	NOUN
bptjm-21	35	22	’s	’s	PART
bptjm-21	35	23	nucleic	nucleic	ADJ
bptjm-21	35	24	acid	acid	NOUN
bptjm-21	35	25	substrate	substrate	NOUN
bptjm-21	35	26	,	,	PUNCT
bptjm-21	35	27	which	which	PRON
bptjm-21	35	28	inspired	inspire	VERB
bptjm-21	35	29	the	the	DET
bptjm-21	35	30	dna	dna	PROPN
bptjm-21	35	31	deamination	deamination	NOUN
bptjm-21	35	32	model	model	NOUN
bptjm-21	35	33	and	and	CCONJ
bptjm-21	35	34	identi	identi	NOUN
bptjm-21	35	35	�	�	NOUN
bptjm-21	35	36	cation	cation	NOUN
bptjm-21	35	37	of	of	ADP
bptjm-21	35	38	downstream	downstream	ADJ
bptjm-21	35	39	players	player	NOUN
bptjm-21	35	40	in	in	ADP
bptjm-21	35	41	the	the	DET
bptjm-21	35	42	csr	csr	NOUN
bptjm-21	35	43	pathway	pathway	NOUN
bptjm-21	35	44	such	such	ADJ
bptjm-21	35	45	as	as	ADP
bptjm-21	35	46	the	the	DET
bptjm-21	35	47	dna	dna	PROPN
bptjm-21	35	48	glycosylase	glycosylase	NOUN
bptjm-21	35	49	ung19	ung19	PROPN
bptjm-21	35	50	.	.	PUNCT
bptjm-21	36	1	subsequently	subsequently	ADV
bptjm-21	36	2	,	,	PUNCT
bptjm-21	36	3	this	this	DET
bptjm-21	36	4	discovery	discovery	NOUN
bptjm-21	36	5	led	lead	VERB
bptjm-21	36	6	to	to	ADP
bptjm-21	36	7	a	a	DET
bptjm-21	36	8	race	race	NOUN
bptjm-21	36	9	to	to	PART
bptjm-21	36	10	uncover	uncover	VERB
bptjm-21	36	11	ssdna	ssdna	ADV
bptjm-21	36	12	as	as	ADP
bptjm-21	36	13	the	the	DET
bptjm-21	36	14	target	target	NOUN
bptjm-21	36	15	of	of	ADP
bptjm-21	36	16	aid	aid	NOUN
bptjm-21	36	17	’s	’s	PART
bptjm-21	36	18	enzymatic	enzymatic	ADJ
bptjm-21	36	19	activity	activity	NOUN
bptjm-21	36	20	and	and	CCONJ
bptjm-21	36	21	its	its	PRON
bptjm-21	36	22	dependence	dependence	NOUN
bptjm-21	36	23	on	on	ADP
bptjm-21	36	24	transcription	transcription	NOUN
bptjm-21	36	25	for	for	ADP
bptjm-21	36	26	deamination19	deamination19	NOUN
bptjm-21	36	27	.	.	PUNCT
bptjm-21	37	1	it	it	PRON
bptjm-21	37	2	is	be	AUX
bptjm-21	37	3	important	important	ADJ
bptjm-21	37	4	to	to	PART
bptjm-21	37	5	note	note	VERB
bptjm-21	37	6	that	that	SCONJ
bptjm-21	37	7	aid	aid	NOUN
bptjm-21	37	8	deaminates	deaminate	VERB
bptjm-21	37	9	c→u	c→u	NUM
bptjm-21	37	10	only	only	ADV
bptjm-21	37	11	on	on	ADP
bptjm-21	37	12	ssdna	ssdna	ADV
bptjm-21	37	13	and	and	CCONJ
bptjm-21	37	14	does	do	AUX
bptjm-21	37	15	not	not	PART
bptjm-21	37	16	function	function	VERB
bptjm-21	37	17	on	on	ADP
bptjm-21	37	18	dsdna	dsdna	NOUN
bptjm-21	37	19	or	or	CCONJ
bptjm-21	37	20	rna12	rna12	ADJ
bptjm-21	37	21	.	.	PUNCT
bptjm-21	38	1	figure	figure	NOUN
bptjm-21	38	2	2	2	NUM
bptjm-21	38	3	depicts	depict	VERB
bptjm-21	38	4	this	this	DET
bptjm-21	38	5	type	type	NOUN
bptjm-21	38	6	of	of	ADP
bptjm-21	38	7	deamination	deamination	NOUN
bptjm-21	38	8	reaction	reaction	NOUN
bptjm-21	38	9	.	.	PUNCT
bptjm-21	39	1	nearly	nearly	ADV
bptjm-21	39	2	two	two	NUM
bptjm-21	39	3	decades	decade	NOUN
bptjm-21	39	4	prior	prior	ADV
bptjm-21	39	5	to	to	ADP
bptjm-21	39	6	this	this	DET
bptjm-21	39	7	research	research	NOUN
bptjm-21	39	8	,	,	PUNCT
bptjm-21	39	9	there	there	PRON
bptjm-21	39	10	was	be	VERB
bptjm-21	39	11	an	an	DET
bptjm-21	39	12	observation	observation	NOUN
bptjm-21	39	13	that	that	SCONJ
bptjm-21	39	14	noncoding	noncode	VERB
bptjm-21	39	15	rna	rna	NOUN
bptjm-21	39	16	transcripts	transcript	NOUN
bptjm-21	39	17	originated	originate	VERB
bptjm-21	39	18	from	from	ADP
bptjm-21	39	19	within	within	ADP
bptjm-21	39	20	the	the	DET
bptjm-21	39	21	igh	igh	PROPN
bptjm-21	39	22	locus	locus	NOUN
bptjm-21	39	23	and	and	CCONJ
bptjm-21	39	24	could	could	AUX
bptjm-21	39	25	be	be	AUX
bptjm-21	39	26	playing	play	VERB
bptjm-21	39	27	a	a	DET
bptjm-21	39	28	role	role	NOUN
bptjm-21	39	29	in	in	ADP
bptjm-21	39	30	csr19	csr19	PROPN
bptjm-21	39	31	.	.	PUNCT
bptjm-21	40	1	figure	figure	NOUN
bptjm-21	40	2	2	2	NUM
bptjm-21	40	3	:	:	PUNCT
bptjm-21	40	4	cytosine	cytosine	NOUN
bptjm-21	40	5	to	to	ADP
bptjm-21	40	6	uracil	uracil	ADJ
bptjm-21	40	7	deamination	deamination	NOUN
bptjm-21	40	8	reaction	reaction	NOUN
bptjm-21	40	9	wherein	wherein	SCONJ
bptjm-21	40	10	an	an	DET
bptjm-21	40	11	amine	amine	ADJ
bptjm-21	40	12	group	group	NOUN
bptjm-21	40	13	is	be	AUX
bptjm-21	40	14	removed	remove	VERB
bptjm-21	40	15	shm	shm	NOUN
bptjm-21	40	16	generates	generate	NOUN
bptjm-21	40	17	point	point	NOUN
bptjm-21	40	18	mutations	mutation	NOUN
bptjm-21	40	19	in	in	ADP
bptjm-21	40	20	the	the	DET
bptjm-21	40	21	ig	ig	PROPN
bptjm-21	40	22	variable	variable	ADJ
bptjm-21	40	23	regions	region	NOUN
bptjm-21	40	24	while	while	SCONJ
bptjm-21	40	25	csr	csr	NOUN
bptjm-21	40	26	exchanges	exchange	NOUN
bptjm-21	40	27	the	the	DET
bptjm-21	40	28	ig	ig	PROPN
bptjm-21	40	29	heavy	heavy	ADJ
bptjm-21	40	30	chain	chain	NOUN
bptjm-21	40	31	constant	constant	ADJ
bptjm-21	40	32	region	region	NOUN
bptjm-21	40	33	,	,	PUNCT
bptjm-21	40	34	and	and	CCONJ
bptjm-21	40	35	ultimately	ultimately	ADV
bptjm-21	40	36	this	this	PRON
bptjm-21	40	37	gives	give	VERB
bptjm-21	40	38	rise	rise	NOUN
bptjm-21	40	39	to	to	ADP
bptjm-21	40	40	antibodies	antibody	NOUN
bptjm-21	40	41	with	with	ADP
bptjm-21	40	42	enhanced	enhance	VERB
bptjm-21	40	43	a	a	DET
bptjm-21	40	44	�	�	NOUN
bptjm-21	40	45	nity	nity	NOUN
bptjm-21	40	46	and	and	CCONJ
bptjm-21	40	47	new	new	ADJ
bptjm-21	40	48	e	e	PROPN
bptjm-21	40	49	�	�	PROPN
bptjm-21	40	50	ector	ector	NOUN
bptjm-21	40	51	functions20	functions20	PROPN
bptjm-21	40	52	.	.	PUNCT
bptjm-21	41	1	aid	aid	NOUN
bptjm-21	41	2	initiates	initiate	VERB
bptjm-21	41	3	both	both	DET
bptjm-21	41	4	these	these	DET
bptjm-21	41	5	processes	process	NOUN
bptjm-21	41	6	through	through	ADP
bptjm-21	41	7	deamination	deamination	NOUN
bptjm-21	41	8	of	of	ADP
bptjm-21	41	9	cytosine	cytosine	NOUN
bptjm-21	41	10	to	to	ADP
bptjm-21	41	11	uracil	uracil	PROPN
bptjm-21	41	12	in	in	ADP
bptjm-21	41	13	ig	ig	PROPN
bptjm-21	41	14	variable	variable	NOUN
bptjm-21	41	15	and	and	CCONJ
bptjm-21	41	16	switch	switch	VERB
bptjm-21	41	17	gene	gene	NOUN
bptjm-21	41	18	regions	region	NOUN
bptjm-21	41	19	,	,	PUNCT
bptjm-21	41	20	and	and	CCONJ
bptjm-21	41	21	the	the	DET
bptjm-21	41	22	resultingu	resultingu	NOUN
bptjm-21	41	23	:	:	PUNCT
bptjm-21	41	24	g	g	NOUN
bptjm-21	41	25	mismatches	mismatch	NOUN
bptjm-21	41	26	are	be	AUX
bptjm-21	41	27	berkeley	berkeley	PROPN
bptjm-21	41	28	pharma	pharma	PROPN
bptjm-21	41	29	tech	tech	NOUN
bptjm-21	41	30	journal	journal	NOUN
bptjm-21	41	31	of	of	ADP
bptjm-21	41	32	medicine	medicine	NOUN
bptjm-21	42	1	|	|	ADV
bptjm-21	42	2	110	110	NUM
bptjm-21	42	3	subsequently	subsequently	ADV
bptjm-21	42	4	processed	process	VERB
bptjm-21	42	5	by	by	ADP
bptjm-21	42	6	uracil	uracil	NOUN
bptjm-21	42	7	-	-	PUNCT
bptjm-21	42	8	dna	dna	PROPN
bptjm-21	42	9	glycosylase	glycosylase	NOUN
bptjm-21	42	10	(	(	PUNCT
bptjm-21	42	11	ung2	ung2	PROPN
bptjm-21	42	12	)	)	PUNCT
bptjm-21	42	13	and	and	CCONJ
bptjm-21	42	14	a	a	DET
bptjm-21	42	15	pathway	pathway	NOUN
bptjm-21	42	16	that	that	PRON
bptjm-21	42	17	requires	require	VERB
bptjm-21	42	18	the	the	DET
bptjm-21	42	19	mechanism	mechanism	NOUN
bptjm-21	42	20	by	by	ADP
bptjm-21	42	21	which	which	PRON
bptjm-21	42	22	aid	aid	NOUN
bptjm-21	42	23	works	work	NOUN
bptjm-21	42	24	has	have	AUX
bptjm-21	42	25	not	not	PART
bptjm-21	42	26	been	be	AUX
bptjm-21	42	27	entirely	entirely	ADV
bptjm-21	42	28	discerned	discern	VERB
bptjm-21	42	29	.	.	PUNCT
bptjm-21	43	1	namely	namely	ADV
bptjm-21	43	2	,	,	PUNCT
bptjm-21	43	3	the	the	DET
bptjm-21	43	4	mechanism	mechanism	NOUN
bptjm-21	43	5	of	of	ADP
bptjm-21	43	6	aid	aid	NOUN
bptjm-21	43	7	targeting	target	VERB
bptjm-21	43	8	has	have	AUX
bptjm-21	43	9	especially	especially	ADV
bptjm-21	43	10	been	be	AUX
bptjm-21	43	11	a	a	DET
bptjm-21	43	12	long	long	ADV
bptjm-21	43	13	-	-	PUNCT
bptjm-21	43	14	standing	stand	VERB
bptjm-21	43	15	mystery10	mystery10	NOUN
bptjm-21	43	16	.	.	PUNCT
bptjm-21	44	1	currently	currently	ADV
bptjm-21	44	2	,	,	PUNCT
bptjm-21	44	3	there	there	PRON
bptjm-21	44	4	are	be	VERB
bptjm-21	44	5	many	many	ADJ
bptjm-21	44	6	di	di	NOUN
bptjm-21	44	7	�	�	PROPN
bptjm-21	44	8	erent	erent	NOUN
bptjm-21	44	9	�	�	NOUN
bptjm-21	44	10	ndings	nding	NOUN
bptjm-21	44	11	that	that	PRON
bptjm-21	44	12	are	be	AUX
bptjm-21	44	13	piecing	piece	VERB
bptjm-21	44	14	together	together	ADV
bptjm-21	44	15	the	the	DET
bptjm-21	44	16	puzzle	puzzle	NOUN
bptjm-21	44	17	of	of	ADP
bptjm-21	44	18	how	how	SCONJ
bptjm-21	44	19	exactly	exactly	ADV
bptjm-21	44	20	aid	aid	NOUN
bptjm-21	44	21	works	work	VERB
bptjm-21	44	22	.	.	PUNCT
bptjm-21	45	1	in	in	ADP
bptjm-21	45	2	terms	term	NOUN
bptjm-21	45	3	of	of	ADP
bptjm-21	45	4	frequency	frequency	NOUN
bptjm-21	45	5	,	,	PUNCT
bptjm-21	45	6	the	the	DET
bptjm-21	45	7	number	number	NOUN
bptjm-21	45	8	of	of	ADP
bptjm-21	45	9	molecules	molecule	NOUN
bptjm-21	45	10	containing	contain	VERB
bptjm-21	45	11	deamination	deamination	NOUN
bptjm-21	45	12	in	in	ADP
bptjm-21	45	13	both	both	DET
bptjm-21	45	14	dna	dna	PROPN
bptjm-21	45	15	strands	strand	NOUN
bptjm-21	45	16	at	at	ADP
bptjm-21	45	17	the	the	DET
bptjm-21	45	18	acceptor	acceptor	NOUN
bptjm-21	45	19	switch	switch	NOUN
bptjm-21	45	20	region	region	NOUN
bptjm-21	45	21	corresponds	correspond	VERB
bptjm-21	45	22	to	to	ADP
bptjm-21	45	23	its	its	PRON
bptjm-21	45	24	class	class	NOUN
bptjm-21	45	25	switch	switch	NOUN
bptjm-21	45	26	e	e	NOUN
bptjm-21	45	27	�	�	NOUN
bptjm-21	45	28	ciency	ciency	NOUN
bptjm-21	45	29	.	.	PUNCT
bptjm-21	46	1	it	it	PRON
bptjm-21	46	2	has	have	AUX
bptjm-21	46	3	been	be	AUX
bptjm-21	46	4	proposed	propose	VERB
bptjm-21	46	5	that	that	SCONJ
bptjm-21	46	6	the	the	DET
bptjm-21	46	7	minimal	minimal	ADJ
bptjm-21	46	8	requirement	requirement	NOUN
bptjm-21	46	9	for	for	ADP
bptjm-21	46	10	a	a	DET
bptjm-21	46	11	dna	dna	PROPN
bptjm-21	46	12	double	double	ADJ
bptjm-21	46	13	-	-	PUNCT
bptjm-21	46	14	strand	strand	NOUN
bptjm-21	46	15	break	break	NOUN
bptjm-21	46	16	(	(	PUNCT
bptjm-21	46	17	dsb	dsb	NOUN
bptjm-21	46	18	)	)	PUNCT
bptjm-21	46	19	formation	formation	NOUN
bptjm-21	46	20	is	be	AUX
bptjm-21	46	21	as	as	ADV
bptjm-21	46	22	low	low	ADJ
bptjm-21	46	23	as	as	ADP
bptjm-21	46	24	only	only	ADV
bptjm-21	46	25	one	one	NUM
bptjm-21	46	26	aid	aid	NOUN
bptjm-21	46	27	deamination	deamination	NOUN
bptjm-21	46	28	event	event	NOUN
bptjm-21	46	29	on	on	ADP
bptjm-21	46	30	both	both	DET
bptjm-21	46	31	dna	dna	PROPN
bptjm-21	46	32	strands4	strands4	PROPN
bptjm-21	46	33	.	.	PUNCT
bptjm-21	47	1	there	there	PRON
bptjm-21	47	2	are	be	VERB
bptjm-21	47	3	also	also	ADV
bptjm-21	47	4	several	several	ADJ
bptjm-21	47	5	proposed	propose	VERB
bptjm-21	47	6	mechanisms	mechanism	NOUN
bptjm-21	47	7	for	for	ADP
bptjm-21	47	8	aid	aid	NOUN
bptjm-21	47	9	function	function	NOUN
bptjm-21	47	10	.	.	PUNCT
bptjm-21	48	1	aid	aid	NOUN
bptjm-21	48	2	may	may	AUX
bptjm-21	48	3	target	target	VERB
bptjm-21	48	4	template	template	NOUN
bptjm-21	48	5	and	and	CCONJ
bptjm-21	48	6	non	non	ADJ
bptjm-21	48	7	-	-	ADJ
bptjm-21	48	8	template	template	ADJ
bptjm-21	48	9	strands	strand	NOUN
bptjm-21	48	10	at	at	ADP
bptjm-21	48	11	similar	similar	ADJ
bptjm-21	48	12	frequencies	frequency	NOUN
bptjm-21	48	13	and	and	CCONJ
bptjm-21	48	14	predominantly	predominantly	ADV
bptjm-21	48	15	after	after	SCONJ
bptjm-21	48	16	r	r	NOUN
bptjm-21	48	17	-	-	PUNCT
bptjm-21	48	18	loops	loop	NOUN
bptjm-21	48	19	are	be	AUX
bptjm-21	48	20	processed	process	VERB
bptjm-21	48	21	by	by	ADP
bptjm-21	48	22	cellular	cellular	ADJ
bptjm-21	48	23	enzymes	enzyme	NOUN
bptjm-21	48	24	that	that	PRON
bptjm-21	48	25	expose	expose	VERB
bptjm-21	48	26	dna	dna	NOUN
bptjm-21	48	27	on	on	ADP
bptjm-21	48	28	both	both	DET
bptjm-21	48	29	dna	dna	PROPN
bptjm-21	48	30	strands4	strands4	PROPN
bptjm-21	48	31	.	.	PUNCT
bptjm-21	49	1	additionally	additionally	ADV
bptjm-21	49	2	,	,	PUNCT
bptjm-21	49	3	aid	aid	NOUN
bptjm-21	49	4	footprints	footprint	NOUN
bptjm-21	49	5	may	may	AUX
bptjm-21	49	6	be	be	AUX
bptjm-21	49	7	distributed	distribute	VERB
bptjm-21	49	8	evenly	evenly	ADV
bptjm-21	49	9	across	across	ADP
bptjm-21	49	10	the	the	DET
bptjm-21	49	11	entire	entire	ADJ
bptjm-21	49	12	length	length	NOUN
bptjm-21	49	13	of	of	ADP
bptjm-21	49	14	the	the	DET
bptjm-21	49	15	s	s	NOUN
bptjm-21	49	16	region	region	NOUN
bptjm-21	49	17	,	,	PUNCT
bptjm-21	49	18	unlike	unlike	ADP
bptjm-21	49	19	shm	shm	NOUN
bptjm-21	49	20	,	,	PUNCT
bptjm-21	49	21	which	which	PRON
bptjm-21	49	22	is	be	AUX
bptjm-21	49	23	not	not	PART
bptjm-21	49	24	evenly	evenly	ADV
bptjm-21	49	25	distributed	distribute	VERB
bptjm-21	49	26	over	over	ADP
bptjm-21	49	27	a	a	DET
bptjm-21	49	28	distance	distance	NOUN
bptjm-21	49	29	;	;	PUNCT
bptjm-21	49	30	thus	thus	ADV
bptjm-21	49	31	aid	aid	NOUN
bptjm-21	49	32	deaminates	deaminate	NOUN
bptjm-21	49	33	s	s	PART
bptjm-21	49	34	and	and	CCONJ
bptjm-21	49	35	v	v	ADJ
bptjm-21	49	36	regions	region	NOUN
bptjm-21	49	37	with	with	ADP
bptjm-21	49	38	distinct	distinct	ADJ
bptjm-21	49	39	mechanisms	mechanism	NOUN
bptjm-21	49	40	.	.	PUNCT
bptjm-21	50	1	it	it	PRON
bptjm-21	50	2	has	have	AUX
bptjm-21	50	3	also	also	ADV
bptjm-21	50	4	been	be	AUX
bptjm-21	50	5	suggested	suggest	VERB
bptjm-21	50	6	that	that	SCONJ
bptjm-21	50	7	aid	aid	NOUN
bptjm-21	50	8	-	-	PUNCT
bptjm-21	50	9	mediated	mediate	VERB
bptjm-21	50	10	dna	dna	NOUN
bptjm-21	50	11	demethylation	demethylation	NOUN
bptjm-21	50	12	occurs	occur	VERB
bptjm-21	50	13	due	due	ADJ
bptjm-21	50	14	to	to	ADP
bptjm-21	50	15	the	the	DET
bptjm-21	50	16	deamination	deamination	NOUN
bptjm-21	50	17	of	of	ADP
bptjm-21	50	18	methylated	methylate	VERB
bptjm-21	50	19	cytidine	cytidine	NOUN
bptjm-21	50	20	residues	residue	NOUN
bptjm-21	50	21	in	in	ADP
bptjm-21	50	22	single	single	ADJ
bptjm-21	50	23	-	-	PUNCT
bptjm-21	50	24	stranded	strand	VERB
bptjm-21	50	25	dna	dna	NOUN
bptjm-21	50	26	,	,	PUNCT
bptjm-21	50	27	followed	follow	VERB
bptjm-21	50	28	by	by	ADP
bptjm-21	50	29	dna	dna	PROPN
bptjm-21	50	30	repair7	repair7	NOUN
bptjm-21	50	31	.	.	PUNCT
bptjm-21	51	1	a	a	DET
bptjm-21	51	2	long	long	ADV
bptjm-21	51	3	-	-	PUNCT
bptjm-21	51	4	standing	stand	VERB
bptjm-21	51	5	hypothesis	hypothesis	NOUN
bptjm-21	51	6	on	on	ADP
bptjm-21	51	7	aid	aid	NOUN
bptjm-21	51	8	targeting	target	VERB
bptjm-21	51	9	,	,	PUNCT
bptjm-21	51	10	known	know	VERB
bptjm-21	51	11	as	as	ADP
bptjm-21	51	12	the	the	DET
bptjm-21	51	13	hotspot	hotspot	NOUN
bptjm-21	51	14	hypothesis	hypothesis	NOUN
bptjm-21	51	15	,	,	PUNCT
bptjm-21	51	16	has	have	AUX
bptjm-21	51	17	recently	recently	ADV
bptjm-21	51	18	been	be	AUX
bptjm-21	51	19	under	under	ADP
bptjm-21	51	20	re	re	NOUN
bptjm-21	51	21	-	-	NOUN
bptjm-21	51	22	evaluation	evaluation	NOUN
bptjm-21	51	23	.	.	PUNCT
bptjm-21	52	1	this	this	DET
bptjm-21	52	2	hypothesis	hypothesis	NOUN
bptjm-21	52	3	considered	consider	VERB
bptjm-21	52	4	a	a	DET
bptjm-21	52	5	short	short	ADJ
bptjm-21	52	6	sequence	sequence	NOUN
bptjm-21	52	7	motif	motif	NOUN
bptjm-21	52	8	(	(	PUNCT
bptjm-21	52	9	agct	agct	PROPN
bptjm-21	52	10	)	)	PUNCT
bptjm-21	52	11	conserved	conserve	VERB
bptjm-21	52	12	in	in	ADP
bptjm-21	52	13	all	all	DET
bptjm-21	52	14	s	s	PART
bptjm-21	52	15	regions	region	NOUN
bptjm-21	52	16	as	as	ADP
bptjm-21	52	17	functionally	functionally	ADV
bptjm-21	52	18	important	important	ADJ
bptjm-21	52	19	for	for	ADP
bptjm-21	52	20	csr	csr	NOUN
bptjm-21	52	21	,	,	PUNCT
bptjm-21	52	22	proposing	propose	VERB
bptjm-21	52	23	that	that	SCONJ
bptjm-21	52	24	it	it	PRON
bptjm-21	52	25	exerts	exert	VERB
bptjm-21	52	26	its	its	PRON
bptjm-21	52	27	function	function	NOUN
bptjm-21	52	28	via	via	ADP
bptjm-21	52	29	its	its	PRON
bptjm-21	52	30	overlapping	overlap	VERB
bptjm-21	52	31	aid	aid	NOUN
bptjm-21	52	32	hotspot	hotspot	NOUN
bptjm-21	52	33	structure23	structure23	NOUN
bptjm-21	52	34	.	.	PUNCT
bptjm-21	53	1	however	however	ADV
bptjm-21	53	2	,	,	PUNCT
bptjm-21	53	3	an	an	DET
bptjm-21	53	4	initial	initial	ADJ
bptjm-21	53	5	weakness	weakness	NOUN
bptjm-21	53	6	of	of	ADP
bptjm-21	53	7	this	this	DET
bptjm-21	53	8	theory	theory	NOUN
bptjm-21	53	9	was	be	AUX
bptjm-21	53	10	that	that	SCONJ
bptjm-21	53	11	these	these	DET
bptjm-21	53	12	sequences	sequence	NOUN
bptjm-21	53	13	are	be	AUX
bptjm-21	53	14	very	very	ADV
bptjm-21	53	15	common	common	ADJ
bptjm-21	53	16	in	in	ADP
bptjm-21	53	17	the	the	DET
bptjm-21	53	18	genome23	genome23	NOUN
bptjm-21	53	19	.	.	PUNCT
bptjm-21	54	1	another	another	DET
bptjm-21	54	2	study	study	NOUN
bptjm-21	54	3	determined	determine	VERB
bptjm-21	54	4	one	one	NUM
bptjm-21	54	5	of	of	ADP
bptjm-21	54	6	the	the	DET
bptjm-21	54	7	�	�	PROPN
bptjm-21	54	8	rst	rst	PROPN
bptjm-21	54	9	crystal	crystal	NOUN
bptjm-21	54	10	structures	structure	NOUN
bptjm-21	54	11	of	of	ADP
bptjm-21	54	12	maltose	maltose	ADJ
bptjm-21	54	13	-	-	PUNCT
bptjm-21	54	14	binding	bind	VERB
bptjm-21	54	15	protein	protein	NOUN
bptjm-21	54	16	(	(	PUNCT
bptjm-21	54	17	mbp)-fused	mbp)-fuse	VERB
bptjm-21	54	18	aid	aid	NOUN
bptjm-21	54	19	and	and	CCONJ
bptjm-21	54	20	its	its	PRON
bptjm-21	54	21	complex	complex	NOUN
bptjm-21	54	22	with	with	ADP
bptjm-21	54	23	cytidine	cytidine	NOUN
bptjm-21	54	24	(	(	PUNCT
bptjm-21	54	25	c	c	NOUN
bptjm-21	54	26	)	)	PUNCT
bptjm-21	54	27	,	,	PUNCT
bptjm-21	54	28	deoxycytidine	deoxycytidine	INTJ
bptjm-21	54	29	(	(	PUNCT
bptjm-21	54	30	dc	dc	PROPN
bptjm-21	54	31	)	)	PUNCT
bptjm-21	54	32	,	,	PUNCT
bptjm-21	54	33	and	and	CCONJ
bptjm-21	54	34	deoxycytidine	deoxycytidine	ADJ
bptjm-21	54	35	monophosphate	monophosphate	NOUN
bptjm-21	54	36	(	(	PUNCT
bptjm-21	54	37	dcmp	dcmp	PROPN
bptjm-21	54	38	)	)	PUNCT
bptjm-21	54	39	.	.	PUNCT
bptjm-21	55	1	these	these	DET
bptjm-21	55	2	structures	structure	NOUN
bptjm-21	55	3	can	can	AUX
bptjm-21	55	4	help	help	VERB
bptjm-21	55	5	explain	explain	VERB
bptjm-21	55	6	the	the	DET
bptjm-21	55	7	discrimination	discrimination	NOUN
bptjm-21	55	8	between	between	ADP
bptjm-21	55	9	dna	dna	PROPN
bptjm-21	55	10	and	and	CCONJ
bptjm-21	55	11	rna	rna	PROPN
bptjm-21	55	12	in	in	ADP
bptjm-21	55	13	aid	aid	NOUN
bptjm-21	55	14	catalysis	catalysis	NOUN
bptjm-21	55	15	and	and	CCONJ
bptjm-21	55	16	reveal	reveal	VERB
bptjm-21	55	17	that	that	DET
bptjm-21	55	18	aid	aid	NOUN
bptjm-21	55	19	has	have	VERB
bptjm-21	55	20	a	a	DET
bptjm-21	55	21	bifurcated	bifurcated	ADJ
bptjm-21	55	22	substrate	substrate	NOUN
bptjm-21	55	23	-	-	PUNCT
bptjm-21	55	24	binding	bind	VERB
bptjm-21	55	25	surface10	surface10	NOUN
bptjm-21	55	26	.	.	PUNCT
bptjm-21	56	1	this	this	PRON
bptjm-21	56	2	supports	support	VERB
bptjm-21	56	3	the	the	DET
bptjm-21	56	4	theory	theory	NOUN
bptjm-21	56	5	that	that	SCONJ
bptjm-21	56	6	one	one	NUM
bptjm-21	56	7	aid	aid	NOUN
bptjm-21	56	8	recognizes	recognize	VERB
bptjm-21	56	9	two	two	NUM
bptjm-21	56	10	adjacent	adjacent	ADJ
bptjm-21	56	11	ssdna	ssdna	NOUN
bptjm-21	56	12	overhangs	overhang	NOUN
bptjm-21	56	13	from	from	ADP
bptjm-21	56	14	one	one	NUM
bptjm-21	56	15	structured	structured	ADJ
bptjm-21	56	16	substrate	substrate	NOUN
bptjm-21	56	17	to	to	PART
bptjm-21	56	18	achieve	achieve	VERB
bptjm-21	56	19	high	high	ADJ
bptjm-21	56	20	a	a	DET
bptjm-21	56	21	�	�	NOUN
bptjm-21	56	22	nity10	nity10	NOUN
bptjm-21	56	23	.	.	PUNCT
bptjm-21	57	1	g4	g4	NOUN
bptjm-21	57	2	structured	structure	VERB
bptjm-21	57	3	substrates	substrate	NOUN
bptjm-21	57	4	induce	induce	VERB
bptjm-21	57	5	aid	aid	NOUN
bptjm-21	57	6	cooperative	cooperative	ADJ
bptjm-21	57	7	berkeley	berkeley	PROPN
bptjm-21	57	8	pharma	pharma	PROPN
bptjm-21	57	9	tech	tech	NOUN
bptjm-21	57	10	journal	journal	NOUN
bptjm-21	57	11	of	of	ADP
bptjm-21	57	12	medicine	medicine	NOUN
bptjm-21	57	13	|	|	ADV
bptjm-21	57	14	111	111	NUM
bptjm-21	57	15	oligomerization	oligomerization	NOUN
bptjm-21	57	16	,	,	PUNCT
bptjm-21	57	17	which	which	PRON
bptjm-21	57	18	could	could	AUX
bptjm-21	57	19	promote	promote	VERB
bptjm-21	57	20	clustered	clustered	ADJ
bptjm-21	57	21	mutations	mutation	NOUN
bptjm-21	57	22	in	in	ADP
bptjm-21	57	23	the	the	DET
bptjm-21	57	24	ig	ig	PROPN
bptjm-21	57	25	s	s	PART
bptjm-21	57	26	regions10	regions10	NOUN
bptjm-21	57	27	.	.	PUNCT
bptjm-21	58	1	overall	overall	ADV
bptjm-21	58	2	,	,	PUNCT
bptjm-21	58	3	the	the	DET
bptjm-21	58	4	bifurcated	bifurcated	ADJ
bptjm-21	58	5	substrate	substrate	NOUN
bptjm-21	58	6	binding	bind	VERB
bptjm-21	58	7	surface	surface	NOUN
bptjm-21	58	8	and	and	CCONJ
bptjm-21	58	9	oligomerization	oligomerization	NOUN
bptjm-21	58	10	interface	interface	NOUN
bptjm-21	58	11	are	be	AUX
bptjm-21	58	12	both	both	CCONJ
bptjm-21	58	13	an	an	DET
bptjm-21	58	14	essential	essential	ADJ
bptjm-21	58	15	component	component	NOUN
bptjm-21	58	16	of	of	ADP
bptjm-21	58	17	csr	csr	NOUN
bptjm-21	58	18	and	and	CCONJ
bptjm-21	58	19	help	help	VERB
bptjm-21	58	20	elucidate	elucidate	VERB
bptjm-21	58	21	recognition	recognition	NOUN
bptjm-21	58	22	of	of	ADP
bptjm-21	58	23	structured	structured	ADJ
bptjm-21	58	24	substrates	substrate	NOUN
bptjm-21	58	25	as	as	ADP
bptjm-21	58	26	an	an	DET
bptjm-21	58	27	important	important	ADJ
bptjm-21	58	28	aid	aid	NOUN
bptjm-21	58	29	-	-	PUNCT
bptjm-21	58	30	targeting	target	VERB
bptjm-21	58	31	mechanism	mechanism	NOUN
bptjm-21	58	32	,	,	PUNCT
bptjm-21	58	33	speci	speci	PROPN
bptjm-21	58	34	�	�	X
bptjm-21	58	35	cally	cally	ADV
bptjm-21	58	36	in	in	ADP
bptjm-21	58	37	the	the	DET
bptjm-21	58	38	ig	ig	PROPN
bptjm-21	58	39	s	s	PART
bptjm-21	58	40	regions10	regions10	NOUN
bptjm-21	58	41	.	.	PUNCT
bptjm-21	59	1	it	it	PRON
bptjm-21	59	2	has	have	AUX
bptjm-21	59	3	therefore	therefore	ADV
bptjm-21	59	4	been	be	AUX
bptjm-21	59	5	suggested	suggest	VERB
bptjm-21	59	6	that	that	SCONJ
bptjm-21	59	7	g4	g4	NOUN
bptjm-21	59	8	substrates	substrate	NOUN
bptjm-21	59	9	mimicking	mimic	VERB
bptjm-21	59	10	ig	ig	PROPN
bptjm-21	59	11	s	s	PART
bptjm-21	59	12	regions	region	NOUN
bptjm-21	59	13	are	be	AUX
bptjm-21	59	14	preferred	preferred	ADJ
bptjm-21	59	15	aid	aid	NOUN
bptjm-21	59	16	targets	target	NOUN
bptjm-21	59	17	in	in	ADP
bptjm-21	59	18	vitro	vitro	NOUN
bptjm-21	59	19	.	.	PUNCT
bptjm-21	60	1	this	this	DET
bptjm-21	60	2	recent	recent	ADJ
bptjm-21	60	3	�	�	PROPN
bptjm-21	60	4	nding	nding	NOUN
bptjm-21	60	5	is	be	AUX
bptjm-21	60	6	a	a	DET
bptjm-21	60	7	departure	departure	NOUN
bptjm-21	60	8	from	from	ADP
bptjm-21	60	9	our	our	PRON
bptjm-21	60	10	previous	previous	ADJ
bptjm-21	60	11	understanding	understanding	NOUN
bptjm-21	60	12	of	of	ADP
bptjm-21	60	13	aid	aid	NOUN
bptjm-21	60	14	targeting	target	VERB
bptjm-21	60	15	.	.	PUNCT
bptjm-21	61	1	this	this	DET
bptjm-21	61	2	data	data	NOUN
bptjm-21	61	3	also	also	ADV
bptjm-21	61	4	posits	posit	VERB
bptjm-21	61	5	that	that	PRON
bptjm-21	61	6	aid	aid	NOUN
bptjm-21	61	7	preference	preference	NOUN
bptjm-21	61	8	for	for	ADP
bptjm-21	61	9	these	these	DET
bptjm-21	61	10	substrates	substrate	NOUN
bptjm-21	61	11	is	be	AUX
bptjm-21	61	12	likely	likely	ADJ
bptjm-21	61	13	due	due	ADP
bptjm-21	61	14	to	to	ADP
bptjm-21	61	15	their	their	PRON
bptjm-21	61	16	bundled	bundled	ADJ
bptjm-21	61	17	ssdna	ssdna	NOUN
bptjm-21	61	18	overhangs	overhang	NOUN
bptjm-21	61	19	structure	structure	NOUN
bptjm-21	61	20	rather	rather	ADV
bptjm-21	61	21	than	than	ADP
bptjm-21	61	22	the	the	DET
bptjm-21	61	23	primary	primary	ADJ
bptjm-21	61	24	sequence	sequence	NOUN
bptjm-21	61	25	motif	motif	NOUN
bptjm-21	61	26	,	,	PUNCT
bptjm-21	61	27	which	which	PRON
bptjm-21	61	28	was	be	AUX
bptjm-21	61	29	long	long	ADV
bptjm-21	61	30	believed	believe	VERB
bptjm-21	61	31	to	to	PART
bptjm-21	61	32	bewhy	bewhy	ADV
bptjm-21	61	33	aid	aid	VERB
bptjm-21	61	34	preferred	prefer	VERB
bptjm-21	61	35	these	these	DET
bptjm-21	61	36	substrates10	substrates10	NOUN
bptjm-21	61	37	.	.	PUNCT
bptjm-21	62	1	it	it	PRON
bptjm-21	62	2	is	be	AUX
bptjm-21	62	3	important	important	ADJ
bptjm-21	62	4	to	to	PART
bptjm-21	62	5	recognize	recognize	VERB
bptjm-21	62	6	that	that	SCONJ
bptjm-21	62	7	a	a	DET
bptjm-21	62	8	de	de	X
bptjm-21	62	9	�	�	NOUN
bptjm-21	62	10	nitive	nitive	ADJ
bptjm-21	62	11	complex	complex	ADJ
bptjm-21	62	12	structure	structure	NOUN
bptjm-21	62	13	with	with	ADP
bptjm-21	62	14	fully	fully	ADV
bptjm-21	62	15	characterized	characterize	VERB
bptjm-21	62	16	substrate	substrate	NOUN
bptjm-21	62	17	conformation	conformation	NOUN
bptjm-21	62	18	is	be	AUX
bptjm-21	62	19	still	still	ADV
bptjm-21	62	20	lacking	lack	VERB
bptjm-21	62	21	and	and	CCONJ
bptjm-21	62	22	must	must	AUX
bptjm-21	62	23	be	be	AUX
bptjm-21	62	24	developed10	developed10	PROPN
bptjm-21	62	25	.	.	PUNCT
bptjm-21	63	1	many	many	ADJ
bptjm-21	63	2	proposed	proposed	ADJ
bptjm-21	63	3	therapies	therapy	NOUN
bptjm-21	63	4	suggest	suggest	VERB
bptjm-21	63	5	that	that	SCONJ
bptjm-21	63	6	selective	selective	ADJ
bptjm-21	63	7	inhibition	inhibition	NOUN
bptjm-21	63	8	of	of	ADP
bptjm-21	63	9	aid	aid	NOUN
bptjm-21	63	10	may	may	AUX
bptjm-21	63	11	ameliorate	ameliorate	VERB
bptjm-21	63	12	the	the	DET
bptjm-21	63	13	conditions	condition	NOUN
bptjm-21	63	14	.	.	PUNCT
bptjm-21	64	1	ultimately	ultimately	ADV
bptjm-21	64	2	,	,	PUNCT
bptjm-21	64	3	further	further	ADJ
bptjm-21	64	4	experimentation	experimentation	NOUN
bptjm-21	64	5	and	and	CCONJ
bptjm-21	64	6	analysis	analysis	NOUN
bptjm-21	64	7	with	with	ADP
bptjm-21	64	8	more	more	ADV
bptjm-21	64	9	sensitive	sensitive	ADJ
bptjm-21	64	10	techniques	technique	NOUN
bptjm-21	64	11	that	that	PRON
bptjm-21	64	12	may	may	AUX
bptjm-21	64	13	eventually	eventually	ADV
bptjm-21	64	14	be	be	AUX
bptjm-21	64	15	developed	develop	VERB
bptjm-21	64	16	is	be	AUX
bptjm-21	64	17	needed	need	VERB
bptjm-21	64	18	to	to	PART
bptjm-21	64	19	more	more	ADV
bptjm-21	64	20	fully	fully	ADV
bptjm-21	64	21	understand	understand	VERB
bptjm-21	64	22	the	the	DET
bptjm-21	64	23	mechanism	mechanism	NOUN
bptjm-21	64	24	of	of	ADP
bptjm-21	64	25	aid	aid	NOUN
bptjm-21	64	26	inhibition	inhibition	NOUN
bptjm-21	64	27	.	.	PUNCT
bptjm-21	65	1	given	give	VERB
bptjm-21	65	2	that	that	SCONJ
bptjm-21	65	3	the	the	DET
bptjm-21	65	4	crystal	crystal	NOUN
bptjm-21	65	5	structure	structure	NOUN
bptjm-21	65	6	of	of	ADP
bptjm-21	65	7	aid	aid	NOUN
bptjm-21	65	8	has	have	AUX
bptjm-21	65	9	recently	recently	ADV
bptjm-21	65	10	been	be	AUX
bptjm-21	65	11	resolved	resolve	VERB
bptjm-21	65	12	,	,	PUNCT
bptjm-21	65	13	future	future	ADJ
bptjm-21	65	14	e	e	NOUN
bptjm-21	65	15	�	�	NOUN
bptjm-21	65	16	orts	ort	NOUN
bptjm-21	65	17	would	would	AUX
bptjm-21	65	18	certainly	certainly	ADV
bptjm-21	65	19	bene	bene	VERB
bptjm-21	65	20	�	�	PROPN
bptjm-21	65	21	t	t	PROPN
bptjm-21	65	22	from	from	ADP
bptjm-21	65	23	structural	structural	ADJ
bptjm-21	65	24	modeling	modeling	NOUN
bptjm-21	65	25	approaches10	approaches10	NOUN
bptjm-21	65	26	.	.	PUNCT
bptjm-21	66	1	a	a	PRON
bptjm-21	66	2	more	more	ADV
bptjm-21	66	3	de	de	ADP
bptjm-21	66	4	�	�	NOUN
bptjm-21	66	5	nitive	nitive	ADJ
bptjm-21	66	6	structure	structure	NOUN
bptjm-21	66	7	could	could	AUX
bptjm-21	66	8	serve	serve	VERB
bptjm-21	66	9	as	as	ADP
bptjm-21	66	10	a	a	DET
bptjm-21	66	11	template	template	NOUN
bptjm-21	66	12	for	for	ADP
bptjm-21	66	13	potential	potential	ADJ
bptjm-21	66	14	therapeutic	therapeutic	ADJ
bptjm-21	66	15	intervention	intervention	NOUN
bptjm-21	66	16	against	against	ADP
bptjm-21	66	17	aid10	aid10	PROPN
bptjm-21	66	18	.	.	PUNCT
bptjm-21	67	1	progress	progress	NOUN
bptjm-21	67	2	on	on	ADP
bptjm-21	67	3	aid	aid	NOUN
bptjm-21	67	4	structure	structure	NOUN
bptjm-21	67	5	is	be	AUX
bptjm-21	67	6	very	very	ADV
bptjm-21	67	7	timely	timely	ADJ
bptjm-21	67	8	alongside	alongside	ADP
bptjm-21	67	9	the	the	DET
bptjm-21	67	10	growing	grow	VERB
bptjm-21	67	11	knowledge	knowledge	NOUN
bptjm-21	67	12	about	about	ADP
bptjm-21	67	13	ig	ig	PROPN
bptjm-21	67	14	class	class	NOUN
bptjm-21	67	15	switch	switch	NOUN
bptjm-21	67	16	region	region	NOUN
bptjm-21	67	17	nucleic	nucleic	ADJ
bptjm-21	67	18	acid	acid	NOUN
bptjm-21	67	19	structures	structure	NOUN
bptjm-21	67	20	,	,	PUNCT
bptjm-21	67	21	which	which	PRON
bptjm-21	67	22	are	be	AUX
bptjm-21	67	23	supported	support	VERB
bptjm-21	67	24	by	by	ADP
bptjm-21	67	25	functional	functional	ADJ
bptjm-21	67	26	studies24	studies24	NOUN
bptjm-21	67	27	.	.	PUNCT
bptjm-21	68	1	already	already	ADV
bptjm-21	68	2	,	,	PUNCT
bptjm-21	68	3	we	we	PRON
bptjm-21	68	4	are	be	AUX
bptjm-21	68	5	seeing	see	VERB
bptjm-21	68	6	promising	promising	ADJ
bptjm-21	68	7	results	result	NOUN
bptjm-21	68	8	from	from	ADP
bptjm-21	68	9	initiatives	initiative	NOUN
bptjm-21	68	10	focusing	focus	VERB
bptjm-21	68	11	on	on	ADP
bptjm-21	68	12	aid	aid	NOUN
bptjm-21	68	13	.	.	PUNCT
bptjm-21	69	1	platforms	platform	NOUN
bptjm-21	69	2	like	like	ADP
bptjm-21	69	3	genevestigator	genevestigator	NOUN
bptjm-21	69	4	consolidate	consolidate	VERB
bptjm-21	69	5	publicly	publicly	ADV
bptjm-21	69	6	available	available	ADJ
bptjm-21	69	7	studies	study	NOUN
bptjm-21	69	8	from	from	ADP
bptjm-21	69	9	microarrays	microarray	NOUN
bptjm-21	69	10	,	,	PUNCT
bptjm-21	69	11	mrna	mrna	PROPN
bptjm-21	69	12	sequencing	sequencing	NOUN
bptjm-21	69	13	,	,	PUNCT
bptjm-21	69	14	and	and	CCONJ
bptjm-21	69	15	more	more	ADV
bptjm-21	69	16	under	under	ADP
bptjm-21	69	17	healthy	healthy	ADJ
bptjm-21	69	18	conditions	condition	NOUN
bptjm-21	69	19	versus	versus	ADP
bptjm-21	69	20	diseased	diseased	ADJ
bptjm-21	69	21	states25	states25	NOUN
bptjm-21	69	22	.	.	PUNCT
bptjm-21	70	1	using	use	VERB
bptjm-21	70	2	these	these	DET
bptjm-21	70	3	comparisons	comparison	NOUN
bptjm-21	70	4	is	be	AUX
bptjm-21	70	5	one	one	NUM
bptjm-21	70	6	potential	potential	ADJ
bptjm-21	70	7	strategy	strategy	NOUN
bptjm-21	70	8	for	for	ADP
bptjm-21	70	9	a	a	DET
bptjm-21	70	10	comprehensive	comprehensive	ADJ
bptjm-21	70	11	analysis	analysis	NOUN
bptjm-21	70	12	of	of	ADP
bptjm-21	70	13	the	the	DET
bptjm-21	70	14	role	role	NOUN
bptjm-21	70	15	of	of	ADP
bptjm-21	70	16	aid	aid	NOUN
bptjm-21	70	17	in	in	ADP
bptjm-21	70	18	the	the	DET
bptjm-21	70	19	pathobiology	pathobiology	NOUN
bptjm-21	70	20	of	of	ADP
bptjm-21	70	21	immuneor	immuneor	PROPN
bptjm-21	70	22	in	in	ADP
bptjm-21	70	23	�	�	NOUN
bptjm-21	70	24	ammatory	ammatory	NOUN
bptjm-21	70	25	-	-	PUNCT
bptjm-21	70	26	based	base	VERB
bptjm-21	70	27	diseases	disease	NOUN
bptjm-21	70	28	and	and	CCONJ
bptjm-21	70	29	cancer25	cancer25	NOUN
bptjm-21	70	30	.	.	PUNCT
bptjm-21	71	1	it	it	PRON
bptjm-21	71	2	has	have	AUX
bptjm-21	71	3	also	also	ADV
bptjm-21	71	4	been	be	AUX
bptjm-21	71	5	suggested	suggest	VERB
bptjm-21	71	6	that	that	SCONJ
bptjm-21	71	7	we	we	PRON
bptjm-21	71	8	may	may	AUX
bptjm-21	71	9	eventually	eventually	ADV
bptjm-21	71	10	be	be	AUX
bptjm-21	71	11	able	able	ADJ
bptjm-21	71	12	to	to	PART
bptjm-21	71	13	analyze	analyze	VERB
bptjm-21	71	14	aid	aid	NOUN
bptjm-21	71	15	gene	gene	NOUN
bptjm-21	71	16	signatures	signature	NOUN
bptjm-21	71	17	to	to	PART
bptjm-21	71	18	get	get	VERB
bptjm-21	71	19	decisive	decisive	ADJ
bptjm-21	71	20	determinants	determinant	NOUN
bptjm-21	71	21	of	of	ADP
bptjm-21	71	22	patient	patient	NOUN
bptjm-21	71	23	-	-	PUNCT
bptjm-21	71	24	speci	speci	NOUN
bptjm-21	71	25	�	�	PROPN
bptjm-21	71	26	c	c	NOUN
bptjm-21	71	27	or	or	CCONJ
bptjm-21	71	28	patient	patient	NOUN
bptjm-21	71	29	-	-	PUNCT
bptjm-21	71	30	group	group	NOUN
bptjm-21	71	31	-	-	PUNCT
bptjm-21	71	32	speci	speci	NOUN
bptjm-21	71	33	�	�	PROPN
bptjm-21	71	34	c	c	PROPN
bptjm-21	71	35	antiviral	antiviral	ADJ
bptjm-21	71	36	response	response	NOUN
bptjm-21	71	37	,	,	PUNCT
bptjm-21	71	38	which	which	PRON
bptjm-21	71	39	could	could	AUX
bptjm-21	71	40	allow	allow	VERB
bptjm-21	71	41	us	we	PRON
bptjm-21	71	42	to	to	PART
bptjm-21	71	43	understand	understand	VERB
bptjm-21	71	44	how	how	SCONJ
bptjm-21	71	45	viruses	virus	NOUN
bptjm-21	71	46	can	can	AUX
bptjm-21	71	47	impact	impact	VERB
bptjm-21	71	48	di	di	NOUN
bptjm-21	71	49	�	�	PROPN
bptjm-21	71	50	erent	erent	NOUN
bptjm-21	71	51	individuals25	individuals25	NOUN
bptjm-21	71	52	.	.	PUNCT
bptjm-21	72	1	berkeley	berkeley	PROPN
bptjm-21	72	2	pharma	pharma	PROPN
bptjm-21	72	3	tech	tech	PROPN
bptjm-21	72	4	journal	journal	NOUN
bptjm-21	72	5	of	of	ADP
bptjm-21	72	6	medicine	medicine	NOUN
bptjm-21	72	7	|	|	ADV
bptjm-21	72	8	112	112	NUM
bptjm-21	72	9	estrogen	estrogen	NOUN
bptjm-21	72	10	and	and	CCONJ
bptjm-21	72	11	aid	aid	NOUN
bptjm-21	72	12	estrogen	estrogen	NOUN
bptjm-21	72	13	has	have	AUX
bptjm-21	72	14	been	be	AUX
bptjm-21	72	15	found	find	VERB
bptjm-21	72	16	to	to	PART
bptjm-21	72	17	reverse	reverse	VERB
bptjm-21	72	18	the	the	DET
bptjm-21	72	19	repression	repression	NOUN
bptjm-21	72	20	of	of	ADP
bptjm-21	72	21	aid	aid	NOUN
bptjm-21	72	22	,	,	PUNCT
bptjm-21	72	23	resulting	result	VERB
bptjm-21	72	24	in	in	ADP
bptjm-21	72	25	a	a	DET
bptjm-21	72	26	subsequent	subsequent	ADJ
bptjm-21	72	27	boost	boost	NOUN
bptjm-21	72	28	in	in	ADP
bptjm-21	72	29	aid	aid	NOUN
bptjm-21	72	30	expression	expression	NOUN
bptjm-21	72	31	.	.	PUNCT
bptjm-21	73	1	this	this	PRON
bptjm-21	73	2	is	be	AUX
bptjm-21	73	3	proposed	propose	VERB
bptjm-21	73	4	to	to	PART
bptjm-21	73	5	occur	occur	VERB
bptjm-21	73	6	through	through	ADP
bptjm-21	73	7	the	the	DET
bptjm-21	73	8	upregulation	upregulation	NOUN
bptjm-21	73	9	of	of	ADP
bptjm-21	73	10	hoxc4	hoxc4	NOUN
bptjm-21	73	11	,	,	PUNCT
bptjm-21	73	12	which	which	PRON
bptjm-21	73	13	,	,	PUNCT
bptjm-21	73	14	together	together	ADV
bptjm-21	73	15	with	with	ADP
bptjm-21	73	16	nf	nf	NOUN
bptjm-21	73	17	-	-	PUNCT
bptjm-21	73	18	κb	κb	ADJ
bptjm-21	73	19	,	,	PUNCT
bptjm-21	73	20	critically	critically	ADV
bptjm-21	73	21	mediates	mediate	NOUN
bptjm-21	73	22	aid	aid	NOUN
bptjm-21	73	23	promoter	promoter	NOUN
bptjm-21	73	24	activation6	activation6	NOUN
bptjm-21	73	25	.	.	PUNCT
bptjm-21	74	1	there	there	PRON
bptjm-21	74	2	may	may	AUX
bptjm-21	74	3	,	,	PUNCT
bptjm-21	74	4	however	however	ADV
bptjm-21	74	5	,	,	PUNCT
bptjm-21	74	6	be	be	AUX
bptjm-21	74	7	additional	additional	ADJ
bptjm-21	74	8	epigenetic	epigenetic	ADJ
bptjm-21	74	9	mechanisms	mechanism	NOUN
bptjm-21	74	10	at	at	ADP
bptjm-21	74	11	play	play	NOUN
bptjm-21	74	12	that	that	PRON
bptjm-21	74	13	serve	serve	VERB
bptjm-21	74	14	to	to	PART
bptjm-21	74	15	regulate	regulate	VERB
bptjm-21	74	16	aid	aid	NOUN
bptjm-21	74	17	expression	expression	NOUN
bptjm-21	74	18	.	.	PUNCT
bptjm-21	75	1	estrogen	estrogen	NOUN
bptjm-21	75	2	reverses	reverse	VERB
bptjm-21	75	3	hdi	hdi	NOUN
bptjm-21	75	4	-	-	PUNCT
bptjm-21	75	5	mediated	mediate	VERB
bptjm-21	75	6	inhibition	inhibition	NOUN
bptjm-21	75	7	of	of	ADP
bptjm-21	75	8	aid	aid	NOUN
bptjm-21	75	9	and	and	CCONJ
bptjm-21	75	10	csr	csr	X
bptjm-21	75	11	in	in	ADP
bptjm-21	75	12	ab	ab	PROPN
bptjm-21	75	13	and	and	CCONJ
bptjm-21	75	14	autoantibody	autoantibody	ADJ
bptjm-21	75	15	responses	response	NOUN
bptjm-21	75	16	through	through	ADP
bptjm-21	75	17	the	the	DET
bptjm-21	75	18	downregulation	downregulation	NOUN
bptjm-21	75	19	of	of	ADP
bptjm-21	75	20	b	b	NOUN
bptjm-21	75	21	cell	cell	NOUN
bptjm-21	75	22	mir-26a	mir-26a	NOUN
bptjm-21	75	23	,	,	PUNCT
bptjm-21	75	24	which	which	PRON
bptjm-21	75	25	targets	target	VERB
bptjm-21	75	26	aid	aid	NOUN
bptjm-21	75	27	mrna	mrna	PROPN
bptjm-21	75	28	’s	’s	PART
bptjm-21	75	29	3’utr6	3’utr6	NUM
bptjm-21	75	30	.	.	PUNCT
bptjm-21	76	1	as	as	SCONJ
bptjm-21	76	2	epigenetic	epigenetic	ADJ
bptjm-21	76	3	modi	modi	PROPN
bptjm-21	76	4	�	�	PROPN
bptjm-21	76	5	ers	ers	PROPN
bptjm-21	76	6	,	,	PUNCT
bptjm-21	76	7	scfa	scfa	ADJ
bptjm-21	76	8	hdis	hdi	NOUN
bptjm-21	76	9	,	,	PUNCT
bptjm-21	76	10	like	like	ADP
bptjm-21	76	11	mir-26a	mir-26a	NOUN
bptjm-21	76	12	and	and	CCONJ
bptjm-21	76	13	mir-125a	mir-125a	NOUN
bptjm-21	76	14	,	,	PUNCT
bptjm-21	76	15	inhibit	inhibit	VERB
bptjm-21	76	16	aid	aid	NOUN
bptjm-21	76	17	expression	expression	NOUN
bptjm-21	76	18	and	and	CCONJ
bptjm-21	76	19	csr	csr	NOUN
bptjm-21	76	20	through	through	ADP
bptjm-21	76	21	the	the	DET
bptjm-21	76	22	upregulation	upregulation	NOUN
bptjm-21	76	23	of	of	ADP
bptjm-21	76	24	select	select	ADJ
bptjm-21	76	25	b	b	PROPN
bptjm-21	76	26	cell	cell	NOUN
bptjm-21	76	27	mirnas	mirna	NOUN
bptjm-21	76	28	,	,	PUNCT
bptjm-21	76	29	which	which	PRON
bptjm-21	76	30	silence	silence	NOUN
bptjm-21	76	31	aid26	aid26	VERB
bptjm-21	76	32	.	.	PUNCT
bptjm-21	77	1	this	this	PRON
bptjm-21	77	2	is	be	AUX
bptjm-21	77	3	interesting	interesting	ADJ
bptjm-21	77	4	as	as	SCONJ
bptjm-21	77	5	it	it	PRON
bptjm-21	77	6	may	may	AUX
bptjm-21	77	7	provide	provide	VERB
bptjm-21	77	8	an	an	DET
bptjm-21	77	9	explanation	explanation	NOUN
bptjm-21	77	10	for	for	ADP
bptjm-21	77	11	the	the	DET
bptjm-21	77	12	female	female	ADJ
bptjm-21	77	13	bias	bias	NOUN
bptjm-21	77	14	in	in	ADP
bptjm-21	77	15	autoantibody	autoantibody	ADJ
bptjm-21	77	16	-	-	PUNCT
bptjm-21	77	17	mediated	mediate	VERB
bptjm-21	77	18	autoimmune	autoimmune	ADJ
bptjm-21	77	19	diseases	disease	NOUN
bptjm-21	77	20	like	like	ADP
bptjm-21	77	21	lupus2	lupus2	NOUN
bptjm-21	77	22	.	.	PUNCT
bptjm-21	78	1	yet	yet	ADV
bptjm-21	78	2	,	,	PUNCT
bptjm-21	78	3	an	an	DET
bptjm-21	78	4	experimental	experimental	ADJ
bptjm-21	78	5	and	and	CCONJ
bptjm-21	78	6	fully	fully	ADV
bptjm-21	78	7	functioning	function	VERB
bptjm-21	78	8	in	in	ADP
bptjm-21	78	9	vivo	vivo	ADJ
bptjm-21	78	10	model	model	NOUN
bptjm-21	78	11	of	of	ADP
bptjm-21	78	12	the	the	DET
bptjm-21	78	13	human	human	ADJ
bptjm-21	78	14	immune	immune	ADJ
bptjm-21	78	15	system	system	NOUN
bptjm-21	78	16	is	be	AUX
bptjm-21	78	17	needed	need	VERB
bptjm-21	78	18	in	in	ADP
bptjm-21	78	19	order	order	NOUN
bptjm-21	78	20	to	to	PART
bptjm-21	78	21	understand	understand	VERB
bptjm-21	78	22	the	the	DET
bptjm-21	78	23	epigenetic	epigenetic	ADJ
bptjm-21	78	24	mechanisms	mechanism	NOUN
bptjm-21	78	25	relating	relate	VERB
bptjm-21	78	26	to	to	ADP
bptjm-21	78	27	the	the	DET
bptjm-21	78	28	human	human	PROPN
bptjm-21	78	29	ab	ab	PROPN
bptjm-21	78	30	and	and	CCONJ
bptjm-21	78	31	autoantibody	autoantibody	VERB
bptjm-21	78	32	response6	response6	PROPN
bptjm-21	78	33	.	.	PUNCT
bptjm-21	79	1	autoimmune	autoimmune	ADJ
bptjm-21	79	2	diseases	disease	NOUN
bptjm-21	79	3	cellular	cellular	ADJ
bptjm-21	79	4	reprogramming	reprogramming	NOUN
bptjm-21	79	5	,	,	PUNCT
bptjm-21	79	6	broadly	broadly	ADV
bptjm-21	79	7	,	,	PUNCT
bptjm-21	79	8	is	be	AUX
bptjm-21	79	9	a	a	DET
bptjm-21	79	10	mechanism	mechanism	NOUN
bptjm-21	79	11	that	that	PRON
bptjm-21	79	12	must	must	AUX
bptjm-21	79	13	be	be	AUX
bptjm-21	79	14	further	far	ADV
bptjm-21	79	15	explored	explore	VERB
bptjm-21	79	16	.	.	PUNCT
bptjm-21	80	1	currently	currently	ADV
bptjm-21	80	2	,	,	PUNCT
bptjm-21	80	3	there	there	PRON
bptjm-21	80	4	are	be	VERB
bptjm-21	80	5	three	three	NUM
bptjm-21	80	6	approaches	approach	NOUN
bptjm-21	80	7	to	to	PART
bptjm-21	80	8	induce	induce	VERB
bptjm-21	80	9	reprogramming	reprogramme	VERB
bptjm-21	80	10	:	:	PUNCT
bptjm-21	80	11	cell	cell	NOUN
bptjm-21	80	12	fusion	fusion	NOUN
bptjm-21	80	13	,	,	PUNCT
bptjm-21	80	14	nuclear	nuclear	ADJ
bptjm-21	80	15	transfer	transfer	NOUN
bptjm-21	80	16	,	,	PUNCT
bptjm-21	80	17	and	and	CCONJ
bptjm-21	80	18	ipsc14	ipsc14	NOUN
bptjm-21	80	19	.	.	PUNCT
bptjm-21	81	1	cell	cell	NOUN
bptjm-21	81	2	fusion	fusion	NOUN
bptjm-21	81	3	is	be	AUX
bptjm-21	81	4	a	a	DET
bptjm-21	81	5	great	great	ADJ
bptjm-21	81	6	way	way	NOUN
bptjm-21	81	7	to	to	PART
bptjm-21	81	8	understand	understand	VERB
bptjm-21	81	9	nuclear	nuclear	ADJ
bptjm-21	81	10	plasticity	plasticity	NOUN
bptjm-21	81	11	and	and	CCONJ
bptjm-21	81	12	is	be	AUX
bptjm-21	81	13	a	a	DET
bptjm-21	81	14	main	main	ADJ
bptjm-21	81	15	element	element	NOUN
bptjm-21	81	16	of	of	ADP
bptjm-21	81	17	many	many	ADJ
bptjm-21	81	18	cancer	cancer	NOUN
bptjm-21	81	19	processes14	processes14	NOUN
bptjm-21	81	20	.	.	PUNCT
bptjm-21	82	1	nuclear	nuclear	ADJ
bptjm-21	82	2	transfer	transfer	NOUN
bptjm-21	82	3	,	,	PUNCT
bptjm-21	82	4	more	more	ADV
bptjm-21	82	5	commonly	commonly	ADV
bptjm-21	82	6	referred	refer	VERB
bptjm-21	82	7	to	to	ADP
bptjm-21	82	8	as	as	ADP
bptjm-21	82	9	cloning	cloning	NOUN
bptjm-21	82	10	,	,	PUNCT
bptjm-21	82	11	has	have	VERB
bptjm-21	82	12	potential	potential	ADJ
bptjm-21	82	13	therapeutic	therapeutic	ADJ
bptjm-21	82	14	applications	application	NOUN
bptjm-21	82	15	,	,	PUNCT
bptjm-21	82	16	although	although	SCONJ
bptjm-21	82	17	ethical	ethical	ADJ
bptjm-21	82	18	concerns	concern	NOUN
bptjm-21	82	19	exist14	exist14	NOUN
bptjm-21	82	20	.	.	PUNCT
bptjm-21	83	1	ipsc	ipsc	PROPN
bptjm-21	83	2	technology	technology	PROPN
bptjm-21	83	3	is	be	AUX
bptjm-21	83	4	anexcellent	anexcellent	ADJ
bptjm-21	83	5	option	option	NOUN
bptjm-21	83	6	given	give	VERB
bptjm-21	83	7	that	that	SCONJ
bptjm-21	83	8	it	it	PRON
bptjm-21	83	9	has	have	AUX
bptjm-21	83	10	potential	potential	ADJ
bptjm-21	83	11	therapeutic	therapeutic	ADJ
bptjm-21	83	12	applications	application	NOUN
bptjm-21	83	13	for	for	ADP
bptjm-21	83	14	clinical	clinical	ADJ
bptjm-21	83	15	use	use	NOUN
bptjm-21	83	16	without	without	ADP
bptjm-21	83	17	ethical	ethical	ADJ
bptjm-21	83	18	concerns	concern	NOUN
bptjm-21	83	19	and	and	CCONJ
bptjm-21	83	20	can	can	AUX
bptjm-21	83	21	be	be	AUX
bptjm-21	83	22	used	use	VERB
bptjm-21	83	23	to	to	PART
bptjm-21	83	24	model	model	VERB
bptjm-21	83	25	human	human	ADJ
bptjm-21	83	26	diseases	disease	NOUN
bptjm-21	83	27	and	and	CCONJ
bptjm-21	83	28	screen	screen	NOUN
bptjm-21	83	29	potential	potential	ADJ
bptjm-21	83	30	new	new	ADJ
bptjm-21	83	31	treatments27	treatments27	NOUN
bptjm-21	83	32	.	.	PUNCT
bptjm-21	84	1	dna	dna	PROPN
bptjm-21	84	2	methylation	methylation	NOUN
bptjm-21	84	3	is	be	AUX
bptjm-21	84	4	a	a	DET
bptjm-21	84	5	major	major	ADJ
bptjm-21	84	6	barrier	barrier	NOUN
bptjm-21	84	7	to	to	ADP
bptjm-21	84	8	induced	induce	VERB
bptjm-21	84	9	pluripotent	pluripotent	ADJ
bptjm-21	84	10	stem	stem	NOUN
bptjm-21	84	11	(	(	PUNCT
bptjm-21	84	12	ips	ips	NOUN
bptjm-21	84	13	)	)	PUNCT
bptjm-21	84	14	cell	cell	NOUN
bptjm-21	84	15	reprogramming	reprogramming	NOUN
bptjm-21	84	16	,	,	PUNCT
bptjm-21	84	17	and	and	CCONJ
bptjm-21	84	18	putative	putative	ADJ
bptjm-21	84	19	dna	dna	NOUN
bptjm-21	84	20	demethylase	demethylase	NOUN
bptjm-21	84	21	protein	protein	NOUN
bptjm-21	84	22	aid	aid	NOUN
bptjm-21	84	23	can	can	AUX
bptjm-21	84	24	erase	erase	VERB
bptjm-21	84	25	dna	dna	PROPN
bptjm-21	84	26	methylation	methylation	NOUN
bptjm-21	84	27	at	at	ADP
bptjm-21	84	28	pluripotency	pluripotency	ADJ
bptjm-21	84	29	gene	gene	NOUN
bptjm-21	84	30	promoters	promoter	NOUN
bptjm-21	84	31	,	,	PUNCT
bptjm-21	84	32	which	which	PRON
bptjm-21	84	33	will	will	AUX
bptjm-21	84	34	subsequently	subsequently	ADV
bptjm-21	84	35	allow	allow	VERB
bptjm-21	84	36	cellular	cellular	ADJ
bptjm-21	84	37	reprogramming14	reprogramming14	NOUN
bptjm-21	84	38	.	.	PUNCT
bptjm-21	85	1	autoimmune	autoimmune	ADJ
bptjm-21	85	2	diseases	disease	NOUN
bptjm-21	85	3	are	be	AUX
bptjm-21	85	4	detrimental	detrimental	ADJ
bptjm-21	85	5	to	to	ADP
bptjm-21	85	6	the	the	DET
bptjm-21	85	7	health	health	NOUN
bptjm-21	85	8	and	and	CCONJ
bptjm-21	85	9	wellbeing	wellbeing	NOUN
bptjm-21	85	10	of	of	ADP
bptjm-21	85	11	individuals	individual	NOUN
bptjm-21	85	12	globally	globally	ADV
bptjm-21	85	13	.	.	PUNCT
bptjm-21	86	1	berkeley	berkeley	PROPN
bptjm-21	86	2	pharma	pharma	PROPN
bptjm-21	86	3	tech	tech	PROPN
bptjm-21	86	4	journal	journal	NOUN
bptjm-21	86	5	of	of	ADP
bptjm-21	86	6	medicine	medicine	NOUN
bptjm-21	86	7	|	|	ADV
bptjm-21	86	8	113	113	NUM
bptjm-21	86	9	one	one	NUM
bptjm-21	86	10	example	example	NOUN
bptjm-21	86	11	of	of	ADP
bptjm-21	86	12	such	such	DET
bptjm-21	86	13	a	a	DET
bptjm-21	86	14	disease	disease	NOUN
bptjm-21	86	15	is	be	AUX
bptjm-21	86	16	common	common	ADJ
bptjm-21	86	17	variable	variable	ADJ
bptjm-21	86	18	immunode	immunode	PROPN
bptjm-21	86	19	�	�	PROPN
bptjm-21	86	20	ciency	ciency	NOUN
bptjm-21	86	21	(	(	PUNCT
bptjm-21	86	22	cvid	cvid	NOUN
bptjm-21	86	23	)	)	PUNCT
bptjm-21	86	24	,	,	PUNCT
bptjm-21	86	25	which	which	PRON
bptjm-21	86	26	is	be	AUX
bptjm-21	86	27	a	a	DET
bptjm-21	86	28	primary	primary	ADJ
bptjm-21	86	29	immunode	immunode	PROPN
bptjm-21	86	30	�	�	PROPN
bptjm-21	86	31	ciency	ciency	NOUN
bptjm-21	86	32	characterized	characterize	VERB
bptjm-21	86	33	by	by	ADP
bptjm-21	86	34	hypogammaglobulinemia	hypogammaglobulinemia	NOUN
bptjm-21	86	35	and	and	CCONJ
bptjm-21	86	36	di	di	NOUN
bptjm-21	86	37	�	�	PROPN
bptjm-21	86	38	erent	erent	NOUN
bptjm-21	86	39	degrees	degree	NOUN
bptjm-21	86	40	of	of	ADP
bptjm-21	86	41	b	b	PROPN
bptjm-21	86	42	cell	cell	NOUN
bptjm-21	86	43	compartment	compartment	NOUN
bptjm-21	86	44	alteration28	alteration28	ADV
bptjm-21	86	45	.	.	PUNCT
bptjm-21	87	1	we	we	PRON
bptjm-21	87	2	found	find	VERB
bptjm-21	87	3	reduced	reduce	VERB
bptjm-21	87	4	bcl-2	bcl-2	PUNCT
bptjm-21	87	5	protein	protein	NOUN
bptjm-21	87	6	levels	level	NOUN
bptjm-21	87	7	in	in	ADP
bptjm-21	87	8	memory	memory	NOUN
bptjm-21	87	9	b	b	PROPN
bptjm-21	87	10	cells	cell	NOUN
bptjm-21	87	11	from	from	ADP
bptjm-21	87	12	cvid	cvid	PROPN
bptjm-21	87	13	.	.	PUNCT
bptjm-21	88	1	hypertension	hypertension	NOUN
bptjm-21	88	2	is	be	AUX
bptjm-21	88	3	another	another	DET
bptjm-21	88	4	medical	medical	ADJ
bptjm-21	88	5	condition	condition	NOUN
bptjm-21	88	6	where	where	SCONJ
bptjm-21	88	7	the	the	DET
bptjm-21	88	8	study	study	NOUN
bptjm-21	88	9	of	of	ADP
bptjm-21	88	10	aid	aid	NOUN
bptjm-21	88	11	can	can	AUX
bptjm-21	88	12	be	be	AUX
bptjm-21	88	13	useful	useful	ADJ
bptjm-21	88	14	.	.	PUNCT
bptjm-21	89	1	in	in	ADP
bptjm-21	89	2	the	the	DET
bptjm-21	89	3	usa	usa	PROPN
bptjm-21	89	4	,	,	PUNCT
bptjm-21	89	5	nearly	nearly	ADV
bptjm-21	89	6	50	50	NUM
bptjm-21	89	7	%	%	NOUN
bptjm-21	89	8	of	of	ADP
bptjm-21	89	9	the	the	DET
bptjm-21	89	10	adult	adult	NOUN
bptjm-21	89	11	population	population	NOUN
bptjm-21	89	12	has	have	VERB
bptjm-21	89	13	hypertension	hypertension	NOUN
bptjm-21	89	14	,	,	PUNCT
bptjm-21	89	15	and	and	CCONJ
bptjm-21	89	16	prevalence	prevalence	NOUN
bptjm-21	89	17	increases	increase	VERB
bptjm-21	89	18	to	to	ADP
bptjm-21	89	19	~80	~80	NOUN
bptjm-21	89	20	%	%	NOUN
bptjm-21	89	21	at	at	ADP
bptjm-21	89	22	advanced	advanced	ADJ
bptjm-21	89	23	age29	age29	NOUN
bptjm-21	89	24	.	.	PUNCT
bptjm-21	90	1	b	b	X
bptjm-21	90	2	cell	cell	NOUN
bptjm-21	90	3	ig	ig	PROPN
bptjm-21	90	4	production	production	NOUN
bptjm-21	90	5	is	be	AUX
bptjm-21	90	6	dependent	dependent	ADJ
bptjm-21	90	7	on	on	ADP
bptjm-21	90	8	a	a	DET
bptjm-21	90	9	subset	subset	NOUN
bptjm-21	90	10	of	of	ADP
bptjm-21	90	11	b	b	PROPN
bptjm-21	90	12	cells	cell	NOUN
bptjm-21	90	13	called	call	VERB
bptjm-21	90	14	gc	gc	PROPN
bptjm-21	90	15	b	b	PROPN
bptjm-21	90	16	cells	cell	NOUN
bptjm-21	90	17	,	,	PUNCT
bptjm-21	90	18	which	which	PRON
bptjm-21	90	19	are	be	AUX
bptjm-21	90	20	dependent	dependent	ADJ
bptjm-21	90	21	on	on	ADP
bptjm-21	90	22	aid	aid	NOUN
bptjm-21	90	23	and	and	CCONJ
bptjm-21	90	24	may	may	AUX
bptjm-21	90	25	play	play	VERB
bptjm-21	90	26	a	a	DET
bptjm-21	90	27	causal	causal	ADJ
bptjm-21	90	28	role	role	NOUN
bptjm-21	90	29	in	in	ADP
bptjm-21	90	30	the	the	DET
bptjm-21	90	31	pathophysiology	pathophysiology	NOUN
bptjm-21	90	32	of	of	ADP
bptjm-21	90	33	hypertension	hypertension	NOUN
bptjm-21	90	34	.	.	PUNCT
bptjm-21	91	1	the	the	DET
bptjm-21	91	2	gc	gc	PROPN
bptjm-21	91	3	reaction	reaction	NOUN
bptjm-21	91	4	is	be	AUX
bptjm-21	91	5	driven	drive	VERB
bptjm-21	91	6	by	by	ADP
bptjm-21	91	7	il-21	il-21	PRON
bptjm-21	91	8	and	and	CCONJ
bptjm-21	91	9	t	t	X
bptjm-21	91	10	follicular	follicular	ADJ
bptjm-21	91	11	helper	helper	NOUN
bptjm-21	91	12	(	(	PUNCT
bptjm-21	91	13	tfh	tfh	NOUN
bptjm-21	91	14	)	)	PUNCT
bptjm-21	91	15	cells	cell	NOUN
bptjm-21	91	16	,	,	PUNCT
bptjm-21	91	17	which	which	PRON
bptjm-21	91	18	are	be	AUX
bptjm-21	91	19	transcription	transcription	NOUN
bptjm-21	91	20	factors	factor	NOUN
bptjm-21	91	21	associated	associate	VERB
bptjm-21	91	22	with	with	ADP
bptjm-21	91	23	aid	aid	NOUN
bptjm-21	91	24	and	and	CCONJ
bptjm-21	91	25	have	have	AUX
bptjm-21	91	26	been	be	AUX
bptjm-21	91	27	demonstrated	demonstrate	VERB
bptjm-21	91	28	to	to	PART
bptjm-21	91	29	play	play	VERB
bptjm-21	91	30	a	a	DET
bptjm-21	91	31	role	role	NOUN
bptjm-21	91	32	in	in	ADP
bptjm-21	91	33	hypertension	hypertension	NOUN
bptjm-21	91	34	and	and	CCONJ
bptjm-21	91	35	hypertensive	hypertensive	ADJ
bptjm-21	91	36	end	end	NOUN
bptjm-21	91	37	-	-	PUNCT
bptjm-21	91	38	organ	organ	NOUN
bptjm-21	91	39	damage30	damage30	NOUN
bptjm-21	91	40	.	.	PUNCT
bptjm-21	92	1	it	it	PRON
bptjm-21	92	2	is	be	AUX
bptjm-21	92	3	possible	possible	ADJ
bptjm-21	92	4	that	that	SCONJ
bptjm-21	92	5	b	b	PROPN
bptjm-21	92	6	cells	cell	NOUN
bptjm-21	92	7	and	and	CCONJ
bptjm-21	92	8	ig	ig	PRON
bptjm-21	92	9	contribute	contribute	VERB
bptjm-21	92	10	to	to	ADP
bptjm-21	92	11	hypertension	hypertension	NOUN
bptjm-21	92	12	in	in	ADP
bptjm-21	92	13	speci	speci	PROPN
bptjm-21	92	14	�	�	PROPN
bptjm-21	92	15	c	c	PROPN
bptjm-21	92	16	cases	case	NOUN
bptjm-21	92	17	as	as	ADP
bptjm-21	92	18	in	in	ADP
bptjm-21	92	19	autoimmune	autoimmune	ADJ
bptjm-21	92	20	diseases	disease	NOUN
bptjm-21	92	21	or	or	CCONJ
bptjm-21	92	22	preeclampsia31	preeclampsia31	NOUN
bptjm-21	92	23	.	.	PUNCT
bptjm-21	93	1	however	however	ADV
bptjm-21	93	2	,	,	PUNCT
bptjm-21	93	3	future	future	ADJ
bptjm-21	93	4	studies	study	NOUN
bptjm-21	93	5	should	should	AUX
bptjm-21	93	6	investigate	investigate	VERB
bptjm-21	93	7	inducible	inducible	ADJ
bptjm-21	93	8	genetic	genetic	ADJ
bptjm-21	93	9	b	b	NOUN
bptjm-21	93	10	cell	cell	NOUN
bptjm-21	93	11	deletion	deletion	NOUN
bptjm-21	93	12	in	in	ADP
bptjm-21	93	13	adult	adult	NOUN
bptjm-21	93	14	animals	animal	NOUN
bptjm-21	93	15	to	to	PART
bptjm-21	93	16	determine	determine	VERB
bptjm-21	93	17	if	if	SCONJ
bptjm-21	93	18	b	b	PROPN
bptjm-21	93	19	cells	cell	NOUN
bptjm-21	93	20	are	be	AUX
bptjm-21	93	21	viable	viable	ADJ
bptjm-21	93	22	therapeutic	therapeutic	ADJ
bptjm-21	93	23	targets	target	NOUN
bptjm-21	93	24	for	for	ADP
bptjm-21	93	25	hypertension31	hypertension31	NOUN
bptjm-21	93	26	.	.	PUNCT
bptjm-21	94	1	multiple	multiple	ADJ
bptjm-21	94	2	sclerosis	sclerosis	NOUN
bptjm-21	94	3	(	(	PUNCT
bptjm-21	94	4	ms	ms	NOUN
bptjm-21	94	5	)	)	PUNCT
bptjm-21	94	6	is	be	AUX
bptjm-21	94	7	another	another	DET
bptjm-21	94	8	debilitating	debilitating	ADJ
bptjm-21	94	9	chronic	chronic	ADJ
bptjm-21	94	10	disease	disease	NOUN
bptjm-21	94	11	.	.	PUNCT
bptjm-21	95	1	b	b	X
bptjm-21	95	2	cell	cell	NOUN
bptjm-21	95	3	depleting	deplete	VERB
bptjm-21	95	4	therapies	therapy	NOUN
bptjm-21	95	5	are	be	AUX
bptjm-21	95	6	a	a	DET
bptjm-21	95	7	potential	potential	ADJ
bptjm-21	95	8	way	way	NOUN
bptjm-21	95	9	to	to	PART
bptjm-21	95	10	ameliorate	ameliorate	VERB
bptjm-21	95	11	symptoms	symptom	NOUN
bptjm-21	95	12	in	in	ADP
bptjm-21	95	13	ms	ms	NOUN
bptjm-21	95	14	given	give	VERB
bptjm-21	95	15	that	that	SCONJ
bptjm-21	95	16	b	b	NOUN
bptjm-21	95	17	cells	cell	NOUN
bptjm-21	95	18	play	play	VERB
bptjm-21	95	19	a	a	DET
bptjm-21	95	20	critical	critical	ADJ
bptjm-21	95	21	role	role	NOUN
bptjm-21	95	22	in	in	ADP
bptjm-21	95	23	the	the	DET
bptjm-21	95	24	ms	ms	PROPN
bptjm-21	95	25	disease	disease	PROPN
bptjm-21	95	26	process32	process32	PROPN
bptjm-21	95	27	.	.	PUNCT
bptjm-21	96	1	there	there	PRON
bptjm-21	96	2	is	be	VERB
bptjm-21	96	3	a	a	DET
bptjm-21	96	4	presence	presence	NOUN
bptjm-21	96	5	of	of	ADP
bptjm-21	96	6	b	b	NOUN
bptjm-21	96	7	cells	cell	NOUN
bptjm-21	96	8	in	in	ADP
bptjm-21	96	9	active	active	ADJ
bptjm-21	96	10	lesions	lesion	NOUN
bptjm-21	96	11	and	and	CCONJ
bptjm-21	96	12	the	the	DET
bptjm-21	96	13	cerebrospinal	cerebrospinal	ADJ
bptjm-21	96	14	�	�	PROPN
bptjm-21	96	15	uid	uid	PROPN
bptjm-21	96	16	of	of	ADP
bptjm-21	96	17	ms	ms	PROPN
bptjm-21	96	18	patients32	patients32	PROPN
bptjm-21	96	19	.	.	PUNCT
bptjm-21	97	1	in	in	ADP
bptjm-21	97	2	a	a	DET
bptjm-21	97	3	recent	recent	ADJ
bptjm-21	97	4	study	study	NOUN
bptjm-21	97	5	,	,	PUNCT
bptjm-21	97	6	the	the	DET
bptjm-21	97	7	community	community	NOUN
bptjm-21	97	8	was	be	AUX
bptjm-21	97	9	able	able	ADJ
bptjm-21	97	10	toglean	toglean	ADJ
bptjm-21	97	11	more	more	ADJ
bptjm-21	97	12	information	information	NOUN
bptjm-21	97	13	on	on	ADP
bptjm-21	97	14	the	the	DET
bptjm-21	97	15	role	role	NOUN
bptjm-21	97	16	of	of	ADP
bptjm-21	97	17	secondary	secondary	ADJ
bptjm-21	97	18	diversity	diversity	NOUN
bptjm-21	97	19	of	of	ADP
bptjm-21	97	20	the	the	DET
bptjm-21	97	21	bcr	bcr	NOUN
bptjm-21	97	22	in	in	ADP
bptjm-21	97	23	experimental	experimental	ADJ
bptjm-21	97	24	autoimmune	autoimmune	ADJ
bptjm-21	97	25	encephalomyelitis	encephalomyelitis	NOUN
bptjm-21	97	26	(	(	PUNCT
bptjm-21	97	27	eae	eae	PROPN
bptjm-21	97	28	)	)	PUNCT
bptjm-21	97	29	and	and	CCONJ
bptjm-21	97	30	identify	identify	VERB
bptjm-21	97	31	igg	igg	PROPN
bptjm-21	97	32	class	class	NOUN
bptjm-21	97	33	-	-	PUNCT
bptjm-21	97	34	switched	switch	VERB
bptjm-21	97	35	b	b	NOUN
bptjm-21	97	36	cells	cell	NOUN
bptjm-21	97	37	as	as	ADP
bptjm-21	97	38	potential	potential	ADJ
bptjm-21	97	39	therapeutic	therapeutic	ADJ
bptjm-21	97	40	targets	target	NOUN
bptjm-21	97	41	for	for	ADP
bptjm-21	97	42	the	the	DET
bptjm-21	97	43	treatment	treatment	NOUN
bptjm-21	97	44	of	of	ADP
bptjm-21	97	45	ms32	ms32	PROPN
bptjm-21	97	46	.	.	PUNCT
bptjm-21	97	47	aid	aid	NOUN
bptjm-21	97	48	was	be	AUX
bptjm-21	97	49	also	also	ADV
bptjm-21	97	50	found	find	VERB
bptjm-21	97	51	to	to	PART
bptjm-21	97	52	presumably	presumably	ADV
bptjm-21	97	53	still	still	ADV
bptjm-21	97	54	exert	exert	VERB
bptjm-21	97	55	some	some	DET
bptjm-21	97	56	subtle	subtle	ADJ
bptjm-21	97	57	e	e	NOUN
bptjm-21	97	58	�	�	NOUN
bptjm-21	97	59	ect	ect	VERB
bptjm-21	97	60	on	on	ADP
bptjm-21	97	61	rmog	rmog	NOUN
bptjm-21	97	62	-	-	PUNCT
bptjm-21	97	63	induced	induced	ADJ
bptjm-21	97	64	(	(	PUNCT
bptjm-21	97	65	myelin	myelin	NOUN
bptjm-21	97	66	oligodendrocyte	oligodendrocyte	NOUN
bptjm-21	97	67	glycoprotein	glycoprotein	NOUN
bptjm-21	97	68	)	)	PUNCT
bptjm-21	97	69	disease	disease	NOUN
bptjm-21	97	70	trajectory32	trajectory32	ADV
bptjm-21	97	71	.	.	PUNCT
bptjm-21	98	1	arthritis	arthritis	NOUN
bptjm-21	98	2	is	be	AUX
bptjm-21	98	3	a	a	DET
bptjm-21	98	4	debilitating	debilitate	VERB
bptjm-21	98	5	disease	disease	NOUN
bptjm-21	98	6	that	that	PRON
bptjm-21	98	7	can	can	AUX
bptjm-21	98	8	result	result	VERB
bptjm-21	98	9	in	in	ADP
bptjm-21	98	10	a	a	DET
bptjm-21	98	11	lot	lot	NOUN
bptjm-21	98	12	of	of	ADP
bptjm-21	98	13	pain	pain	NOUN
bptjm-21	98	14	a	a	DET
bptjm-21	98	15	potential	potential	ADJ
bptjm-21	98	16	novel	novel	ADJ
bptjm-21	98	17	treatment	treatment	NOUN
bptjm-21	98	18	for	for	ADP
bptjm-21	98	19	in	in	ADP
bptjm-21	98	20	�	�	NOUN
bptjm-21	98	21	ammatory	ammatory	NOUN
bptjm-21	98	22	arthritis	arthritis	NOUN
bptjm-21	98	23	includes	include	VERB
bptjm-21	98	24	fraxinellone33	fraxinellone33	NOUN
bptjm-21	98	25	.	.	PUNCT
bptjm-21	99	1	the	the	DET
bptjm-21	99	2	therapeutic	therapeutic	ADJ
bptjm-21	99	3	e	e	NOUN
bptjm-21	99	4	�	�	NOUN
bptjm-21	99	5	ect	ect	NOUN
bptjm-21	99	6	of	of	ADP
bptjm-21	99	7	fraxinellone	fraxinellone	NOUN
bptjm-21	99	8	was	be	AUX
bptjm-21	99	9	associated	associate	VERB
bptjm-21	99	10	with	with	ADP
bptjm-21	99	11	the	the	DET
bptjm-21	99	12	inhibition	inhibition	NOUN
bptjm-21	99	13	of	of	ADP
bptjm-21	99	14	cellular	cellular	ADJ
bptjm-21	99	15	di	di	PROPN
bptjm-21	99	16	�	�	PROPN
bptjm-21	99	17	erentiation	erentiation	NOUN
bptjm-21	99	18	and	and	CCONJ
bptjm-21	99	19	activation	activation	NOUN
bptjm-21	99	20	.	.	PUNCT
bptjm-21	100	1	it	it	PRON
bptjm-21	100	2	has	have	AUX
bptjm-21	100	3	been	be	AUX
bptjm-21	100	4	shown	show	VERB
bptjm-21	100	5	to	to	PART
bptjm-21	100	6	attenuate	attenuate	VERB
bptjm-21	100	7	the	the	DET
bptjm-21	100	8	clinical	clinical	ADJ
bptjm-21	100	9	and	and	CCONJ
bptjm-21	100	10	histologic	histologic	ADJ
bptjm-21	100	11	features	feature	NOUN
bptjm-21	100	12	of	of	ADP
bptjm-21	100	13	in	in	ADP
bptjm-21	100	14	�	�	NOUN
bptjm-21	100	15	ammatory	ammatory	NOUN
bptjm-21	100	16	arthritis	arthritis	NOUN
bptjm-21	100	17	in	in	ADP
bptjm-21	100	18	mice33	mice33	NOUN
bptjm-21	100	19	.	.	PUNCT
bptjm-21	101	1	there	there	ADV
bptjm-21	101	2	berkeley	berkeley	PROPN
bptjm-21	101	3	pharma	pharma	PROPN
bptjm-21	101	4	tech	tech	NOUN
bptjm-21	101	5	journal	journal	NOUN
bptjm-21	101	6	of	of	ADP
bptjm-21	101	7	medicine	medicine	NOUN
bptjm-21	101	8	|	|	ADV
bptjm-21	101	9	114	114	NUM
bptjm-21	101	10	was	be	AUX
bptjm-21	101	11	a	a	DET
bptjm-21	101	12	lower	low	ADJ
bptjm-21	101	13	expression	expression	NOUN
bptjm-21	101	14	of	of	ADP
bptjm-21	101	15	aid	aid	NOUN
bptjm-21	101	16	and	and	CCONJ
bptjm-21	101	17	blimp-1	blimp-1	NUM
bptjm-21	101	18	following	follow	VERB
bptjm-21	101	19	treatment	treatment	NOUN
bptjm-21	101	20	with	with	ADP
bptjm-21	101	21	fraxinellone33	fraxinellone33	NOUN
bptjm-21	101	22	.	.	PUNCT
bptjm-21	102	1	remarkably	remarkably	ADV
bptjm-21	102	2	,	,	PUNCT
bptjm-21	102	3	it	it	PRON
bptjm-21	102	4	also	also	ADV
bptjm-21	102	5	alleviated	alleviate	VERB
bptjm-21	102	6	synovial	synovial	ADJ
bptjm-21	102	7	in	in	ADP
bptjm-21	102	8	�	�	PROPN
bptjm-21	102	9	ammation	ammation	NOUN
bptjm-21	102	10	and	and	CCONJ
bptjm-21	102	11	osteoclastogenesis	osteoclastogenesis	NOUN
bptjm-21	102	12	in	in	ADP
bptjm-21	102	13	mice33	mice33	NOUN
bptjm-21	102	14	.	.	PUNCT
bptjm-21	103	1	other	other	ADJ
bptjm-21	103	2	drugs	drug	NOUN
bptjm-21	103	3	such	such	ADJ
bptjm-21	103	4	as	as	ADP
bptjm-21	103	5	belimumab	belimumab	NOUN
bptjm-21	103	6	,	,	PUNCT
bptjm-21	103	7	a	a	DET
bptjm-21	103	8	targeted	target	VERB
bptjm-21	103	9	therapy	therapy	NOUN
bptjm-21	103	10	approved	approve	VERB
bptjm-21	103	11	for	for	ADP
bptjm-21	103	12	systemic	systemic	ADJ
bptjm-21	103	13	lupus	lupus	PROPN
bptjm-21	103	14	erythematosus	erythematosus	NOUN
bptjm-21	103	15	(	(	PUNCT
bptjm-21	103	16	sle	sle	PROPN
bptjm-21	103	17	)	)	PUNCT
bptjm-21	103	18	,	,	PUNCT
bptjm-21	103	19	serve	serve	VERB
bptjm-21	103	20	as	as	ADP
bptjm-21	103	21	examples	example	NOUN
bptjm-21	103	22	of	of	ADP
bptjm-21	103	23	how	how	SCONJ
bptjm-21	103	24	targeted	target	VERB
bptjm-21	103	25	therapies	therapy	NOUN
bptjm-21	103	26	that	that	PRON
bptjm-21	103	27	disrupt	disrupt	VERB
bptjm-21	103	28	the	the	DET
bptjm-21	103	29	aid	aid	NOUN
bptjm-21	103	30	pathway	pathway	NOUN
bptjm-21	103	31	can	can	AUX
bptjm-21	103	32	be	be	AUX
bptjm-21	103	33	bene	bene	NOUN
bptjm-21	103	34	�	�	PROPN
bptjm-21	103	35	cial34	cial34	NOUN
bptjm-21	103	36	.	.	PUNCT
bptjm-21	104	1	further	further	ADJ
bptjm-21	104	2	investigation	investigation	NOUN
bptjm-21	104	3	is	be	AUX
bptjm-21	104	4	needed	need	VERB
bptjm-21	104	5	to	to	PART
bptjm-21	104	6	see	see	VERB
bptjm-21	104	7	the	the	DET
bptjm-21	104	8	side	side	NOUN
bptjm-21	104	9	e	e	NOUN
bptjm-21	104	10	�	�	NOUN
bptjm-21	104	11	ects	ect	VERB
bptjm-21	104	12	on	on	ADP
bptjm-21	104	13	normal	normal	ADJ
bptjm-21	104	14	cells	cell	NOUN
bptjm-21	104	15	.	.	PUNCT
bptjm-21	105	1	cancer	cancer	NOUN
bptjm-21	105	2	aid	aid	NOUN
bptjm-21	105	3	,	,	PUNCT
bptjm-21	105	4	as	as	SCONJ
bptjm-21	105	5	previously	previously	ADV
bptjm-21	105	6	mentioned	mention	VERB
bptjm-21	105	7	,	,	PUNCT
bptjm-21	105	8	has	have	AUX
bptjm-21	105	9	been	be	AUX
bptjm-21	105	10	largely	largely	ADV
bptjm-21	105	11	suggested	suggest	VERB
bptjm-21	105	12	to	to	PART
bptjm-21	105	13	induce	induce	VERB
bptjm-21	105	14	cancerpromoting	cancerpromote	VERB
bptjm-21	105	15	mutation	mutation	NOUN
bptjm-21	105	16	.	.	PUNCT
bptjm-21	106	1	aid	aid	NOUN
bptjm-21	106	2	is	be	AUX
bptjm-21	106	3	expressed	express	VERB
bptjm-21	106	4	in	in	ADP
bptjm-21	106	5	more	more	ADJ
bptjm-21	106	6	than	than	ADP
bptjm-21	106	7	40	40	NUM
bptjm-21	106	8	%	%	NOUN
bptjm-21	106	9	of	of	ADP
bptjm-21	106	10	primary	primary	ADJ
bptjm-21	106	11	human	human	ADJ
bptjm-21	106	12	chronic	chronic	ADJ
bptjm-21	106	13	lymphocytic	lymphocytic	ADJ
bptjm-21	106	14	leukemia	leukemia	NOUN
bptjm-21	106	15	(	(	PUNCT
bptjm-21	106	16	cll	cll	NOUN
bptjm-21	106	17	)	)	PUNCT
bptjm-21	106	18	cases	case	NOUN
bptjm-21	106	19	,	,	PUNCT
bptjm-21	106	20	but	but	CCONJ
bptjm-21	106	21	aid	aid	NOUN
bptjm-21	106	22	expression	expression	NOUN
bptjm-21	106	23	can	can	AUX
bptjm-21	106	24	be	be	AUX
bptjm-21	106	25	harnessed	harness	VERB
bptjm-21	106	26	for	for	ADP
bptjm-21	106	27	antileukemic	antileukemic	ADJ
bptjm-21	106	28	e	e	NOUN
bptjm-21	106	29	�	�	NOUN
bptjm-21	106	30	ect	ect	VERB
bptjm-21	106	31	after	after	ADP
bptjm-21	106	32	inhibition	inhibition	NOUN
bptjm-21	106	33	of	of	ADP
bptjm-21	106	34	the	the	DET
bptjm-21	106	35	rad51	rad51	ADJ
bptjm-21	106	36	homologous	homologous	ADJ
bptjm-21	106	37	recombination	recombination	NOUN
bptjm-21	106	38	(	(	PUNCT
bptjm-21	106	39	hr	hr	NOUN
bptjm-21	106	40	)	)	PUNCT
bptjm-21	106	41	factor	factor	NOUN
bptjm-21	106	42	4,4’-diisothiocyanatostilbene-2	4,4’-diisothiocyanatostilbene-2	PROPN
bptjm-21	106	43	-	-	PUNCT
bptjm-21	106	44	2’-disulfonic	2’-disulfonic	NUM
bptjm-21	106	45	acid	acid	NOUN
bptjm-21	106	46	(	(	PUNCT
bptjm-21	106	47	dids)16	dids)16	PROPN
bptjm-21	106	48	.	.	PUNCT
bptjm-21	107	1	this	this	PRON
bptjm-21	107	2	is	be	AUX
bptjm-21	107	3	a	a	DET
bptjm-21	107	4	novel	novel	ADJ
bptjm-21	107	5	antineoplastic	antineoplastic	ADJ
bptjm-21	107	6	role	role	NOUN
bptjm-21	107	7	of	of	ADP
bptjm-21	107	8	aid	aid	NOUN
bptjm-21	107	9	that	that	PRON
bptjm-21	107	10	can	can	AUX
bptjm-21	107	11	be	be	AUX
bptjm-21	107	12	triggered	trigger	VERB
bptjm-21	107	13	by	by	ADP
bptjm-21	107	14	inhibition	inhibition	NOUN
bptjm-21	107	15	of	of	ADP
bptjm-21	107	16	hr	hr	NOUN
bptjm-21	107	17	,	,	PUNCT
bptjm-21	107	18	which	which	PRON
bptjm-21	107	19	is	be	AUX
bptjm-21	107	20	a	a	DET
bptjm-21	107	21	new	new	ADJ
bptjm-21	107	22	paradigm	paradigm	NOUN
bptjm-21	107	23	to	to	PART
bptjm-21	107	24	treat	treat	VERB
bptjm-21	107	25	aid	aid	NOUN
bptjm-21	107	26	-	-	PUNCT
bptjm-21	107	27	expressing	express	VERB
bptjm-21	107	28	tumors	tumor	NOUN
bptjm-21	107	29	and	and	CCONJ
bptjm-21	107	30	has	have	AUX
bptjm-21	107	31	had	have	VERB
bptjm-21	107	32	proof	proof	NOUN
bptjm-21	107	33	of	of	ADP
bptjm-21	107	34	principle	principle	ADJ
bptjm-21	107	35	studies	study	NOUN
bptjm-21	107	36	conducted16	conducted16	X
bptjm-21	107	37	.	.	PUNCT
bptjm-21	108	1	this	this	DET
bptjm-21	108	2	treatment	treatment	NOUN
bptjm-21	108	3	has	have	AUX
bptjm-21	108	4	also	also	ADV
bptjm-21	108	5	been	be	AUX
bptjm-21	108	6	suggested	suggest	VERB
bptjm-21	108	7	for	for	ADP
bptjm-21	108	8	use	use	NOUN
bptjm-21	108	9	in	in	ADP
bptjm-21	108	10	type	type	NOUN
bptjm-21	108	11	1	1	NUM
bptjm-21	108	12	diabetes6	diabetes6	NOUN
bptjm-21	108	13	.	.	PUNCT
bptjm-21	109	1	another	another	DET
bptjm-21	109	2	avenue	avenue	NOUN
bptjm-21	109	3	that	that	PRON
bptjm-21	109	4	has	have	AUX
bptjm-21	109	5	been	be	AUX
bptjm-21	109	6	considered	consider	VERB
bptjm-21	109	7	is	be	AUX
bptjm-21	109	8	the	the	DET
bptjm-21	109	9	chronic	chronic	ADJ
bptjm-21	109	10	administration	administration	NOUN
bptjm-21	109	11	of	of	ADP
bptjm-21	109	12	hsp90	hsp90	ADJ
bptjm-21	109	13	inhibitors	inhibitor	NOUN
bptjm-21	109	14	,	,	PUNCT
bptjm-21	109	15	which	which	PRON
bptjm-21	109	16	decreases	decrease	VERB
bptjm-21	109	17	aid	aid	NOUN
bptjm-21	109	18	protein	protein	NOUN
bptjm-21	109	19	levels	level	NOUN
bptjm-21	109	20	and	and	CCONJ
bptjm-21	109	21	has	have	AUX
bptjm-21	109	22	been	be	AUX
bptjm-21	109	23	shown	show	VERB
bptjm-21	109	24	to	to	PART
bptjm-21	109	25	reduce	reduce	VERB
bptjm-21	109	26	disease	disease	NOUN
bptjm-21	109	27	severity	severity	NOUN
bptjm-21	109	28	in	in	ADP
bptjm-21	109	29	a	a	DET
bptjm-21	109	30	mouse	mouse	NOUN
bptjm-21	109	31	model	model	NOUN
bptjm-21	109	32	of	of	ADP
bptjm-21	109	33	acute	acute	PROPN
bptjm-21	109	34	b	b	PROPN
bptjm-21	109	35	cell	cell	NOUN
bptjm-21	109	36	lymphoblastic	lymphoblastic	ADJ
bptjm-21	109	37	leukemia	leukemia	NOUN
bptjm-21	109	38	in	in	ADP
bptjm-21	109	39	which	which	PRON
bptjm-21	109	40	aid	aid	NOUN
bptjm-21	109	41	accelerates	accelerate	VERB
bptjm-21	109	42	disease	disease	NOUN
bptjm-21	109	43	progression18	progression18	NOUN
bptjm-21	109	44	.	.	PUNCT
bptjm-21	110	1	this	this	PRON
bptjm-21	110	2	is	be	AUX
bptjm-21	110	3	promising	promise	VERB
bptjm-21	110	4	,	,	PUNCT
bptjm-21	110	5	as	as	SCONJ
bptjm-21	110	6	a	a	DET
bptjm-21	110	7	proof	proof	NOUN
bptjm-21	110	8	-	-	PUNCT
bptjm-21	110	9	of	of	ADP
bptjm-21	110	10	-	-	PUNCT
bptjm-21	110	11	concept	concept	NOUN
bptjm-21	110	12	study	study	NOUN
bptjm-21	110	13	has	have	AUX
bptjm-21	110	14	been	be	AUX
bptjm-21	110	15	published	publish	VERB
bptjm-21	110	16	that	that	PRON
bptjm-21	110	17	showed	show	VERB
bptjm-21	110	18	hsp90	hsp90	ADJ
bptjm-21	110	19	inhibitors	inhibitor	NOUN
bptjm-21	110	20	directly	directly	ADV
bptjm-21	110	21	target	target	VERB
bptjm-21	110	22	aid	aid	NOUN
bptjm-21	110	23	in	in	ADP
bptjm-21	110	24	vivo	vivo	NOUN
bptjm-21	110	25	,	,	PUNCT
bptjm-21	110	26	and	and	CCONJ
bptjm-21	110	27	endogenous	endogenous	ADJ
bptjm-21	110	28	humanaid	humanaid	NOUN
bptjm-21	110	29	is	be	AUX
bptjm-21	110	30	sensitive	sensitive	ADJ
bptjm-21	110	31	to	to	ADP
bptjm-21	110	32	them	they	PRON
bptjm-21	110	33	18	18	NUM
bptjm-21	110	34	.	.	PUNCT
bptjm-21	111	1	yet	yet	ADV
bptjm-21	111	2	another	another	DET
bptjm-21	111	3	study	study	NOUN
bptjm-21	111	4	has	have	AUX
bptjm-21	111	5	suggested	suggest	VERB
bptjm-21	111	6	that	that	SCONJ
bptjm-21	111	7	targeting	target	VERB
bptjm-21	111	8	aid	aid	NOUN
bptjm-21	111	9	is	be	AUX
bptjm-21	111	10	bene	bene	NOUN
bptjm-21	111	11	�	�	PROPN
bptjm-21	111	12	cial	cial	NOUN
bptjm-21	111	13	in	in	ADP
bptjm-21	111	14	the	the	DET
bptjm-21	111	15	immunotherapy	immunotherapy	NOUN
bptjm-21	111	16	ofaid	ofaid	VERB
bptjm-21	111	17	positive	positive	ADJ
bptjm-21	111	18	tumors	tumor	NOUN
bptjm-21	111	19	because	because	SCONJ
bptjm-21	111	20	sirna	sirna	PROPN
bptjm-21	111	21	silencing	silence	VERB
bptjm-21	111	22	of	of	ADP
bptjm-21	111	23	aid	aid	NOUN
bptjm-21	111	24	in	in	ADP
bptjm-21	111	25	plasmacytoma	plasmacytoma	NOUN
bptjm-21	111	26	dramatically	dramatically	ADV
bptjm-21	111	27	increases	increase	VERB
bptjm-21	111	28	its	its	PRON
bptjm-21	111	29	susceptibility	susceptibility	NOUN
bptjm-21	111	30	to	to	ADP
bptjm-21	111	31	immunotherapy	immunotherapy	NOUN
bptjm-21	111	32	by	by	ADP
bptjm-21	111	33	cytotoxic	cytotoxic	ADJ
bptjm-21	111	34	t	t	PROPN
bptjm-21	111	35	lymphocytes15	lymphocytes15	NOUN
bptjm-21	111	36	.	.	PUNCT
bptjm-21	112	1	overall	overall	ADV
bptjm-21	112	2	,	,	PUNCT
bptjm-21	112	3	aid	aid	NOUN
bptjm-21	112	4	has	have	AUX
bptjm-21	112	5	shown	show	VERB
bptjm-21	112	6	to	to	PART
bptjm-21	112	7	be	be	AUX
bptjm-21	112	8	a	a	DET
bptjm-21	112	9	promising	promising	ADJ
bptjm-21	112	10	target	target	NOUN
bptjm-21	112	11	in	in	ADP
bptjm-21	112	12	the	the	DET
bptjm-21	112	13	aforementioned	aforementioned	ADJ
bptjm-21	112	14	instances	instance	NOUN
bptjm-21	112	15	and	and	CCONJ
bptjm-21	112	16	more	more	ADJ
bptjm-21	112	17	research	research	NOUN
bptjm-21	112	18	may	may	AUX
bptjm-21	112	19	yield	yield	VERB
bptjm-21	112	20	additional	additional	ADJ
bptjm-21	112	21	insights	insight	NOUN
bptjm-21	112	22	.	.	PUNCT
bptjm-21	113	1	berkeley	berkeley	PROPN
bptjm-21	113	2	pharma	pharma	PROPN
bptjm-21	113	3	tech	tech	PROPN
bptjm-21	113	4	journal	journal	NOUN
bptjm-21	113	5	of	of	ADP
bptjm-21	113	6	medicine	medicine	NOUN
bptjm-21	113	7	|	|	ADV
bptjm-21	113	8	115	115	NUM
bptjm-21	113	9	conclusion	conclusion	NOUN
bptjm-21	113	10	although	although	SCONJ
bptjm-21	113	11	further	further	ADJ
bptjm-21	113	12	research	research	NOUN
bptjm-21	113	13	will	will	AUX
bptjm-21	113	14	help	help	VERB
bptjm-21	113	15	the	the	DET
bptjm-21	113	16	scientific	scientific	ADJ
bptjm-21	113	17	community	community	NOUN
bptjm-21	113	18	to	to	PART
bptjm-21	113	19	glean	glean	VERB
bptjm-21	113	20	more	more	ADV
bptjm-21	113	21	clear	clear	ADJ
bptjm-21	113	22	insights	insight	NOUN
bptjm-21	113	23	,	,	PUNCT
bptjm-21	113	24	it	it	PRON
bptjm-21	113	25	is	be	AUX
bptjm-21	113	26	clear	clear	ADJ
bptjm-21	113	27	that	that	SCONJ
bptjm-21	113	28	elucidating	elucidate	VERB
bptjm-21	113	29	how	how	SCONJ
bptjm-21	113	30	aid	aid	NOUN
bptjm-21	113	31	works	work	NOUN
bptjm-21	113	32	will	will	AUX
bptjm-21	113	33	help	help	VERB
bptjm-21	113	34	with	with	ADP
bptjm-21	113	35	the	the	DET
bptjm-21	113	36	development	development	NOUN
bptjm-21	113	37	of	of	ADP
bptjm-21	113	38	novel	novel	ADJ
bptjm-21	113	39	therapeutic	therapeutic	ADJ
bptjm-21	113	40	strategies	strategy	NOUN
bptjm-21	113	41	for	for	ADP
bptjm-21	113	42	a	a	DET
bptjm-21	113	43	multitude	multitude	NOUN
bptjm-21	113	44	of	of	ADP
bptjm-21	113	45	diseases	disease	NOUN
bptjm-21	113	46	.	.	PUNCT
bptjm-21	114	1	disrupting	disrupt	VERB
bptjm-21	114	2	the	the	DET
bptjm-21	114	3	aid	aid	NOUN
bptjm-21	114	4	pathway	pathway	NOUN
bptjm-21	114	5	can	can	AUX
bptjm-21	114	6	have	have	VERB
bptjm-21	114	7	potential	potential	ADJ
bptjm-21	114	8	therapeutic	therapeutic	ADJ
bptjm-21	114	9	e	e	NOUN
bptjm-21	114	10	�	�	NOUN
bptjm-21	114	11	ects	ect	NOUN
bptjm-21	114	12	.	.	PUNCT
bptjm-21	115	1	however	however	ADV
bptjm-21	115	2	,	,	PUNCT
bptjm-21	115	3	it	it	PRON
bptjm-21	115	4	is	be	AUX
bptjm-21	115	5	important	important	ADJ
bptjm-21	115	6	to	to	PART
bptjm-21	115	7	remain	remain	VERB
bptjm-21	115	8	cognizant	cognizant	ADJ
bptjm-21	115	9	of	of	ADP
bptjm-21	115	10	the	the	DET
bptjm-21	115	11	fact	fact	NOUN
bptjm-21	115	12	that	that	SCONJ
bptjm-21	115	13	aid	aid	NOUN
bptjm-21	115	14	is	be	AUX
bptjm-21	115	15	a	a	DET
bptjm-21	115	16	complex	complex	ADJ
bptjm-21	115	17	component	component	NOUN
bptjm-21	115	18	of	of	ADP
bptjm-21	115	19	the	the	DET
bptjm-21	115	20	human	human	ADJ
bptjm-21	115	21	immune	immune	ADJ
bptjm-21	115	22	system	system	NOUN
bptjm-21	115	23	,	,	PUNCT
bptjm-21	115	24	which	which	PRON
bptjm-21	115	25	is	be	AUX
bptjm-21	115	26	in	in	ADP
bptjm-21	115	27	and	and	CCONJ
bptjm-21	115	28	of	of	ADP
bptjm-21	115	29	itself	itself	PRON
bptjm-21	115	30	a	a	DET
bptjm-21	115	31	complex	complex	ADJ
bptjm-21	115	32	system	system	NOUN
bptjm-21	115	33	.	.	PUNCT
bptjm-21	116	1	with	with	ADP
bptjm-21	116	2	that	that	PRON
bptjm-21	116	3	in	in	ADP
bptjm-21	116	4	mind	mind	NOUN
bptjm-21	116	5	,	,	PUNCT
bptjm-21	116	6	therapeutic	therapeutic	ADJ
bptjm-21	116	7	approaches	approach	NOUN
bptjm-21	116	8	targeting	target	VERB
bptjm-21	116	9	aid	aid	NOUN
bptjm-21	116	10	must	must	AUX
bptjm-21	116	11	undergo	undergo	VERB
bptjm-21	116	12	a	a	DET
bptjm-21	116	13	variety	variety	NOUN
bptjm-21	116	14	of	of	ADP
bptjm-21	116	15	testing	testing	NOUN
bptjm-21	116	16	and	and	CCONJ
bptjm-21	116	17	considerations	consideration	NOUN
bptjm-21	116	18	.	.	PUNCT
bptjm-21	117	1	berkeley	berkeley	PROPN
bptjm-21	117	2	pharma	pharma	PROPN
bptjm-21	117	3	tech	tech	PROPN
bptjm-21	117	4	journal	journal	NOUN
bptjm-21	117	5	of	of	ADP
bptjm-21	117	6	medicine	medicine	NOUN
bptjm-21	117	7	|	|	ADV
bptjm-21	117	8	116	116	NUM
bptjm-21	117	9	references	reference	NOUN
bptjm-21	117	10	1	1	NUM
bptjm-21	117	11	.	.	PUNCT
bptjm-21	118	1	alvarez	alvarez	PROPN
bptjm-21	118	2	-	-	PUNCT
bptjm-21	118	3	gonzalez	gonzalez	PROPN
bptjm-21	118	4	j	j	PROPN
bptjm-21	118	5	,	,	PUNCT
bptjm-21	118	6	yasgar	yasgar	PROPN
bptjm-21	118	7	a	a	DET
bptjm-21	118	8	,	,	PUNCT
bptjm-21	118	9	maul	maul	NOUN
bptjm-21	118	10	rw	rw	NOUN
bptjm-21	118	11	,	,	PUNCT
bptjm-21	118	12	et	et	PROPN
bptjm-21	118	13	al	al	PROPN
bptjm-21	118	14	.	.	PUNCT
bptjm-21	119	1	small	small	ADJ
bptjm-21	119	2	molecule	molecule	NOUN
bptjm-21	119	3	inhibitors	inhibitor	NOUN
bptjm-21	119	4	of	of	ADP
bptjm-21	119	5	activation	activation	NOUN
bptjm-21	119	6	-	-	PUNCT
bptjm-21	119	7	induced	induce	VERB
bptjm-21	119	8	deaminase	deaminase	NOUN
bptjm-21	119	9	decrease	decrease	NOUN
bptjm-21	119	10	class	class	NOUN
bptjm-21	119	11	switch	switch	NOUN
bptjm-21	119	12	recombination	recombination	NOUN
bptjm-21	119	13	in	in	ADP
bptjm-21	119	14	b	b	NOUN
bptjm-21	119	15	cells	cell	NOUN
bptjm-21	119	16	.	.	PUNCT
bptjm-21	120	1	acs	acs	PROPN
bptjm-21	120	2	pharmacol	pharmacol	PROPN
bptjm-21	120	3	transl	transl	PROPN
bptjm-21	120	4	sci	sci	PROPN
bptjm-21	120	5	.	.	PUNCT
bptjm-21	121	1	2021;4(3):1214	2021;4(3):1214	NUM
bptjm-21	121	2	-	-	SYM
bptjm-21	121	3	1226	1226	NUM
bptjm-21	121	4	.	.	PUNCT
bptjm-21	122	1	published	publish	VERB
bptjm-21	122	2	2021	2021	NUM
bptjm-21	122	3	may	may	AUX
bptjm-21	122	4	7	7	NUM
bptjm-21	122	5	.	.	PUNCT
bptjm-21	123	1	doi:10.1021	doi:10.1021	PROPN
bptjm-21	123	2	/	/	SYM
bptjm-21	123	3	acsptsci.1c00064	acsptsci.1c00064	PROPN
bptjm-21	123	4	2	2	NUM
bptjm-21	123	5	.	.	PUNCT
bptjm-21	123	6	briney	briney	PROPN
bptjm-21	123	7	bs	bs	PROPN
bptjm-21	123	8	,	,	PUNCT
bptjm-21	123	9	crowe	crowe	PROPN
bptjm-21	123	10	je	je	PROPN
bptjm-21	123	11	jr	jr	PROPN
bptjm-21	123	12	.	.	PROPN
bptjm-21	123	13	secondary	secondary	ADJ
bptjm-21	123	14	mechanisms	mechanism	NOUN
bptjm-21	123	15	of	of	ADP
bptjm-21	123	16	diversi	diversi	NOUN
bptjm-21	123	17	�	�	PROPN
bptjm-21	123	18	cation	cation	NOUN
bptjm-21	123	19	in	in	ADP
bptjm-21	123	20	the	the	DET
bptjm-21	123	21	human	human	ADJ
bptjm-21	123	22	antibody	antibody	NOUN
bptjm-21	123	23	repertoire	repertoire	NOUN
bptjm-21	123	24	.	.	PUNCT
bptjm-21	124	1	front	front	NOUN
bptjm-21	124	2	immunol.2013;4:42	immunol.2013;4:42	AUX
bptjm-21	124	3	.	.	PUNCT
bptjm-21	125	1	published	publish	VERB
bptjm-21	125	2	2013	2013	NUM
bptjm-21	125	3	mar	mar	PROPN
bptjm-21	125	4	11	11	NUM
bptjm-21	125	5	.	.	PUNCT
bptjm-21	126	1	doi:10.3389/	doi:10.3389/	PROPN
bptjm-21	126	2	�	�	PROPN
bptjm-21	126	3	mmu.2013.00042	mmu.2013.00042	NUM
bptjm-21	126	4	3	3	NUM
bptjm-21	126	5	.	.	PUNCT
bptjm-21	126	6	cantaert	cantaert	PROPN
bptjm-21	126	7	t	t	PROPN
bptjm-21	126	8	,	,	PUNCT
bptjm-21	126	9	schickel	schickel	PROPN
bptjm-21	126	10	jn	jn	PROPN
bptjm-21	126	11	,	,	PUNCT
bptjm-21	126	12	bannock	bannock	PROPN
bptjm-21	126	13	jm	jm	PROPN
bptjm-21	126	14	,	,	PUNCT
bptjm-21	126	15	et	et	PROPN
bptjm-21	126	16	al	al	PROPN
bptjm-21	126	17	.	.	PUNCT
bptjm-21	126	18	activation	activation	NOUN
bptjm-21	126	19	-	-	PUNCT
bptjm-21	126	20	induced	induce	VERB
bptjm-21	126	21	cytidine	cytidine	NOUN
bptjm-21	126	22	deaminase	deaminase	NOUN
bptjm-21	126	23	expression	expression	NOUN
bptjm-21	126	24	in	in	ADP
bptjm-21	126	25	human	human	PROPN
bptjm-21	126	26	b	b	PROPN
bptjm-21	126	27	cellprecursors	cellprecursor	NOUN
bptjm-21	126	28	is	be	AUX
bptjm-21	126	29	essential	essential	ADJ
bptjm-21	126	30	for	for	ADP
bptjm-21	126	31	central	central	ADJ
bptjm-21	126	32	b	b	PROPN
bptjm-21	126	33	cell	cell	NOUN
bptjm-21	126	34	tolerance	tolerance	NOUN
bptjm-21	126	35	.	.	PUNCT
bptjm-21	127	1	immunity	immunity	NOUN
bptjm-21	127	2	.	.	PUNCT
bptjm-21	128	1	2015;43(5):884	2015;43(5):884	NUM
bptjm-21	128	2	-	-	PUNCT
bptjm-21	128	3	895	895	NUM
bptjm-21	128	4	.	.	PUNCT
bptjm-21	129	1	doi:10.1016	doi:10.1016	PROPN
bptjm-21	129	2	/	/	SYM
bptjm-21	129	3	j.immuni.2015.10.002	j.immuni.2015.10.002	PROPN
bptjm-21	129	4	4	4	NUM
bptjm-21	129	5	.	.	PUNCT
bptjm-21	130	1	chen	chen	PROPN
bptjm-21	130	2	y	y	PROPN
bptjm-21	130	3	,	,	PUNCT
bptjm-21	130	4	dale	dale	PROPN
bptjm-21	130	5	bl	bl	PROPN
bptjm-21	130	6	,	,	PUNCT
bptjm-21	130	7	alexander	alexander	PROPN
bptjm-21	130	8	mr	mr	PROPN
bptjm-21	130	9	,	,	PUNCT
bptjm-21	130	10	et	et	PROPN
bptjm-21	130	11	al	al	PROPN
bptjm-21	130	12	.	.	PUNCT
bptjm-21	130	13	class	class	NOUN
bptjm-21	130	14	switching	switching	NOUN
bptjm-21	130	15	and	and	CCONJ
bptjm-21	130	16	high	high	ADJ
bptjm-21	130	17	-	-	PUNCT
bptjm-21	130	18	a	a	DET
bptjm-21	130	19	�	�	NOUN
bptjm-21	130	20	nity	nity	NOUN
bptjm-21	130	21	immunoglobulin	immunoglobulin	NOUN
bptjm-21	130	22	g	g	PROPN
bptjm-21	130	23	production	production	NOUN
bptjm-21	130	24	by	by	ADP
bptjm-21	130	25	b	b	PROPN
bptjm-21	130	26	cells	cell	NOUN
bptjm-21	130	27	is	be	AUX
bptjm-21	130	28	dispensable	dispensable	ADJ
bptjm-21	130	29	for	for	ADP
bptjm-21	130	30	the	the	DET
bptjm-21	130	31	development	development	NOUN
bptjm-21	130	32	of	of	ADP
bptjm-21	130	33	hypertension	hypertension	NOUN
bptjm-21	130	34	in	in	ADP
bptjm-21	130	35	mice	mouse	NOUN
bptjm-21	130	36	.	.	PUNCT
bptjm-21	131	1	cardiovasc	cardiovasc	PROPN
bptjm-21	131	2	res	res	PROPN
bptjm-21	131	3	.	.	PUNCT
bptjm-21	132	1	2021;117(4):1217	2021;117(4):1217	NUM
bptjm-21	132	2	-	-	SYM
bptjm-21	132	3	1228	1228	NUM
bptjm-21	132	4	.	.	PUNCT
bptjm-21	133	1	doi:10.1093	doi:10.1093	NOUN
bptjm-21	133	2	/	/	SYM
bptjm-21	133	3	cvr	cvr	PROPN
bptjm-21	133	4	/	/	SYM
bptjm-21	133	5	cvaa187	cvaa187	PROPN
bptjm-21	133	6	5	5	NUM
bptjm-21	133	7	.	.	PUNCT
bptjm-21	134	1	dale	dale	PROPN
bptjm-21	134	2	bl	bl	PROPN
bptjm-21	134	3	,	,	PUNCT
bptjm-21	134	4	pandey	pandey	PROPN
bptjm-21	134	5	ak	ak	PROPN
bptjm-21	134	6	,	,	PUNCT
bptjm-21	134	7	chen	chen	PROPN
bptjm-21	134	8	y	y	PROPN
bptjm-21	134	9	,	,	PUNCT
bptjm-21	134	10	et	et	PROPN
bptjm-21	134	11	al	al	PROPN
bptjm-21	134	12	.	.	PROPN
bptjm-21	134	13	critical	critical	ADJ
bptjm-21	134	14	role	role	NOUN
bptjm-21	134	15	of	of	ADP
bptjm-21	134	16	interleukin	interleukin	NOUN
bptjm-21	134	17	21	21	NUM
bptjm-21	134	18	and	and	CCONJ
bptjm-21	134	19	t	t	X
bptjm-21	134	20	follicular	follicular	ADJ
bptjm-21	134	21	helper	helper	NOUN
bptjm-21	134	22	cells	cell	NOUN
bptjm-21	134	23	in	in	ADP
bptjm-21	134	24	hypertension	hypertension	NOUN
bptjm-21	134	25	and	and	CCONJ
bptjm-21	134	26	vascular	vascular	ADJ
bptjm-21	134	27	dysfunction	dysfunction	NOUN
bptjm-21	134	28	.	.	PUNCT
bptjm-21	135	1	jci	jci	PROPN
bptjm-21	135	2	insight	insight	PROPN
bptjm-21	135	3	.	.	PUNCT
bptjm-21	136	1	2019;5(11):e129278	2019;5(11):e129278	NUM
bptjm-21	136	2	.	.	PROPN
bptjm-21	136	3	published	publish	VERB
bptjm-21	136	4	2019	2019	NUM
bptjm-21	136	5	apr	apr	NOUN
bptjm-21	136	6	23	23	NUM
bptjm-21	136	7	.	.	PUNCT
bptjm-21	137	1	doi:10.1172	doi:10.1172	PROPN
bptjm-21	137	2	/	/	SYM
bptjm-21	137	3	jci.insight.129278	jci.insight.129278	PROPN
bptjm-21	137	4	6	6	NUM
bptjm-21	137	5	.	.	PUNCT
bptjm-21	137	6	de	de	PROPN
bptjm-21	137	7	carvalho	carvalho	PROPN
bptjm-21	137	8	dd	dd	PROPN
bptjm-21	137	9	,	,	PUNCT
bptjm-21	137	10	you	you	PRON
bptjm-21	137	11	js	js	VERB
bptjm-21	137	12	,	,	PUNCT
bptjm-21	137	13	jones	jones	PROPN
bptjm-21	137	14	pa	pa	PROPN
bptjm-21	137	15	.	.	PROPN
bptjm-21	137	16	dna	dna	PROPN
bptjm-21	137	17	methylation	methylation	NOUN
bptjm-21	137	18	and	and	CCONJ
bptjm-21	137	19	cellular	cellular	ADJ
bptjm-21	137	20	reprogramming	reprogramming	NOUN
bptjm-21	137	21	.	.	PUNCT
bptjm-21	138	1	trends	trend	NOUN
bptjm-21	138	2	cell	cell	NOUN
bptjm-21	138	3	biol	biol	NOUN
bptjm-21	138	4	.	.	PUNCT
bptjm-21	139	1	2010;20(10):609	2010;20(10):609	PROPN
bptjm-21	139	2	-	-	SYM
bptjm-21	139	3	617	617	NUM
bptjm-21	139	4	.	.	PUNCT
bptjm-21	140	1	doi:10.1016	doi:10.1016	PROPN
bptjm-21	140	2	/	/	SYM
bptjm-21	140	3	j.tcb.2010.08.003	j.tcb.2010.08.003	PROPN
bptjm-21	140	4	7	7	NUM
bptjm-21	140	5	.	.	PUNCT
bptjm-21	140	6	del	del	PROPN
bptjm-21	140	7	pino	pino	PROPN
bptjm-21	140	8	molina	molina	PROPN
bptjm-21	140	9	l	l	PROPN
bptjm-21	140	10	,	,	PUNCT
bptjm-21	140	11	torres	torre	VERB
bptjm-21	140	12	canizales	canizale	NOUN
bptjm-21	140	13	jm	jm	PROPN
bptjm-21	140	14	,	,	PUNCT
bptjm-21	140	15	pernía	pernía	PROPN
bptjm-21	140	16	o	o	PROPN
bptjm-21	140	17	,	,	PUNCT
bptjm-21	140	18	rodríguez	rodríguez	NOUN
bptjm-21	140	19	pena	pena	PROPN
bptjm-21	140	20	r	r	PROPN
bptjm-21	140	21	,	,	PUNCT
bptjm-21	140	22	ibanez	ibanez	PROPN
bptjm-21	140	23	de	de	PROPN
bptjm-21	140	24	caceres	caceres	PROPN
bptjm-21	140	25	i	i	PRON
bptjm-21	140	26	,	,	PUNCT
bptjm-21	140	27	lópez	lópez	PROPN
bptjm-21	140	28	granados	granados	PROPN
bptjm-21	140	29	e.	e.	PROPN
bptjm-21	140	30	defective	defective	ADJ
bptjm-21	140	31	bcl-2	bcl-2	ADJ
bptjm-21	140	32	expression	expression	NOUN
bptjm-21	140	33	in	in	ADP
bptjm-21	140	34	memory	memory	NOUN
bptjm-21	140	35	b	b	PROPN
bptjm-21	140	36	cells	cell	NOUN
bptjm-21	140	37	from	from	ADP
bptjm-21	140	38	common	common	ADJ
bptjm-21	140	39	variable	variable	ADJ
bptjm-21	140	40	immunode	immunode	PROPN
bptjm-21	140	41	�	�	PROPN
bptjm-21	140	42	ciency	ciency	NOUN
bptjm-21	140	43	patients	patient	NOUN
bptjm-21	140	44	.	.	PUNCT
bptjm-21	141	1	clin	clin	PROPN
bptjm-21	141	2	exp	exp	NOUN
bptjm-21	141	3	immunol	immunol	NOUN
bptjm-21	141	4	.	.	PUNCT
bptjm-21	142	1	2021;203(3):341	2021;203(3):341	NUM
bptjm-21	142	2	-	-	SYM
bptjm-21	142	3	350	350	NUM
bptjm-21	142	4	.	.	PUNCT
bptjm-21	143	1	doi:10.1111	doi:10.1111	NOUN
bptjm-21	143	2	/	/	SYM
bptjm-21	143	3	cei.13522	cei.13522	ADP
bptjm-21	143	4	8	8	NOUN
bptjm-21	143	5	.	.	PUNCT
bptjm-21	144	1	galicia	galicia	PROPN
bptjm-21	144	2	g	g	PROPN
bptjm-21	144	3	,	,	PUNCT
bptjm-21	144	4	lee	lee	PROPN
bptjm-21	144	5	dsw	dsw	PROPN
bptjm-21	144	6	,	,	PUNCT
bptjm-21	144	7	ramaglia	ramaglia	PROPN
bptjm-21	144	8	v	v	PROPN
bptjm-21	144	9	,	,	PUNCT
bptjm-21	144	10	et	et	PROPN
bptjm-21	144	11	al	al	PROPN
bptjm-21	144	12	.	.	PUNCT
bptjm-21	144	13	isotype	isotype	NOUN
bptjm-21	144	14	-	-	PUNCT
bptjm-21	144	15	switched	switch	VERB
bptjm-21	144	16	autoantibodies	autoantibody	NOUN
bptjm-21	144	17	are	be	AUX
bptjm-21	144	18	necessary	necessary	ADJ
bptjm-21	144	19	to	to	PART
bptjm-21	144	20	facilitate	facilitate	VERB
bptjm-21	144	21	central	central	ADJ
bptjm-21	144	22	nervous	nervous	ADJ
bptjm-21	144	23	system	system	NOUN
bptjm-21	144	24	autoimmune	autoimmune	ADJ
bptjm-21	144	25	disease	disease	NOUN
bptjm-21	144	26	in	in	ADP
bptjm-21	144	27	aicda-/and	aicda-/and	PROPN
bptjm-21	144	28	ung-/mice	ung-/mice	PROPN
bptjm-21	144	29	.	.	PUNCT
bptjm-21	145	1	j	j	PROPN
bptjm-21	145	2	immunol	immunol	NOUN
bptjm-21	145	3	.	.	PUNCT
bptjm-21	146	1	2018;201(4):1119	2018;201(4):1119	NUM
bptjm-21	146	2	-	-	SYM
bptjm-21	146	3	1130	1130	NUM
bptjm-21	146	4	.	.	PUNCT
bptjm-21	147	1	doi:10.4049	doi:10.4049	PROPN
bptjm-21	147	2	/	/	SYM
bptjm-21	147	3	jimmunol.1700729	jimmunol.1700729	PROPN
bptjm-21	147	4	9	9	NUM
bptjm-21	147	5	.	.	PUNCT
bptjm-21	147	6	han	han	PROPN
bptjm-21	147	7	l	l	PROPN
bptjm-21	147	8	,	,	PUNCT
bptjm-21	147	9	masani	masani	PROPN
bptjm-21	147	10	s	s	PROPN
bptjm-21	147	11	,	,	PUNCT
bptjm-21	147	12	yu	yu	PROPN
bptjm-21	147	13	k.	k.	PROPN
bptjm-21	147	14	overlapping	overlap	VERB
bptjm-21	147	15	activation	activation	NOUN
bptjm-21	147	16	-	-	PUNCT
bptjm-21	147	17	induced	induce	VERB
bptjm-21	147	18	cytidine	cytidine	NOUN
bptjm-21	147	19	deaminase	deaminase	NOUN
bptjm-21	147	20	hotspot	hotspot	NOUN
bptjm-21	147	21	motifs	motif	NOUN
bptjm-21	147	22	in	in	ADP
bptjm-21	147	23	ig	ig	PROPN
bptjm-21	147	24	class	class	NOUN
bptjm-21	147	25	-	-	PUNCT
bptjm-21	147	26	switch	switch	NOUN
bptjm-21	147	27	recombination	recombination	NOUN
bptjm-21	147	28	.	.	PUNCT
bptjm-21	148	1	proc	proc	PROPN
bptjm-21	148	2	natl	natl	PROPN
bptjm-21	148	3	acad	acad	PROPN
bptjm-21	148	4	sci	sci	PROPN
bptjm-21	148	5	u	u	PROPN
bptjm-21	148	6	s	s	PROPN
bptjm-21	148	7	a.	a.	NOUN
bptjm-21	148	8	2011;108(28):11584	2011;108(28):11584	PROPN
bptjm-21	148	9	-	-	NOUN
bptjm-21	148	10	11589	11589	NUM
bptjm-21	148	11	.	.	PUNCT
bptjm-21	149	1	doi:10.1073	doi:10.1073	NOUN
bptjm-21	149	2	/	/	SYM
bptjm-21	150	1	pnas.1018726108	pnas.1018726108	ADP
bptjm-21	150	2	10	10	NUM
bptjm-21	150	3	.	.	PUNCT
bptjm-21	150	4	hu	hu	PROPN
bptjm-21	150	5	y	y	PROPN
bptjm-21	150	6	,	,	PUNCT
bptjm-21	150	7	ericsson	ericsson	PROPN
bptjm-21	150	8	i	i	PROPN
bptjm-21	150	9	,	,	PUNCT
bptjm-21	150	10	doseth	doseth	PROPN
bptjm-21	150	11	b	b	PROPN
bptjm-21	150	12	,	,	PUNCT
bptjm-21	150	13	liabakk	liabakk	PROPN
bptjm-21	150	14	nb	nb	PROPN
bptjm-21	150	15	,	,	PUNCT
bptjm-21	150	16	krokan	krokan	VERB
bptjm-21	150	17	he	he	PRON
bptjm-21	150	18	,	,	PUNCT
bptjm-21	150	19	kavli	kavli	PROPN
bptjm-21	150	20	b.	b.	PROPN
bptjm-21	150	21	activation	activation	NOUN
bptjm-21	150	22	-	-	PUNCT
bptjm-21	150	23	induced	induce	VERB
bptjm-21	150	24	cytidine	cytidine	NOUN
bptjm-21	150	25	deaminase	deaminase	NOUN
bptjm-21	150	26	(	(	PUNCT
bptjm-21	150	27	aid	aid	NOUN
bptjm-21	150	28	)	)	PUNCT
bptjm-21	150	29	is	be	AUX
bptjm-21	150	30	localized	localize	VERB
bptjm-21	150	31	to	to	ADP
bptjm-21	150	32	subnuclear	subnuclear	NOUN
bptjm-21	150	33	domains	domain	NOUN
bptjm-21	150	34	enriched	enrich	VERB
bptjm-21	150	35	in	in	ADP
bptjm-21	150	36	splicing	splicing	NOUN
bptjm-21	150	37	factors	factor	NOUN
bptjm-21	150	38	.	.	PUNCT
bptjm-21	151	1	exp	exp	NOUN
bptjm-21	151	2	cell	cell	NOUN
bptjm-21	151	3	res	re	NOUN
bptjm-21	151	4	.	.	PUNCT
bptjm-21	152	1	2014;322(1):178	2014;322(1):178	NUM
bptjm-21	152	2	-	-	SYM
bptjm-21	152	3	192	192	NUM
bptjm-21	152	4	.	.	PUNCT
bptjm-21	153	1	doi:10.1016	doi:10.1016	PROPN
bptjm-21	153	2	/	/	SYM
bptjm-21	153	3	j.yexcr.2014.01.004	j.yexcr.2014.01.004	PROPN
bptjm-21	153	4	11	11	NUM
bptjm-21	153	5	.	.	PUNCT
bptjm-21	154	1	jeong	jeong	PROPN
bptjm-21	154	2	gs	gs	PROPN
bptjm-21	154	3	,	,	PUNCT
bptjm-21	154	4	byun	byun	PROPN
bptjm-21	154	5	e	e	PROPN
bptjm-21	154	6	,	,	PUNCT
bptjm-21	154	7	li	li	PROPN
bptjm-21	154	8	b	b	PROPN
bptjm-21	154	9	,	,	PUNCT
bptjm-21	154	10	lee	lee	PROPN
bptjm-21	154	11	ds	ds	PROPN
bptjm-21	154	12	,	,	PUNCT
bptjm-21	154	13	kim	kim	PROPN
bptjm-21	154	14	yc	yc	PROPN
bptjm-21	154	15	,	,	PUNCT
bptjm-21	154	16	an	an	DET
bptjm-21	154	17	rb	rb	NOUN
bptjm-21	154	18	.	.	PUNCT
bptjm-21	154	19	neuroprotective	neuroprotective	ADJ
bptjm-21	154	20	e	e	NOUN
bptjm-21	154	21	�	�	NOUN
bptjm-21	154	22	ects	ect	NOUN
bptjm-21	154	23	of	of	ADP
bptjm-21	154	24	constituents	constituent	NOUN
bptjm-21	154	25	of	of	ADP
bptjm-21	154	26	the	the	DET
bptjm-21	154	27	root	root	NOUN
bptjm-21	154	28	bark	bark	NOUN
bptjm-21	154	29	of	of	ADP
bptjm-21	154	30	dictamnus	dictamnus	PROPN
bptjm-21	154	31	dasycarpus	dasycarpus	PROPN
bptjm-21	154	32	in	in	ADP
bptjm-21	154	33	mouse	mouse	NOUN
bptjm-21	154	34	hippocampal	hippocampal	ADJ
bptjm-21	154	35	cells	cell	NOUN
bptjm-21	154	36	[	[	X
bptjm-21	154	37	published	publish	VERB
bptjm-21	154	38	correction	correction	NOUN
bptjm-21	154	39	appears	appear	VERB
bptjm-21	154	40	in	in	ADP
bptjm-21	154	41	arch	arch	ADJ
bptjm-21	154	42	pharmres	pharmre	NOUN
bptjm-21	154	43	.	.	PUNCT
bptjm-21	155	1	2014	2014	NUM
bptjm-21	155	2	mar;37(3):421	mar;37(3):421	ADP
bptjm-21	155	3	]	]	PUNCT
bptjm-21	155	4	.	.	PUNCT
bptjm-21	156	1	arch	arch	ADJ
bptjm-21	156	2	pharm	pharm	NOUN
bptjm-21	156	3	res	re	NOUN
bptjm-21	156	4	.	.	PUNCT
bptjm-21	157	1	2010;33(8):1269	2010;33(8):1269	PROPN
bptjm-21	157	2	-	-	SYM
bptjm-21	157	3	1275	1275	NUM
bptjm-21	157	4	.	.	PUNCT
bptjm-21	158	1	doi:10.1007	doi:10.1007	VERB
bptjm-21	158	2	/	/	SYM
bptjm-21	158	3	s12272	s12272	PROPN
bptjm-21	158	4	-	-	PUNCT
bptjm-21	158	5	010	010	NUM
bptjm-21	158	6	-	-	PUNCT
bptjm-21	158	7	0818	0818	NUM
bptjm-21	158	8	-	-	PUNCT
bptjm-21	158	9	9	9	NUM
bptjm-21	158	10	12	12	NUM
bptjm-21	158	11	.	.	PUNCT
bptjm-21	159	1	kelly	kelly	PROPN
bptjm-21	159	2	c	c	PROPN
bptjm-21	159	3	,	,	PUNCT
bptjm-21	159	4	gangur	gangur	PROPN
bptjm-21	159	5	v.	v.	ADP
bptjm-21	159	6	sex	sex	NOUN
bptjm-21	159	7	disparity	disparity	NOUN
bptjm-21	159	8	in	in	ADP
bptjm-21	159	9	food	food	NOUN
bptjm-21	159	10	allergy	allergy	NOUN
bptjm-21	159	11	:	:	PUNCT
bptjm-21	159	12	evidence	evidence	NOUN
bptjm-21	159	13	from	from	ADP
bptjm-21	159	14	the	the	DET
bptjm-21	159	15	pubmed	pubmed	PROPN
bptjm-21	159	16	database	database	PROPN
bptjm-21	159	17	.	.	PUNCT
bptjm-21	160	1	j	j	PROPN
bptjm-21	160	2	allergy	allergy	PROPN
bptjm-21	160	3	(	(	PUNCT
bptjm-21	160	4	cairo	cairo	PROPN
bptjm-21	160	5	)	)	PUNCT
bptjm-21	160	6	.	.	PUNCT
bptjm-21	161	1	2009;2009:159845	2009;2009:159845	NUM
bptjm-21	161	2	.	.	PUNCT
bptjm-21	162	1	doi:10.1155/2009/159845	doi:10.1155/2009/159845	NUM
bptjm-21	162	2	13	13	NUM
bptjm-21	162	3	.	.	PUNCT
bptjm-21	163	1	kim	kim	PROPN
bptjm-21	163	2	a	a	PROPN
bptjm-21	163	3	,	,	PUNCT
bptjm-21	163	4	han	han	PROPN
bptjm-21	163	5	l	l	PROPN
bptjm-21	163	6	,	,	PUNCT
bptjm-21	163	7	yu	yu	PROPN
bptjm-21	163	8	k.	k.	PROPN
bptjm-21	163	9	immunoglobulin	immunoglobulin	PROPN
bptjm-21	163	10	class	class	PROPN
bptjm-21	163	11	switch	switch	NOUN
bptjm-21	163	12	recombination	recombination	NOUN
bptjm-21	163	13	is	be	AUX
bptjm-21	163	14	initiated	initiate	VERB
bptjm-21	163	15	by	by	ADP
bptjm-21	163	16	rare	rare	ADJ
bptjm-21	163	17	cytosine	cytosine	NOUN
bptjm-21	163	18	deaminationevents	deaminationevent	NOUN
bptjm-21	163	19	at	at	ADP
bptjm-21	163	20	switch	switch	NOUN
bptjm-21	163	21	regions	region	NOUN
bptjm-21	163	22	.	.	PUNCT
bptjm-21	164	1	mol	mol	ADP
bptjm-21	164	2	cell	cell	NOUN
bptjm-21	164	3	biol	biol	NOUN
bptjm-21	164	4	.	.	PUNCT
bptjm-21	165	1	2020;40(16):e00125	2020;40(16):e00125	PROPN
bptjm-21	165	2	-	-	PUNCT
bptjm-21	165	3	20	20	NUM
bptjm-21	165	4	.	.	PUNCT
bptjm-21	166	1	published	publish	VERB
bptjm-21	166	2	2020	2020	NUM
bptjm-21	166	3	jul	jul	PROPN
bptjm-21	166	4	29	29	NUM
bptjm-21	166	5	.	.	PUNCT
bptjm-21	167	1	doi:10.1128	doi:10.1128	VERB
bptjm-21	167	2	/	/	SYM
bptjm-21	167	3	mcb.00125	mcb.00125	NOUN
bptjm-21	167	4	-	-	PUNCT
bptjm-21	167	5	20	20	NUM
bptjm-21	167	6	berkeley	berkeley	PROPN
bptjm-21	167	7	pharma	pharma	PROPN
bptjm-21	167	8	tech	tech	NOUN
bptjm-21	167	9	journal	journal	NOUN
bptjm-21	167	10	of	of	ADP
bptjm-21	167	11	medicine	medicine	NOUN
bptjm-21	167	12	|	|	ADV
bptjm-21	167	13	117	117	NUM
bptjm-21	167	14	14	14	NUM
bptjm-21	167	15	.	.	PUNCT
bptjm-21	168	1	lamont	lamont	PROPN
bptjm-21	168	2	kr	kr	PROPN
bptjm-21	168	3	,	,	PUNCT
bptjm-21	168	4	hasham	hasham	VERB
bptjm-21	168	5	mg	mg	PROPN
bptjm-21	168	6	,	,	PUNCT
bptjm-21	168	7	donghia	donghia	PROPN
bptjm-21	168	8	nm	nm	PROPN
bptjm-21	168	9	,	,	PUNCT
bptjm-21	168	10	et	et	PROPN
bptjm-21	168	11	al	al	PROPN
bptjm-21	168	12	.	.	PUNCT
bptjm-21	169	1	attenuating	attenuate	VERB
bptjm-21	169	2	homologous	homologous	ADJ
bptjm-21	169	3	recombination	recombination	NOUN
bptjm-21	169	4	stimulates	stimulate	VERB
bptjm-21	169	5	an	an	DET
bptjm-21	169	6	aid	aid	NOUN
bptjm-21	169	7	-	-	PUNCT
bptjm-21	169	8	induced	induce	VERB
bptjm-21	169	9	antileukemic	antileukemic	ADJ
bptjm-21	169	10	e	e	NOUN
bptjm-21	169	11	�	�	NOUN
bptjm-21	169	12	ect	ect	NOUN
bptjm-21	169	13	.	.	PUNCT
bptjm-21	170	1	j	j	PROPN
bptjm-21	170	2	exp	exp	NOUN
bptjm-21	170	3	med	med	PROPN
bptjm-21	170	4	.	.	PUNCT
bptjm-21	171	1	2013;210(5):1021	2013;210(5):1021	NUM
bptjm-21	171	2	-	-	SYM
bptjm-21	171	3	1033	1033	NUM
bptjm-21	171	4	.	.	PUNCT
bptjm-21	172	1	doi:10.1084	doi:10.1084	PROPN
bptjm-21	172	2	/	/	SYM
bptjm-21	172	3	jem.20121258	jem.20121258	PROPN
bptjm-21	172	4	15	15	NUM
bptjm-21	172	5	.	.	PUNCT
bptjm-21	173	1	liu	liu	PROPN
bptjm-21	173	2	jq	jq	PROPN
bptjm-21	173	3	,	,	PUNCT
bptjm-21	173	4	joshi	joshi	PROPN
bptjm-21	173	5	ps	ps	PROPN
bptjm-21	173	6	,	,	PUNCT
bptjm-21	173	7	wang	wang	PROPN
bptjm-21	173	8	c	c	PROPN
bptjm-21	173	9	,	,	PUNCT
bptjm-21	173	10	et	et	PROPN
bptjm-21	173	11	al	al	PROPN
bptjm-21	173	12	.	.	PUNCT
bptjm-21	174	1	targeting	target	VERB
bptjm-21	174	2	activation	activation	NOUN
bptjm-21	174	3	-	-	PUNCT
bptjm-21	174	4	induced	induce	VERB
bptjm-21	174	5	cytidine	cytidine	NOUN
bptjm-21	174	6	deaminase	deaminase	NOUN
bptjm-21	174	7	overcomes	overcome	VERB
bptjm-21	174	8	tumor	tumor	NOUN
bptjm-21	174	9	evasion	evasion	NOUN
bptjm-21	174	10	of	of	ADP
bptjm-21	174	11	immunotherapy	immunotherapy	NOUN
bptjm-21	174	12	by	by	ADP
bptjm-21	174	13	ctls	ctls	PROPN
bptjm-21	174	14	.	.	PUNCT
bptjm-21	175	1	j	j	PROPN
bptjm-21	175	2	immunol	immunol	NOUN
bptjm-21	175	3	.	.	PUNCT
bptjm-21	176	1	2010;184(10):5435	2010;184(10):5435	NUM
bptjm-21	176	2	-	-	SYM
bptjm-21	176	3	5443	5443	NUM
bptjm-21	176	4	.	.	PUNCT
bptjm-21	177	1	doi:10.4049	doi:10.4049	PROPN
bptjm-21	177	2	/	/	SYM
bptjm-21	177	3	jimmunol.0903322	jimmunol.0903322	PROPN
bptjm-21	177	4	16	16	NUM
bptjm-21	177	5	.	.	PUNCT
bptjm-21	178	1	meshcheryakova	meshcheryakova	PROPN
bptjm-21	178	2	a	a	PRON
bptjm-21	178	3	,	,	PUNCT
bptjm-21	178	4	pietschmann	pietschmann	NOUN
bptjm-21	178	5	p	p	NOUN
bptjm-21	178	6	,	,	PUNCT
bptjm-21	178	7	zimmermann	zimmermann	PROPN
bptjm-21	178	8	p	p	NOUN
bptjm-21	178	9	,	,	PUNCT
bptjm-21	178	10	rogozin	rogozin	PROPN
bptjm-21	178	11	ib	ib	PROPN
bptjm-21	178	12	,	,	PUNCT
bptjm-21	178	13	mechtcheriakova	mechtcheriakova	PROPN
bptjm-21	178	14	d.	d.	PROPN
bptjm-21	178	15	aid	aid	PROPN
bptjm-21	178	16	and	and	CCONJ
bptjm-21	178	17	apobecs	apobec	NOUN
bptjm-21	178	18	asmultifaceted	asmultifacete	VERB
bptjm-21	178	19	intrinsic	intrinsic	ADJ
bptjm-21	178	20	virus	virus	NOUN
bptjm-21	178	21	-	-	PUNCT
bptjm-21	178	22	restricting	restrict	VERB
bptjm-21	178	23	factors	factor	NOUN
bptjm-21	178	24	:	:	PUNCT
bptjm-21	178	25	emerging	emerge	VERB
bptjm-21	178	26	concepts	concept	NOUN
bptjm-21	178	27	in	in	ADP
bptjm-21	178	28	the	the	DET
bptjm-21	178	29	light	light	NOUN
bptjm-21	178	30	of	of	ADP
bptjm-21	178	31	covid-19	covid-19	PROPN
bptjm-21	178	32	.	.	PUNCT
bptjm-21	179	1	front	front	ADJ
bptjm-21	179	2	immunol	immunol	NOUN
bptjm-21	179	3	.	.	PUNCT
bptjm-21	180	1	2021;12:690416	2021;12:690416	NUM
bptjm-21	180	2	.	.	PUNCT
bptjm-21	180	3	published	publish	VERB
bptjm-21	180	4	2021	2021	NUM
bptjm-21	180	5	jul	jul	PROPN
bptjm-21	180	6	1	1	NUM
bptjm-21	180	7	.	.	PUNCT
bptjm-21	181	1	doi:10.3389/	doi:10.3389/	PROPN
bptjm-21	181	2	�	�	PROPN
bptjm-21	181	3	mmu.2021.690416	mmu.2021.690416	PROPN
bptjm-21	181	4	17	17	NUM
bptjm-21	181	5	.	.	PUNCT
bptjm-21	182	1	miyazaki	miyazaki	PROPN
bptjm-21	182	2	y	y	PROPN
bptjm-21	182	3	,	,	PUNCT
bptjm-21	182	4	inoue	inoue	PROPN
bptjm-21	182	5	h	h	PROPN
bptjm-21	182	6	,	,	PUNCT
bptjm-21	182	7	kikuchi	kikuchi	PROPN
bptjm-21	182	8	k	k	PROPN
bptjm-21	182	9	,	,	PUNCT
bptjm-21	182	10	ochiai	ochiai	PROPN
bptjm-21	182	11	k	k	PROPN
bptjm-21	182	12	,	,	PUNCT
bptjm-21	182	13	kusama	kusama	PROPN
bptjm-21	182	14	k.	k.	PROPN
bptjm-21	182	15	activation	activation	NOUN
bptjm-21	182	16	-	-	PUNCT
bptjm-21	182	17	induced	induce	VERB
bptjm-21	182	18	cytidine	cytidine	NOUN
bptjm-21	182	19	deaminase	deaminase	PROPN
bptjm-21	182	20	mrna	mrna	PROPN
bptjm-21	182	21	expression	expression	NOUN
bptjm-21	182	22	in	in	ADP
bptjm-21	182	23	oral	oral	ADJ
bptjm-21	182	24	squamous	squamous	ADJ
bptjm-21	182	25	cell	cell	NOUN
bptjm-21	182	26	carcinoma	carcinoma	NOUN
bptjm-21	182	27	-	-	PUNCT
bptjm-21	182	28	derived	derive	VERB
bptjm-21	182	29	cell	cell	NOUN
bptjm-21	182	30	lines	line	NOUN
bptjm-21	182	31	is	be	AUX
bptjm-21	182	32	upregulated	upregulate	VERB
bptjm-21	182	33	by	by	ADP
bptjm-21	182	34	in	in	ADP
bptjm-21	182	35	�	�	PROPN
bptjm-21	182	36	ammatory	ammatory	NOUN
bptjm-21	182	37	cytokines	cytokine	NOUN
bptjm-21	182	38	.	.	PUNCT
bptjm-21	183	1	j	j	PROPN
bptjm-21	183	2	oral	oral	PROPN
bptjm-21	183	3	sci	sci	PROPN
bptjm-21	183	4	.	.	PUNCT
bptjm-21	184	1	2012;54(1):71	2012;54(1):71	NUM
bptjm-21	184	2	-	-	SYM
bptjm-21	184	3	75	75	NUM
bptjm-21	184	4	.	.	PUNCT
bptjm-21	184	5	doi:10.2334	doi:10.2334	PROPN
bptjm-21	184	6	/	/	SYM
bptjm-21	184	7	josnusd.54.71	josnusd.54.71	PROPN
bptjm-21	184	8	18	18	NUM
bptjm-21	184	9	.	.	PUNCT
bptjm-21	184	10	montamat	montamat	NOUN
bptjm-21	184	11	-	-	PUNCT
bptjm-21	184	12	sicotte	sicotte	NOUN
bptjm-21	184	13	d	d	PROPN
bptjm-21	184	14	,	,	PUNCT
bptjm-21	184	15	litzler	litzler	NOUN
bptjm-21	184	16	lc	lc	PROPN
bptjm-21	184	17	,	,	PUNCT
bptjm-21	184	18	abreu	abreu	PROPN
bptjm-21	184	19	c	c	PROPN
bptjm-21	184	20	,	,	PUNCT
bptjm-21	184	21	et	et	PROPN
bptjm-21	184	22	al	al	PROPN
bptjm-21	184	23	.	.	PUNCT
bptjm-21	185	1	hsp90	hsp90	ADJ
bptjm-21	185	2	inhibitors	inhibitor	NOUN
bptjm-21	185	3	decrease	decrease	VERB
bptjm-21	185	4	aid	aid	NOUN
bptjm-21	185	5	levels	level	NOUN
bptjm-21	185	6	and	and	CCONJ
bptjm-21	185	7	activity	activity	NOUN
bptjm-21	185	8	in	in	ADP
bptjm-21	185	9	mice	mouse	NOUN
bptjm-21	185	10	and	and	CCONJ
bptjm-21	185	11	in	in	ADP
bptjm-21	185	12	human	human	ADJ
bptjm-21	185	13	cells	cell	NOUN
bptjm-21	185	14	.	.	PUNCT
bptjm-21	186	1	eur	eur	PROPN
bptjm-21	186	2	j	j	PROPN
bptjm-21	186	3	immunol	immunol	NOUN
bptjm-21	186	4	.	.	PUNCT
bptjm-21	187	1	2015;45(8):2365	2015;45(8):2365	NUM
bptjm-21	187	2	-	-	SYM
bptjm-21	187	3	2376	2376	NUM
bptjm-21	187	4	.	.	PUNCT
bptjm-21	188	1	doi:10.1002	doi:10.1002	NOUN
bptjm-21	188	2	/	/	SYM
bptjm-21	188	3	eji.201545462	eji.201545462	PROPN
bptjm-21	188	4	19	19	NUM
bptjm-21	188	5	.	.	PUNCT
bptjm-21	189	1	morgan	morgan	PROPN
bptjm-21	189	2	hd	hd	PROPN
bptjm-21	189	3	,	,	PUNCT
bptjm-21	189	4	dean	dean	PROPN
bptjm-21	189	5	w	w	PROPN
bptjm-21	189	6	,	,	PUNCT
bptjm-21	189	7	coker	coker	NOUN
bptjm-21	189	8	ha	ha	PROPN
bptjm-21	189	9	,	,	PUNCT
bptjm-21	189	10	reik	reik	PROPN
bptjm-21	189	11	w	w	PROPN
bptjm-21	189	12	,	,	PUNCT
bptjm-21	189	13	petersen	petersen	PROPN
bptjm-21	189	14	-	-	PUNCT
bptjm-21	189	15	mahrt	mahrt	PROPN
bptjm-21	189	16	sk	sk	PROPN
bptjm-21	189	17	.	.	NOUN
bptjm-21	189	18	activation	activation	NOUN
bptjm-21	189	19	-	-	PUNCT
bptjm-21	189	20	induced	induce	VERB
bptjm-21	189	21	cytidine	cytidine	NOUN
bptjm-21	189	22	deaminase	deaminase	NOUN
bptjm-21	189	23	deaminates	deaminate	VERB
bptjm-21	189	24	5	5	NUM
bptjm-21	189	25	-	-	NOUN
bptjm-21	189	26	methylcytosine	methylcytosine	NOUN
bptjm-21	189	27	in	in	ADP
bptjm-21	189	28	dna	dna	PROPN
bptjm-21	189	29	and	and	CCONJ
bptjm-21	189	30	is	be	AUX
bptjm-21	189	31	expressed	express	VERB
bptjm-21	189	32	in	in	ADP
bptjm-21	189	33	pluripotent	pluripotent	ADJ
bptjm-21	189	34	tissues	tissue	NOUN
bptjm-21	189	35	:	:	PUNCT
bptjm-21	189	36	implications	implication	NOUN
bptjm-21	189	37	for	for	ADP
bptjm-21	189	38	epigenetic	epigenetic	ADJ
bptjm-21	189	39	reprogramming	reprogramming	NOUN
bptjm-21	189	40	.	.	PUNCT
bptjm-21	190	1	j	j	PROPN
bptjm-21	190	2	biol	biol	PROPN
bptjm-21	190	3	chem	chem	NOUN
bptjm-21	190	4	.	.	PUNCT
bptjm-21	191	1	2004;279(50):52353	2004;279(50):52353	NUM
bptjm-21	191	2	-	-	SYM
bptjm-21	191	3	52360	52360	NUM
bptjm-21	191	4	.	.	PUNCT
bptjm-21	192	1	doi:10.1074	doi:10.1074	PROPN
bptjm-21	192	2	/	/	SYM
bptjm-21	192	3	jbc.m407695200	jbc.m407695200	PROPN
bptjm-21	192	4	20	20	NUM
bptjm-21	192	5	.	.	PUNCT
bptjm-21	193	1	moroney	moroney	PROPN
bptjm-21	193	2	jb	jb	PROPN
bptjm-21	193	3	,	,	PUNCT
bptjm-21	193	4	chupp	chupp	PROPN
bptjm-21	193	5	dp	dp	PROPN
bptjm-21	193	6	,	,	PUNCT
bptjm-21	193	7	xu	xu	PROPN
bptjm-21	194	1	z	z	PROPN
bptjm-21	194	2	,	,	PUNCT
bptjm-21	194	3	zan	zan	PROPN
bptjm-21	194	4	h	h	PROPN
bptjm-21	194	5	,	,	PUNCT
bptjm-21	194	6	casali	casali	PROPN
bptjm-21	194	7	p.	p.	NOUN
bptjm-21	194	8	epigenetics	epigenetic	NOUN
bptjm-21	194	9	of	of	ADP
bptjm-21	194	10	the	the	DET
bptjm-21	194	11	antibody	antibody	NOUN
bptjm-21	194	12	and	and	CCONJ
bptjm-21	194	13	autoantibody	autoantibody	ADJ
bptjm-21	194	14	response	response	NOUN
bptjm-21	194	15	.	.	PUNCT
bptjm-21	195	1	curr	curr	PROPN
bptjm-21	195	2	opin	opin	PROPN
bptjm-21	195	3	immunol	immunol	NOUN
bptjm-21	195	4	.	.	PUNCT
bptjm-21	196	1	2020;67:75	2020;67:75	NUM
bptjm-21	196	2	-	-	SYM
bptjm-21	196	3	86	86	NUM
bptjm-21	196	4	.	.	PUNCT
bptjm-21	197	1	doi:10.1016	doi:10.1016	PROPN
bptjm-21	197	2	/	/	SYM
bptjm-21	197	3	j.coi.2020.09.004	j.coi.2020.09.004	PROPN
bptjm-21	197	4	21	21	NUM
bptjm-21	197	5	.	.	PUNCT
bptjm-21	198	1	pham	pham	PROPN
bptjm-21	198	2	p	p	PROPN
bptjm-21	198	3	,	,	PUNCT
bptjm-21	198	4	a	a	DET
bptjm-21	198	5	�	�	PROPN
bptjm-21	198	6	f	f	PROPN
bptjm-21	198	7	sa	sa	PROPN
bptjm-21	198	8	,	,	PUNCT
bptjm-21	198	9	shimoda	shimoda	PROPN
bptjm-21	198	10	m	m	PROPN
bptjm-21	198	11	,	,	PUNCT
bptjm-21	198	12	et	et	PROPN
bptjm-21	198	13	al	al	PROPN
bptjm-21	198	14	.	.	PROPN
bptjm-21	199	1	structural	structural	ADJ
bptjm-21	199	2	analysis	analysis	NOUN
bptjm-21	199	3	of	of	ADP
bptjm-21	199	4	the	the	DET
bptjm-21	199	5	activation	activation	NOUN
bptjm-21	199	6	-	-	PUNCT
bptjm-21	199	7	induced	induce	VERB
bptjm-21	199	8	deoxycytidine	deoxycytidine	ADJ
bptjm-21	199	9	deaminase	deaminase	NOUN
bptjm-21	199	10	required	require	VERB
bptjm-21	199	11	in	in	ADP
bptjm-21	199	12	immunoglobulin	immunoglobulin	PROPN
bptjm-21	199	13	diversi	diversi	PROPN
bptjm-21	199	14	�	�	PROPN
bptjm-21	199	15	cation	cation	NOUN
bptjm-21	199	16	.	.	PUNCT
bptjm-21	200	1	dna	dna	PROPN
bptjm-21	200	2	repair	repair	NOUN
bptjm-21	200	3	(	(	PUNCT
bptjm-21	200	4	amst	amst	NOUN
bptjm-21	200	5	)	)	PUNCT
bptjm-21	200	6	.	.	PUNCT
bptjm-21	201	1	2016;43:48	2016;43:48	NUM
bptjm-21	201	2	-	-	SYM
bptjm-21	201	3	56	56	NUM
bptjm-21	201	4	.	.	PUNCT
bptjm-21	201	5	doi:10.1016	doi:10.1016	PROPN
bptjm-21	201	6	/	/	SYM
bptjm-21	201	7	j.dnarep.2016.05.029	j.dnarep.2016.05.029	PROPN
bptjm-21	201	8	22	22	NUM
bptjm-21	201	9	.	.	PUNCT
bptjm-21	202	1	qiao	qiao	PROPN
bptjm-21	202	2	q	q	PROPN
bptjm-21	202	3	,	,	PUNCT
bptjm-21	202	4	wang	wang	PROPN
bptjm-21	202	5	l	l	PROPN
bptjm-21	202	6	,	,	PUNCT
bptjm-21	202	7	meng	meng	PROPN
bptjm-21	202	8	fl	fl	PROPN
bptjm-21	202	9	,	,	PUNCT
bptjm-21	202	10	hwang	hwang	PROPN
bptjm-21	202	11	jk	jk	PROPN
bptjm-21	202	12	,	,	PUNCT
bptjm-21	202	13	alt	alt	VERB
bptjm-21	202	14	fw	fw	PROPN
bptjm-21	202	15	,	,	PUNCT
bptjm-21	202	16	wu	wu	PROPN
bptjm-21	202	17	h.	h.	PROPN
bptjm-21	202	18	aid	aid	PROPN
bptjm-21	202	19	recognizes	recognize	VERB
bptjm-21	202	20	structured	structure	VERB
bptjm-21	202	21	dna	dna	NOUN
bptjm-21	202	22	for	for	ADP
bptjm-21	202	23	class	class	NOUN
bptjm-21	202	24	switch	switch	NOUN
bptjm-21	202	25	recombination	recombination	NOUN
bptjm-21	202	26	.	.	PUNCT
bptjm-21	203	1	mol	mol	ADP
bptjm-21	203	2	cell	cell	NOUN
bptjm-21	203	3	.	.	PUNCT
bptjm-21	204	1	2017;67(3):361	2017;67(3):361	NOUN
bptjm-21	204	2	-	-	PUNCT
bptjm-21	204	3	373.e4	373.e4	NUM
bptjm-21	204	4	.	.	PUNCT
bptjm-21	205	1	doi:10.1016	doi:10.1016	PROPN
bptjm-21	205	2	/	/	SYM
bptjm-21	205	3	j.molcel.2017.06.034	j.molcel.2017.06.034	PROPN
bptjm-21	205	4	23	23	NUM
bptjm-21	205	5	.	.	PUNCT
bptjm-21	206	1	rada	rada	PROPN
bptjm-21	206	2	c	c	PROPN
bptjm-21	206	3	,	,	PUNCT
bptjm-21	206	4	di	di	PROPN
bptjm-21	206	5	noia	noia	PROPN
bptjm-21	206	6	jm	jm	PROPN
bptjm-21	206	7	,	,	PUNCT
bptjm-21	206	8	neuberger	neuberger	PROPN
bptjm-21	206	9	ms	ms	PROPN
bptjm-21	206	10	.	.	PROPN
bptjm-21	206	11	mismatch	mismatch	PROPN
bptjm-21	206	12	recognition	recognition	NOUN
bptjm-21	206	13	and	and	CCONJ
bptjm-21	206	14	uracil	uracil	ADJ
bptjm-21	206	15	excision	excision	NOUN
bptjm-21	206	16	provide	provide	VERB
bptjm-21	206	17	complementary	complementary	ADJ
bptjm-21	206	18	paths	path	NOUN
bptjm-21	206	19	to	to	ADP
bptjm-21	206	20	both	both	DET
bptjm-21	206	21	switching	switch	VERB
bptjm-21	206	22	and	and	CCONJ
bptjm-21	206	23	the	the	DET
bptjm-21	206	24	a	a	PROPN
bptjm-21	206	25	/	/	SYM
bptjm-21	206	26	t	t	NOUN
bptjm-21	206	27	-	-	PUNCT
bptjm-21	206	28	focused	focus	VERB
bptjm-21	206	29	phase	phase	NOUN
bptjm-21	206	30	of	of	ADP
bptjm-21	206	31	somatic	somatic	ADJ
bptjm-21	206	32	mutation	mutation	NOUN
bptjm-21	206	33	.	.	PUNCT
bptjm-21	207	1	mol	mol	ADP
bptjm-21	207	2	cell	cell	NOUN
bptjm-21	207	3	.	.	PUNCT
bptjm-21	208	1	2004;16(2):163	2004;16(2):163	NUM
bptjm-21	208	2	-	-	PUNCT
bptjm-21	208	3	171	171	NUM
bptjm-21	208	4	.	.	PUNCT
bptjm-21	209	1	doi:10.1016	doi:10.1016	PROPN
bptjm-21	209	2	/	/	SYM
bptjm-21	210	1	j.molcel.2004.10.011	j.molcel.2004.10.011	PROPN
bptjm-21	210	2	24	24	NUM
bptjm-21	210	3	.	.	PUNCT
bptjm-21	211	1	ratiu	ratiu	PROPN
bptjm-21	211	2	jj	jj	PROPN
bptjm-21	211	3	,	,	PUNCT
bptjm-21	211	4	racine	racine	PROPN
bptjm-21	211	5	jj	jj	PROPN
bptjm-21	211	6	,	,	PUNCT
bptjm-21	211	7	hasham	hasham	VERB
bptjm-21	211	8	mg	mg	PROPN
bptjm-21	211	9	,	,	PUNCT
bptjm-21	211	10	et	et	PROPN
bptjm-21	211	11	al	al	PROPN
bptjm-21	211	12	.	.	PUNCT
bptjm-21	212	1	genetic	genetic	ADJ
bptjm-21	212	2	and	and	CCONJ
bptjm-21	212	3	small	small	ADJ
bptjm-21	212	4	molecule	molecule	NOUN
bptjm-21	212	5	disruption	disruption	NOUN
bptjm-21	212	6	of	of	ADP
bptjm-21	212	7	the	the	DET
bptjm-21	212	8	aid	aid	NOUN
bptjm-21	212	9	/	/	SYM
bptjm-21	212	10	rad51	rad51	ADJ
bptjm-21	212	11	axis	axis	NOUN
bptjm-21	212	12	similarlyprotects	similarlyprotect	NOUN
bptjm-21	212	13	nonobese	nonobese	PRON
bptjm-21	212	14	diabetic	diabetic	ADJ
bptjm-21	212	15	mice	mouse	NOUN
bptjm-21	212	16	from	from	ADP
bptjm-21	212	17	type	type	NOUN
bptjm-21	212	18	1	1	NUM
bptjm-21	212	19	diabetes	diabetes	NOUN
bptjm-21	212	20	through	through	ADP
bptjm-21	212	21	expansion	expansion	NOUN
bptjm-21	212	22	of	of	ADP
bptjm-21	212	23	regulatory	regulatory	ADJ
bptjm-21	212	24	b	b	NOUN
bptjm-21	212	25	lymphocytes	lymphocyte	NOUN
bptjm-21	212	26	.	.	PUNCT
bptjm-21	213	1	j	j	PROPN
bptjm-21	213	2	immunol	immunol	NOUN
bptjm-21	213	3	.	.	PUNCT
bptjm-21	214	1	2017;198(11):4255	2017;198(11):4255	NUM
bptjm-21	214	2	-	-	SYM
bptjm-21	214	3	4267	4267	NUM
bptjm-21	214	4	.	.	PUNCT
bptjm-21	215	1	doi:10.4049	doi:10.4049	PROPN
bptjm-21	215	2	/	/	SYM
bptjm-21	215	3	jimmunol.1700024	jimmunol.1700024	PROPN
bptjm-21	215	4	25	25	NUM
bptjm-21	215	5	.	.	PUNCT
bptjm-21	216	1	sanchez	sanchez	PROPN
bptjm-21	216	2	hn	hn	PROPN
bptjm-21	216	3	,	,	PUNCT
bptjm-21	216	4	moroney	moroney	PROPN
bptjm-21	216	5	jb	jb	PROPN
bptjm-21	216	6	,	,	PUNCT
bptjm-21	216	7	gan	gan	PROPN
bptjm-21	216	8	h	h	PROPN
bptjm-21	216	9	,	,	PUNCT
bptjm-21	216	10	et	et	PROPN
bptjm-21	216	11	al	al	PROPN
bptjm-21	216	12	.	.	PUNCT
bptjm-21	217	1	b	b	X
bptjm-21	217	2	cell	cell	NOUN
bptjm-21	217	3	-	-	PUNCT
bptjm-21	217	4	intrinsic	intrinsic	ADJ
bptjm-21	217	5	epigenetic	epigenetic	ADJ
bptjm-21	217	6	modulation	modulation	NOUN
bptjm-21	217	7	of	of	ADP
bptjm-21	217	8	antibody	antibody	NOUN
bptjm-21	217	9	responses	response	NOUN
bptjm-21	217	10	by	by	ADP
bptjm-21	217	11	dietary	dietary	ADJ
bptjm-21	217	12	�	�	NOUN
bptjm-21	217	13	ber	ber	NOUN
bptjm-21	217	14	-	-	PUNCT
bptjm-21	217	15	derived	derive	VERB
bptjm-21	217	16	short	short	ADJ
bptjm-21	217	17	-	-	PUNCT
bptjm-21	217	18	chain	chain	NOUN
bptjm-21	217	19	fatty	fatty	NOUN
bptjm-21	217	20	acids	acid	NOUN
bptjm-21	217	21	.	.	PUNCT
bptjm-21	218	1	nat	nat	PROPN
bptjm-21	218	2	commun	commun	PROPN
bptjm-21	218	3	.	.	PUNCT
bptjm-21	219	1	2020;11(1):60	2020;11(1):60	X
bptjm-21	219	2	.	.	PROPN
bptjm-21	219	3	published	publish	VERB
bptjm-21	219	4	2020	2020	NUM
bptjm-21	219	5	jan	jan	PROPN
bptjm-21	219	6	2	2	NUM
bptjm-21	219	7	.	.	PUNCT
bptjm-21	219	8	doi:10.1038	doi:10.1038	NOUN
bptjm-21	219	9	/	/	SYM
bptjm-21	219	10	s41467	s41467	NOUN
bptjm-21	219	11	-	-	PUNCT
bptjm-21	219	12	019	019	NUM
bptjm-21	219	13	-	-	PUNCT
bptjm-21	219	14	13603	13603	NUM
bptjm-21	219	15	-	-	SYM
bptjm-21	219	16	6	6	NUM
bptjm-21	219	17	26	26	NUM
bptjm-21	219	18	.	.	PUNCT
bptjm-21	220	1	saribasak	saribasak	NOUN
bptjm-21	220	2	h	h	PROPN
bptjm-21	220	3	,	,	PUNCT
bptjm-21	220	4	gearhart	gearhart	PROPN
bptjm-21	220	5	pj	pj	PROPN
bptjm-21	220	6	.	.	PROPN
bptjm-21	221	1	does	do	AUX
bptjm-21	221	2	dna	dna	PROPN
bptjm-21	221	3	repair	repair	NOUN
bptjm-21	221	4	occur	occur	VERB
bptjm-21	221	5	during	during	ADP
bptjm-21	221	6	somatic	somatic	ADJ
bptjm-21	221	7	hypermutation	hypermutation	NOUN
bptjm-21	221	8	?	?	PUNCT
bptjm-21	221	9	.	.	PUNCT
bptjm-21	222	1	semin	semin	PROPN
bptjm-21	222	2	immunol	immunol	PROPN
bptjm-21	222	3	.	.	PUNCT
bptjm-21	223	1	2012;24(4):287	2012;24(4):287	NUM
bptjm-21	223	2	-	-	PUNCT
bptjm-21	223	3	292	292	NUM
bptjm-21	223	4	.	.	PUNCT
bptjm-21	223	5	doi:10.1016	doi:10.1016	PROPN
bptjm-21	223	6	/	/	SYM
bptjm-21	223	7	j.smim.2012.05.002	j.smim.2012.05.002	PROPN
bptjm-21	223	8	27	27	NUM
bptjm-21	223	9	.	.	PUNCT
bptjm-21	224	1	wang	wang	PROPN
bptjm-21	224	2	r	r	PROPN
bptjm-21	224	3	,	,	PUNCT
bptjm-21	224	4	zhang	zhang	PROPN
bptjm-21	224	5	x	x	PROPN
bptjm-21	224	6	,	,	PUNCT
bptjm-21	224	7	ding	ding	NOUN
bptjm-21	224	8	h	h	NOUN
bptjm-21	224	9	,	,	PUNCT
bptjm-21	224	10	et	et	PROPN
bptjm-21	224	11	al	al	PROPN
bptjm-21	224	12	.	.	PROPN
bptjm-21	224	13	aid	aid	NOUN
bptjm-21	224	14	recruits	recruit	VERB
bptjm-21	224	15	the	the	DET
bptjm-21	224	16	rna	rna	PROPN
bptjm-21	224	17	exosome	exosome	NOUN
bptjm-21	224	18	to	to	PART
bptjm-21	224	19	degrade	degrade	VERB
bptjm-21	224	20	hiv-1	hiv-1	ADJ
bptjm-21	224	21	nascent	nascent	ADJ
bptjm-21	224	22	transcripts	transcript	NOUN
bptjm-21	224	23	through	through	ADP
bptjm-21	224	24	interaction	interaction	NOUN
bptjm-21	224	25	with	with	ADP
bptjm-21	224	26	the	the	DET
bptjm-21	224	27	tat	tat	NOUN
bptjm-21	224	28	-	-	PUNCT
bptjm-21	224	29	p	p	NOUN
bptjm-21	224	30	-	-	PUNCT
bptjm-21	224	31	tefb	tefb	NOUN
bptjm-21	224	32	-	-	PUNCT
bptjm-21	224	33	tar	tar	NOUN
bptjm-21	224	34	rnp	rnp	PROPN
bptjm-21	224	35	complex	complex	NOUN
bptjm-21	224	36	.	.	PUNCT
bptjm-21	225	1	febs	febs	PROPN
bptjm-21	225	2	lett	lett	PROPN
bptjm-21	225	3	.	.	PUNCT
bptjm-21	226	1	berkeley	berkeley	PROPN
bptjm-21	226	2	pharma	pharma	PROPN
bptjm-21	226	3	tech	tech	PROPN
bptjm-21	226	4	journal	journal	NOUN
bptjm-21	226	5	of	of	ADP
bptjm-21	226	6	medicine	medicine	NOUN
bptjm-21	226	7	|	|	ADV
bptjm-21	226	8	118	118	NUM
bptjm-21	226	9	2018;592(2):284	2018;592(2):284	NUM
bptjm-21	226	10	-	-	PUNCT
bptjm-21	226	11	294	294	NUM
bptjm-21	226	12	.	.	PUNCT
bptjm-21	227	1	doi:10.1002/1873	doi:10.1002/1873	NOUN
bptjm-21	227	2	-	-	PUNCT
bptjm-21	227	3	3468.12954	3468.12954	NUM
bptjm-21	227	4	28	28	NUM
bptjm-21	227	5	.	.	PUNCT
bptjm-21	228	1	whelton	whelton	PROPN
bptjm-21	228	2	pk	pk	PROPN
bptjm-21	228	3	,	,	PUNCT
bptjm-21	228	4	carey	carey	PROPN
bptjm-21	228	5	rm	rm	PROPN
bptjm-21	228	6	,	,	PUNCT
bptjm-21	228	7	aronow	aronow	PROPN
bptjm-21	228	8	ws	ws	PROPN
bptjm-21	228	9	,	,	PUNCT
bptjm-21	228	10	et	et	PROPN
bptjm-21	228	11	al	al	PROPN
bptjm-21	228	12	.	.	PROPN
bptjm-21	228	13	2017	2017	NUM
bptjm-21	228	14	acc	acc	PROPN
bptjm-21	228	15	/	/	SYM
bptjm-21	228	16	aha	aha	INTJ
bptjm-21	228	17	/	/	SYM
bptjm-21	228	18	aapa	aapa	VERB
bptjm-21	228	19	/	/	SYM
bptjm-21	228	20	abc	abc	PROPN
bptjm-21	228	21	/	/	SYM
bptjm-21	228	22	acpm	acpm	NOUN
bptjm-21	228	23	/	/	SYM
bptjm-21	228	24	ags	ag	NOUN
bptjm-21	228	25	/	/	SYM
bptjm-21	228	26	ap	ap	PROPN
bptjm-21	228	27	ha	ha	INTJ
bptjm-21	228	28	/	/	SYM
bptjm-21	228	29	ash	ash	NOUN
bptjm-21	228	30	/	/	SYM
bptjm-21	228	31	aspc	aspc	NOUN
bptjm-21	228	32	/	/	SYM
bptjm-21	228	33	nma	nma	PROPN
bptjm-21	228	34	/	/	SYM
bptjm-21	228	35	pcna	pcna	PROPN
bptjm-21	228	36	guideline	guideline	NOUN
bptjm-21	228	37	for	for	ADP
bptjm-21	228	38	the	the	DET
bptjm-21	228	39	prevention	prevention	NOUN
bptjm-21	228	40	,	,	PUNCT
bptjm-21	228	41	detection	detection	NOUN
bptjm-21	228	42	,	,	PUNCT
bptjm-21	228	43	evaluation	evaluation	NOUN
bptjm-21	228	44	,	,	PUNCT
bptjm-21	228	45	and	and	CCONJ
bptjm-21	228	46	management	management	NOUN
bptjm-21	228	47	of	of	ADP
bptjm-21	228	48	high	high	ADJ
bptjm-21	228	49	blood	blood	NOUN
bptjm-21	228	50	pressure	pressure	NOUN
bptjm-21	228	51	in	in	ADP
bptjm-21	228	52	adults	adult	NOUN
bptjm-21	228	53	:	:	PUNCT
bptjm-21	228	54	executive	executive	ADJ
bptjm-21	228	55	summary	summary	NOUN
bptjm-21	228	56	:	:	PUNCT
bptjm-21	228	57	a	a	DET
bptjm-21	228	58	report	report	NOUN
bptjm-21	228	59	of	of	ADP
bptjm-21	228	60	the	the	DET
bptjm-21	228	61	american	american	PROPN
bptjm-21	228	62	college	college	PROPN
bptjm-21	228	63	of	of	ADP
bptjm-21	228	64	cardiology	cardiology	NOUN
bptjm-21	228	65	/	/	SYM
bptjm-21	228	66	american	american	PROPN
bptjm-21	228	67	heart	heart	PROPN
bptjm-21	228	68	association	association	PROPN
bptjm-21	228	69	task	task	NOUN
bptjm-21	228	70	force	force	NOUN
bptjm-21	228	71	on	on	ADP
bptjm-21	228	72	clinical	clinical	ADJ
bptjm-21	228	73	practice	practice	NOUN
bptjm-21	228	74	guidelines	guideline	NOUN
bptjm-21	228	75	[	[	X
bptjm-21	228	76	published	publish	VERB
bptjm-21	228	77	correction	correction	NOUN
bptjm-21	228	78	appears	appear	VERB
bptjm-21	228	79	in	in	ADP
bptjm-21	228	80	hypertension	hypertension	NOUN
bptjm-21	228	81	.	.	PUNCT
bptjm-21	229	1	2018	2018	NUM
bptjm-21	229	2	jun;71(6):e136	jun;71(6):e136	PROPN
bptjm-21	229	3	-	-	PUNCT
bptjm-21	229	4	e139	e139	PROPN
bptjm-21	229	5	]	]	X
bptjm-21	230	1	[	[	X
bptjm-21	230	2	published	publish	VERB
bptjm-21	230	3	correction	correction	NOUN
bptjm-21	230	4	appears	appear	VERB
bptjm-21	230	5	in	in	ADP
bptjm-21	230	6	hypertension	hypertension	NOUN
bptjm-21	230	7	.	.	PUNCT
bptjm-21	231	1	2018	2018	NUM
bptjm-21	231	2	sep;72(3):e33	sep;72(3):e33	NOUN
bptjm-21	231	3	]	]	PUNCT
bptjm-21	231	4	.	.	PUNCT
bptjm-21	232	1	hypertension	hypertension	NOUN
bptjm-21	232	2	.	.	PUNCT
bptjm-21	233	1	2018;71(6):1269	2018;71(6):1269	NUM
bptjm-21	233	2	-	-	SYM
bptjm-21	233	3	1324	1324	NUM
bptjm-21	233	4	.	.	PUNCT
bptjm-21	234	1	doi:10.1161	doi:10.1161	ADJ
bptjm-21	234	2	/	/	SYM
bptjm-21	234	3	hyp.0000000000000066	hyp.0000000000000066	PROPN
bptjm-21	234	4	28	28	NUM
bptjm-21	234	5	.	.	PUNCT
bptjm-21	235	1	white	white	PROPN
bptjm-21	235	2	ca	ca	PROPN
bptjm-21	235	3	,	,	PUNCT
bptjm-21	235	4	pone	pone	PROPN
bptjm-21	235	5	ej	ej	PROPN
bptjm-21	235	6	,	,	PUNCT
bptjm-21	235	7	lam	lam	PROPN
bptjm-21	235	8	t	t	PROPN
bptjm-21	235	9	,	,	PUNCT
bptjm-21	235	10	et	et	PROPN
bptjm-21	235	11	al	al	PROPN
bptjm-21	235	12	.	.	PUNCT
bptjm-21	236	1	histone	histone	NOUN
bptjm-21	236	2	deacetylase	deacetylase	VERB
bptjm-21	236	3	inhibitors	inhibitor	NOUN
bptjm-21	236	4	upregulate	upregulate	VERB
bptjm-21	236	5	b	b	NOUN
bptjm-21	236	6	cell	cell	NOUN
bptjm-21	236	7	micrornas	microrna	NOUN
bptjm-21	236	8	that	that	PRON
bptjm-21	236	9	silence	silence	NOUN
bptjm-21	236	10	aid	aid	NOUN
bptjm-21	236	11	and	and	CCONJ
bptjm-21	236	12	blimp-1	blimp-1	NUM
bptjm-21	236	13	expression	expression	NOUN
bptjm-21	236	14	for	for	ADP
bptjm-21	236	15	epigenetic	epigenetic	ADJ
bptjm-21	236	16	modulation	modulation	NOUN
bptjm-21	236	17	of	of	ADP
bptjm-21	236	18	antibody	antibody	NOUN
bptjm-21	236	19	and	and	CCONJ
bptjm-21	236	20	autoantibody	autoantibody	ADJ
bptjm-21	236	21	responses	response	NOUN
bptjm-21	236	22	.	.	PUNCT
bptjm-21	237	1	j	j	PROPN
bptjm-21	237	2	immunol.2014;193(12):5933	immunol.2014;193(12):5933	NOUN
bptjm-21	237	3	-	-	PUNCT
bptjm-21	237	4	5950	5950	NUM
bptjm-21	237	5	.	.	PUNCT
bptjm-21	238	1	doi:10.4049	doi:10.4049	PROPN
bptjm-21	238	2	/	/	SYM
bptjm-21	238	3	jimmunol.1401702	jimmunol.1401702	PROPN
bptjm-21	238	4	29	29	NUM
bptjm-21	238	5	.	.	PUNCT
bptjm-21	239	1	yamanaka	yamanaka	PROPN
bptjm-21	239	2	s	s	PROPN
bptjm-21	239	3	,	,	PUNCT
bptjm-21	239	4	blau	blau	PROPN
bptjm-21	239	5	hm	hm	INTJ
bptjm-21	239	6	.	.	PUNCT
bptjm-21	240	1	nuclear	nuclear	ADJ
bptjm-21	240	2	reprogramming	reprogramme	VERB
bptjm-21	240	3	to	to	ADP
bptjm-21	240	4	a	a	DET
bptjm-21	240	5	pluripotent	pluripotent	ADJ
bptjm-21	240	6	state	state	NOUN
bptjm-21	240	7	by	by	ADP
bptjm-21	240	8	three	three	NUM
bptjm-21	240	9	approaches	approach	NOUN
bptjm-21	240	10	.	.	PUNCT
bptjm-21	241	1	nature	nature	NOUN
bptjm-21	241	2	.	.	PUNCT
bptjm-21	242	1	2010;465(7299):704	2010;465(7299):704	NUM
bptjm-21	242	2	-	-	SYM
bptjm-21	242	3	712	712	NUM
bptjm-21	242	4	.	.	PUNCT
bptjm-21	242	5	doi:10.1038	doi:10.1038	NOUN
bptjm-21	242	6	/	/	SYM
bptjm-21	242	7	nature09229	nature09229	PROPN
bptjm-21	242	8	30	30	NUM
bptjm-21	242	9	.	.	PUNCT
bptjm-21	243	1	yewdell	yewdell	PROPN
bptjm-21	243	2	wt	wt	PROPN
bptjm-21	243	3	,	,	PUNCT
bptjm-21	243	4	chaudhuri	chaudhuri	PROPN
bptjm-21	243	5	j.	j.	PROPN
bptjm-21	244	1	a	a	DET
bptjm-21	244	2	transcriptional	transcriptional	NOUN
bptjm-21	244	3	serenaid	serenaid	VERB
bptjm-21	244	4	:	:	PUNCT
bptjm-21	244	5	the	the	DET
bptjm-21	244	6	role	role	NOUN
bptjm-21	244	7	of	of	ADP
bptjm-21	244	8	noncoding	noncode	VERB
bptjm-21	244	9	rnas	rna	NOUN
bptjm-21	244	10	in	in	ADP
bptjm-21	244	11	class	class	NOUN
bptjm-21	244	12	switch	switch	NOUN
bptjm-21	244	13	recombination	recombination	NOUN
bptjm-21	244	14	.	.	PUNCT
bptjm-21	245	1	int	int	NOUN
bptjm-21	245	2	immunol	immunol	NOUN
bptjm-21	245	3	.	.	PUNCT
bptjm-21	246	1	2017;29(4):183	2017;29(4):183	NUM
bptjm-21	246	2	-	-	SYM
bptjm-21	246	3	196	196	NUM
bptjm-21	246	4	.	.	PUNCT
bptjm-21	247	1	doi:10.1093	doi:10.1093	NOUN
bptjm-21	247	2	/	/	SYM
bptjm-21	247	3	intimm	intimm	PROPN
bptjm-21	247	4	/	/	SYM
bptjm-21	247	5	dxx027	dxx027	PROPN
bptjm-21	247	6	31	31	NUM
bptjm-21	247	7	.	.	PUNCT
bptjm-21	248	1	yu	yu	PROPN
bptjm-21	249	1	k	k	PROPN
bptjm-21	249	2	,	,	PUNCT
bptjm-21	249	3	lieber	lieber	PROPN
bptjm-21	249	4	mr	mr	PROPN
bptjm-21	249	5	.	.	PROPN
bptjm-21	249	6	current	current	ADJ
bptjm-21	249	7	insights	insight	NOUN
bptjm-21	249	8	into	into	ADP
bptjm-21	249	9	the	the	DET
bptjm-21	249	10	mechanism	mechanism	NOUN
bptjm-21	249	11	of	of	ADP
bptjm-21	249	12	mammalian	mammalian	ADJ
bptjm-21	249	13	immunoglobulin	immunoglobulin	NOUN
bptjm-21	249	14	class	class	NOUN
bptjm-21	249	15	switch	switch	NOUN
bptjm-21	249	16	recombination	recombination	NOUN
bptjm-21	249	17	.	.	PUNCT
bptjm-21	250	1	crit	crit	PROPN
bptjm-21	250	2	rev	rev	PROPN
bptjm-21	250	3	biochem	biochem	PROPN
bptjm-21	250	4	mol	mol	ADP
bptjm-21	250	5	biol	biol	PROPN
bptjm-21	250	6	.	.	PUNCT
bptjm-21	251	1	2019;54(4):333	2019;54(4):333	NUM
bptjm-21	251	2	-	-	SYM
bptjm-21	251	3	351	351	NUM
bptjm-21	251	4	.	.	PUNCT
bptjm-21	252	1	doi:10.1080/10409238.2019.1659227	doi:10.1080/10409238.2019.1659227	PROPN
bptjm-21	252	2	32	32	NUM
bptjm-21	252	3	.	.	PUNCT
bptjm-21	253	1	zan	zan	PROPN
bptjm-21	253	2	h	h	PROPN
bptjm-21	253	3	,	,	PUNCT
bptjm-21	253	4	casali	casali	VERB
bptjm-21	253	5	p.	p.	NOUN
bptjm-21	253	6	regulation	regulation	NOUN
bptjm-21	253	7	of	of	ADP
bptjm-21	253	8	aicda	aicda	NOUN
bptjm-21	253	9	expression	expression	NOUN
bptjm-21	253	10	and	and	CCONJ
bptjm-21	253	11	aid	aid	NOUN
bptjm-21	253	12	activity	activity	NOUN
bptjm-21	253	13	.	.	PUNCT
bptjm-21	254	1	autoimmunity	autoimmunity	NOUN
bptjm-21	254	2	.	.	PUNCT
bptjm-21	255	1	2013;46(2):83	2013;46(2):83	NUM
bptjm-21	255	2	-	-	SYM
bptjm-21	255	3	101	101	NUM
bptjm-21	255	4	.	.	PUNCT
bptjm-21	256	1	doi:10.3109/08916934.2012.749244	doi:10.3109/08916934.2012.749244	PROPN
bptjm-21	256	2	33	33	NUM
bptjm-21	256	3	.	.	PUNCT
bptjm-21	257	1	zhu	zhu	PROPN
bptjm-21	257	2	j	j	PROPN
bptjm-21	257	3	,	,	PUNCT
bptjm-21	257	4	hay	hay	PROPN
bptjm-21	257	5	an	an	PRON
bptjm-21	257	6	,	,	PUNCT
bptjm-21	257	7	potter	potter	NOUN
bptjm-21	257	8	aa	aa	PROPN
bptjm-21	257	9	,	,	PUNCT
bptjm-21	257	10	et	et	PROPN
bptjm-21	257	11	al	al	PROPN
bptjm-21	257	12	.	.	PROPN
bptjm-21	258	1	abrogated	abrogate	VERB
bptjm-21	258	2	aid	aid	NOUN
bptjm-21	258	3	function	function	NOUN
bptjm-21	258	4	prolongs	prolong	VERB
bptjm-21	258	5	survival	survival	NOUN
bptjm-21	258	6	and	and	CCONJ
bptjm-21	258	7	diminishes	diminish	VERB
bptjm-21	258	8	renal	renal	ADJ
bptjm-21	258	9	pathology	pathology	NOUN
bptjm-21	258	10	in	in	ADP
bptjm-21	258	11	the	the	DET
bptjm-21	258	12	bxsb	bxsb	NOUN
bptjm-21	258	13	mouse	mouse	PROPN
bptjm-21	258	14	model	model	NOUN
bptjm-21	258	15	of	of	ADP
bptjm-21	258	16	systemic	systemic	ADJ
bptjm-21	258	17	lupus	lupus	PROPN
bptjm-21	258	18	erythematosus	erythematosus	PROPN
bptjm-21	258	19	.	.	PUNCT
bptjm-21	259	1	j	j	PROPN
bptjm-21	259	2	immunol	immunol	NOUN
bptjm-21	259	3	.	.	PUNCT
bptjm-21	260	1	2020;204(5):1091	2020;204(5):1091	NUM
bptjm-21	260	2	-	-	SYM
bptjm-21	260	3	1100	1100	NUM
bptjm-21	260	4	.	.	PUNCT
bptjm-21	261	1	doi:10.4049	doi:10.4049	PROPN
bptjm-21	261	2	/	/	SYM
bptjm-21	261	3	jimmunol.1900501	jimmunol.1900501	PROPN
bptjm-21	261	4	berkeley	berkeley	PROPN
bptjm-21	261	5	pharma	pharma	PROPN
bptjm-21	261	6	tech	tech	NOUN
bptjm-21	261	7	journal	journal	NOUN
bptjm-21	261	8	of	of	ADP
bptjm-21	261	9	medicine	medicine	NOUN
bptjm-21	261	10	|	|	ADV
bptjm-21	261	11	119	119	NUM
bptjm-21	261	12	front_page_wojtara_revised_final	front_page_wojtara_revised_final	ADJ
bptjm-21	261	13	wojtara	wojtara	NOUN
bptjm-21	261	14	body	body	NOUN
bptjm-21	261	15	template	template	NOUN
bptjm-21	261	16	wojtara	wojtara	NOUN
bptjm-21	261	17	reference	reference	NOUN
bptjm-21	261	18	template-2	template-2	PRON